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PREFACE
The work described in this thesis formed a 
self-contained study into some of the more fundamental 
aspects of zinc metabolism and was carried out as 
part of a project on the role of zinc in wound healing 
involving the Department of Oral Medicine and 
Pathology, Glasgow Dental Hospital and School, the 
Department of Clinical Physics and Bio-engineering, 
Western Regional Hospital Board and the Departments 
of Dermatology and Nuclear Medicine, Glasgow Royal 
Infirmary. The work was carried out mainly in the 
Department of Oral Medicine and Pathology, Glasgow 
Dental Hospital but also in part in the Department of 
Nuclear Medicine, Glasgow Royal Infirmary.
SUMMARY
Zinc is one of the essential trace elements for man and 
there is now considerable evidence to show that a 
deficiency of zinc is related to the poor wound healing 
found in some patients, particularly those with varicose 
ulcers. Oral zinc therapy has been used successfully 
in the treatment of these patients but as zinc is toxic 
in large doses many workers have regarded it with 
disfavour, particularly since little is known about the 
metabolism of either dietary or therapeutic doses of 
zinc in man. The aim of the present work has therefore 
been to study the manner in. which both trace and 
therapeutic amounts of zinc are transported by plasma to 
the organs and tissues and to relate the uptake and 
clearance of zinc from plasma to that of the various 
tissues.
An initial study was carried out on _in vitro binding 
of zinc to the plasma proteins to compare the results 
obtained using protein separation by electrophoresis on 
cellulose acetate and by chromatography using Sephadex 
gels. Chromatography on Sephadex gels was found to be 
the more suitable method, particularly for study of 
endogenous zinc binding and of the binding of trace 
amounts of I’auiozino administered to subjects in vivo. 
While albumin was found to bind virtually all the zinc 
added to plasma in vitro, the endogenous pattern of zinc 
binding has two main components, albumin and a second 
high molecular weight protein fraction coincident with
^-macroglobulin, which has been shown to be a zinc 
me t alio pro tein by other workers. A study of the 
endogenous zinc distribution in normal subjects shoved 
that approximately one third of the plasma zinc was 
bound to Ot^-macroglobulin and the remaining two thirds 
to albumin.
The variation of binding of a tracer dose of radiozinc 
administered orally to two normal volunteers was studied 
as a function of time. It was found that at peak plasma 
zinc-65 level about 90$ of the zinc-65 was bound to 
albumin but this level dropped during the first 2k hours 
to about 75$, a value approximately equal to the 
endogenous proportion. When intravenous clearance of 
zinc-65 was studied it was found that the major part of 
the zinc-65 disappeared very rapidly from plasma, with 
a half-life of about 20 minutes. As this could be 
related to clearance from the albumin fraction it was 
shown that albumin is a transport protein for zinc.
When the uptake of zinc-65 by liver and muscle was 
compared with the disappearance of zinc from plasma it 
was found that the zinc-65 wao cleared very rapidly into 
the liver during the first 2k hours, at a rate which 
corresponded to the clearance of zinc-65 from the 
albumin fraction. Clearance of zinc-65 in plasma into 
the liver stopped when the fraction of the zinc-65 
bound to O^-macroglobulin reached about one third of the 
total. Uptake by muscle was much slower and evidence
has been produced to show that this is due to transfer 
of zinc from liver to muscle by plasma.
The clearance of a therapeutic dose of zinc from 
plasma was then studied in normal volunteers after an 
oral dose of zinc sulphate. It was found that the 
resultant increase in plasma zinc was bound to both 
O^-macroglobulin and albumin fractions, in some cases 
more than doubling the original amounts bound to the 
proteins. After about 6 hours both albumin and 
0^ ^-macroglobulin zinc levels had dropped significantly, 
in some cases back to the original levels, showing that 
Qi^-macroglobulin aiso a transport protein for zinc.
There are thus two transport proteins for zinc, 
albumin and -macroglobulin, which apparently have 
separate functions in the control and clearance of 
absorbed zinc to the tissues.
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1.1 Zinc Deficiency in Bi.o.lof.i.cal Systems
Zinc is an essential constituent for all forms of 
plant and animal life. Although it only constitutes 
about 0 .005/s of the earth's crust it is present in 
living organisms in higher concentration than several 
elements which are more plentiful. Zinc has been found 
in measurable quantities in all of the human and animal 
tissues so far examined and this fact alone suggests an 
important biological role for the element.
Although Raulin showed that zinc was essential for 
the growth of the organism Aspergillus niger as early as 
1869 (Raulin, 1869) it was not until the 1930s that Todd, 
Elvehjein and Hart showed that the element was also 
necessary for the growth and development of animals.
They showed that when weanling rats were fed a diet in 
which the zinc content was considerably reduced their 
rate of growth was severely restricted compared with 
that of normal controls (Todd et al, 193*0* Subsequent 
work showed that many species of animals, notably pigs 
end cattle, are subject to zinc deficiency and that this 
deficiency is fairly common. It was found that zinc 
deficiency produces a similar group of symptoms in 
virtually all species. Besides retarded growth, these 
include skeletal abnormalities, anorexia, fragile skin 
and poor wound healing, and parakeratosis, a skin 
condition producing scaly, flaking skin which has some 
resemblance to psoriasis.
While the addition of zinc to the soil to combat
zJnc deficiency in crops had been tried and found to 
work in the 1920s the widespread incidence of zinc 
deficiency in plants has been established only in the 
last 20 years. Although the symptoms of zinc deficiency 
are different in different species, these are all 
indicative of stunted growth and altered metabolism.
While the commercial importance of zinc deficiency 
in crops and domestic animals encouraged a large volume 
of work in these fields no evidence of a similar 
deficiency of zinc in humans was found for some time.
It was not until 19&1 that the first evidence of a 
possible zinc deficiency state in man was described by 
Prasad and his co-workers. Groups of adult male 
villagers from Iran and Egypt were discovered who were 
suffering from retarded growth and arrested sexual 
development, accompanied by anaemia and rough 
hyperpigmented skin. These dwarfs were thought to 
be suffering from malnutrition caused by a diet consisting 
almost entirely of wholemeal bread. However, only slow 
improvement in growth occurred when they were given a 
diet containing adequate animal protein. It was found 
that when 27mg zinc (as zinc sulphate) was given daily 
as a dietary supplement a highly significant increase 
in growth rate occurred, together with a dramatic 
onset of sexual maturity (Prasad et al, 1961). While 
it was originally assumed that the zinc deficiency 
syndrome was confined to males, later studies by
hHalsted and his coliRa^yes showed that females could 
also be affected (Halsted ot al , 1972).
The comparatively rare occurrence of the zinc 
deficiency syndrome described by Prasad and his 
colleagues is probably due to the ubiquity of zinc, 
which is normally present in adequate amounts in most 
foods. Balance studies based on analysis of the zinc 
content of normal diets over a considerable period have 
shown that the average dietary zinc intake of an adult 
i.s in the range 10 - 15 mg elemental zinc per day (Osis 
et al, 1972; Schlage and Vortberg, 1972), though
considerable variation from day to day occurs. It has 
been shown that normal adults require a minimum daily 
.intake of approximately 7 mg zinc per day (Engel et al, 
1966; Spencer et al, 1972). Although the average Western 
diet easily provides this amount of zinc it is probable 
that zinc deficiency can occur in countries where the 
supply of animal protein in the diet is inadequate.
It has been shown that although the zinc, levels in 
animal and soyabean protein are approximately the same, 
twice as much zinc is absorbed from the animal protein 
(Forbes and Yohe, i960). Hence zinc deficiency might 
be expected to be associated with malnutrition and 
is thought to be an accompaniment cf conditions such 
as kwashiorkor (Sandstead et al, 1965)*
1.2 Zinc Content of Body Tissues
With the development of sensitive methods for trace
5clement analysis, particularly activation analysis and 
atomic absorption spectrometry, the zinc content of 
many tissues and body .fluids has been accurately 
measured. It is found that zinc is distributed fairly 
uniformly in human tissues, within a range of values of 
about 20 - 400 parts per million (ppm). The highest 
tissue zinc levels are found in the choroid and retina 
of the eye and particularly high values are found in teeth, 
with much higher levels in enamel than in dentine 
(Nixon, 1969)« Liver, kidney and muscle all show 
similar high zinc levels of approximately 100 - 200 ppm 
(Liebscher and Smith, 1968). While the zinc content of 
of skin is fairly low the level in epidermis is high, 
similar to that in liver and muscle (Molokhia and 
Portnoy, 1969)* The zinc content of hair has been found 
to vary according to the zinc status of the subject 
and it has been suggested that this might be useful 
as an indicator of possible zinc deficiency (Reinhold ct 
al, 1966; Strain and Pories, 1966). An analysis of 
the trace element content of several cadavers gave 
values for the total zinc content of the adult body in 
the range 1.0 - 2,4 g (Widdowson et al, 195*1 )•
Plasma zinc levels for normal adults have beer? found 
to be in the range 80 - 1ju j*g / 100 ml plasma (Greaves 
and Boyde, 1967; Halsted and Smith, 1970). Normal 
erythrocytes contain much higher concentrations of zinc, 
from 450 - 800 yt*g / 100 ml whole blood. However 
leucocytes contain an even higher concentration,
6—  1 4approximately 1,-4 x 10 g zinc per cell, a level which 
is comparable with the level of iron in erythrocytes 
(Denres et al, 1961). Zinc in erythrocytes is almost 
entirely associated with the enzyme, carbonic anhydrase 
and leucocyte zinc appears to be firmly bound to a 
protein whose function is as yet undiscovered but has 
been found to contain 0. 3^ > of zinc (lloch and Vallee, 1952) 
which is not readily exchangeable.
1.3 Biochemical Role of Zinc
The fairly uniform distribution of zinc in tissues 
has stimulated much work on the biochemistry of zinc 
compounds. Being high in the electrochemical series zinc 
is a highly electropositive metal and reacts readily to 
form compounds as the cation Zn e The first conclusive 
evidence of a definite biological function for zinc was 
produced in 19^0, when Keilin and Mann isolated carbonic 
anhydrase, an enzyme found to contain approximately 0.37° 
zinc which is necessary for the biological activity of 
the enzyme (Keilin and Mann, 19^0). In the 1950s a 
second zinc-containing enzyme, carboxypeptidase, was 
isolated (Valine and Neurath, 195^)• Subsequent work 
has shown that these and many other enzymes need zinc 
for their biological activity, either as a cofactor or 
as an integral part of the molecule. Among the enzymes 
found to be zinc rnetalloproteins are several aldolases, 
several dehydrogenases and alkaline phosphatase. Many 
other enzymes are activated by the presence of zinc,
7for example, enolase, amino~peptidase and tripeptidaso. 
Convincing evidence has also been produced that zinc 
is necessary for the synthesis of both ribonucleic and 
deoxyribonucleic acids. Wacker and Vallee showed that 
RNA and DNA obtained from diverse sources always 
contained significant amounts of several metals, among 
them zinc ('Wacker and Vallee, 1959) suggesting that some 
metals may be necessary for protein synthesis. Later 
experiments showed that when zinc was removed from rat 
liver DNA synthesis was reduced and that infusion with 
zinc could reverse this process (Fujioka and Liebermann, 
196^). has also been shown that zinc deficiency
affects DNA and protein metabolism in the rat (Williams 
and Chesters, 1970)«
1.b Zinc and Wound Healing
The importance of zinc in such fundamental processes 
as enzyme activity and protein synthesis would suggest 
that even minor reductions in the amount of zinc available 
for these processes could have important consequences.
If zinc is necessary for protein synthesis it is also 
essential for the processes of tissue repair. It has been 
shown, using radioisotopes of zinc, that zinc concentrates 
in healing wounds in rats (Savlov et al, 1962) and
poor wound healing is a prominent feature in zinc- 
deficient animals.
The topical application of zinc compounds to assist 
healing in superficial wounds has been used for over 
two thousand years but interest in the use of systemic
8zinc to accelerate wound healing has only been 
aroused in the last 20 years, as a result of the work 
of Pories and Strain. After initial studies showed that 
oral zinc supplements accelerated the healing rate of 
excised wounds and of thermal burns in otherwise normal 
rats (Strain et al, i960), Pories and his colleagues 
carried out a clinical trial on the effects of such 
supplements on wound healing in patients after 
excision of infected pilonidal sinuses. They found tha i, 
tjie healing time was k6 days for the zinc supplemented 
group and 80 days for the control group. As these 
patients were young, otherwise healthy airmen it was 
concluded that zinc is not only essential for wound 
healing but that the body zinc stores are inadequate 
to provide the amount required for optimal healing 
(Pories et al, 1967)*
The suggestion that, in a majority of cases, oral 
zinc therapy can accelerate wound healing, has resulted 
in a number of studies on the effect of zinc therapy 
on the rate of healing, with conflicting results.
Many workers have felt that adverse effects may be 
caused by prolonged zinc therapy and therefore that in 
cases where healing proceeds normally zinc therapy is 
not justified. However in cases where the patient has 
already been shown to have a wound healing problem, oral 
zinc supplements might be of benefit. Patients with 
chronic varicose ulcers fall into this category and
9many studies have been carried out on the effects of sine 
therapy on patients with chronic leg ulcers, on the whole 
with encouraging results. In a study of 104 patients 
with such ulcers Husain found that the ulcers of patients 
receiving 150 mg zinc daily healed in an average time 
of 32 days, compared with 77 days for the control group 
(Husain, 19^9)* Significant improvement has also been 
found by several other workers (Greaves and Skillen,
1970; Hallbddk and Lanner, 1972), though other studies 
have shown no demonstrable improvement (Myers and Cherry, 
1970; Greaves and Ive, 1972).
The success of zinc in promoting healing in some 
patients with wound healing problems would suggest that 
there is a minority suffering from latent zinc deficiency 
which only shows up-when an excessive demand, is made on 
the zinc stores and that in the majority the zinc stores 
are adequate. Henzel and his associates (Henzel et al, 
1970) found a significantly increased output of zinc 
in urine (zincuria) in patients during weight reduction 
for obesity, after severe burns and following major 
operations. This was paralleled by reduced zinc levels 
in serum, erythrocytes and skin but patients with post­
operative healing problems were found to have wound tiecue 
zinc levels which were approximately half those of patient 
where healing was proceeding normally.
1.5 Altered Zinc Metabolism in Pathological Conditions
Lowr plasma zinc levels have been found in several 
disease states, among them myocardial, infarction, peptic
10
ulcers, pulmonary infections, alcoholic cirrhosis and 
Down’s syndrome (Halsted and Smith, 1970). The decrease 
in plasma level in alcoholic cirrhosis has been found to 
be accompanied by an increase in urinary zinc excretion 
(Vallee et al, 1956). A rise in plasma zinc level is 
found in the acute phase of acute intermittent 
porphyria (Roman, 1969)* It is also generally accepted 
that patients suffering from psoriasis have altered zinc 
metabolism. A large number of patients with severe 
psoriasis are found to have low serum zinc concentrations 
and the zinc level in the psoriatic scales is higher 
than that in normal skin (Voorhees et a l 19^9; Molokhia 
and Portnoy, 1970; Greaves, 1971)• In appearance 
psoriasis is similar to parakeratosis in animals, which 
is cured by zinc therapy, but attempts to treat psoriasis 
using oral zinc therapy have been unsuccessful (Voorhees 
et al, 1969).
In pregnancy significantly lowered plasma zinc 
levels are found, possibly reflecting a demand made on 
the maternal zinc stores by the developing fcetus. A 
similar effect is found in women taking oral contraceptives 
and the fall in zinc level in paralleled by a rise in 
plasma copper level (Johnson, 1961; Halsted and Smith,
1970).
The zinc content of tissue, plasma and urine in 
patients suffering from neoplastic disease has been 
studied by several investigators and while significant
11
differences from normal levels have been found no 
consistent overall pattern has so far emerged (Talbct 
and Ross, 1960; Vallberg et al, 1966; Gydrkey et al,
1967). However a definite and consistent change in 
leucocyte zinc is found in patients with various types 
of leukaemia, where the zinc content of the cells is 
found to be approximately half that in normal 
leucocytes (Dennes et al, 1961)•
1*6 Toxic Effects of Zinc
Zinc, like many other heavy metals, is toxic when 
ingested in large amounts, produced by, for example, 
cooking or storing foods with a high acid content in 
galvanised containers. The symptoms of zinc poisoning 
are described as vomiting, stomach cramp and diarrhoea 
(Brown et al, 1964). However studies in rats have 
shown that the toxic effects are mainly due to 
suppression of other essential elements by the greatly 
increased zinc intake. Reductions in magnesium, copper 
and iron stores and alteration in the calcium to 
phosphorus ratio in bone have been observed (Sutton 
and Nelson, 1937; Sadasivan, 1951» Stewart and Magee,
1964; McCall et al, 1961).
High mineral concentrations in the atmosphere, in 
soil and in watpr supplies have been found in areas 
where cancer incidence is high (Stocks, 1960; 
Allon-Price, 1962) and it has been suggested that higher 
than average levels of zinc absorbed from these sources
12
may bo related to the incidence of stomach cancer 
(Stocks and Davies, 1 9 These results, together with 
the animal studies, would suggest that caution must be 
exercised in the use of oral zinc therapy, particularly 
for long periods.
1.? Dynamic Studies of Zinc Metabolism
The recognition of zinc deficiency states in man 
and the development of efficient means for its correction 
can only be achieved from a basic knowledge of the 
various stages of the metabolic cycle of zinc in the 
body. The use of radioactive isotopes of zinc enables 
valuable information to be obtained on the biological 
fate of zinc in the body, as the variation of radiozinc 
levels in tissues and body fluids can be followed, 
provided suitable samples can be obtained for counting. 
While the bulk of the work published on the absorption 
and clearance of radioactive zinc in vivo has been carried 
out in experimental animals several studies on the 
absorption and excretion of trace amounts of the 
radioisotope, zinc-65, in human subjects have been 
published (Ross et al, 195$; Graig and Seigel,1960;
Prasad et al, 1963; Spencer et al, 1965; Spencer et al, 
1966; Sullivan and Heaney, 197^)- These results are 
mostly confined to measurement of zinc-65 activity in 
blood, urine and faeces.
It was found that intravenously administered zinc-65 
disappeared very rapidly from plasma, 90^ » disappearing
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in less tlian two hours and the remaining 10$> more 
slowly, though it was found that this later clearance 
was significantly faster in zinc-deficient subjects 
(Prasad et al, 1963)* Zinc-65 appeared in erythrocytes 
and leucocytes fairly rapidly, with activity remaining 
in the erythrocyte pool for several hundred days. 
Excretion studies showed that the percentage of the dose 
excreted in the faeces was much higher than that in 
urine, showing that the main pathway for excretion of 
absorbed zinc in man is via the intestine. This level 
is higher than that to be expected from zinc secreted in 
bile and pancreatic juice (Spencer et al, 1965).
Studies on the loss of zinc-65 with time in the 
total body mass have shown that the biological half-life 
of zinc in the body.is of the order of several hundred 
days (Furchner and Richmond, 1962; Spencer et al, 1965; 
Newton and Holmes, 1966). Measurements of tissue levels 
of zinc-65 * obtained post mortem at varying times after 
administration of the dose, showed that initially levels 
were highest in liver but after about 70 days the 
activities in muscle and liver were similar (Spencer et 
al, 1965). In studies of the uptake and clearance of 
orallir sidiuiiixs10 zinc***65 it v/sts 1'ounci tii3.t th© plssnis, 
zinc—65 level reached a peak value at between 1 — 
hours after administration of the dose (Spencer et al, 
1966; Husain and Bessent, 1971 )• Calculation of the 
percentage of the dose absorbed gave values in the range 
20 -  9Ofc.
1^1,S Transport of Zinc By Plasma
While these studies have shown that the major 
portion of the absorbed zinc is rapidly incorporated 
into the tissues from plasma and that it remains in 
the body for a considerable time, little is known about 
the mechanism whereby zinc is shared among the tissues 
or about the subsequent fate of the tissue zinc, whether 
it forms an easily mobilised reservoir of zinc or 
whether it is tightly bound and largely unavailable. 
Information of this kind depends on a knowledge of the 
method by which the plasma zinc level is controlled and 
the different forms in which zinc exists in plasma, 
since the plasma is the medium by which all absorbed 
zinc is transported to and from the tissues. It has 
been shown that homeostatic control is exercised over 
the plasma zinc level, since individual plasma levels, 
studied over a considerable period, show little variation 
from the mean (Halsted and Smith, 1970)» The existence 
of such a control suggests that normal plasma levels 
may occur in cases where the body zinc stores are 
considerably reduced.
Plasma is a heterogeneous solution containing a vast 
number of constituents of widely varying molecular weight 
and complexity, from simple ions to proteins whose 
molecular weight is in excess of one million. Many of 
these substances are in transit to various parts of the 
body or are essential for the transport of other
15
substances. While some essential elements are carried 
to the tissues in the ionic form many minerals are 
transported as a complex of the ion with one or more of 
the plasma proteins, and several of the proteins have no 
other known function apart from the transport of one 
particular substance, for example, transferrin, a globulin 
which transports iron absorbed from the gastro—intestinal 
tract and from the cells of the reticulo-endothelial 
system to the bone marrow. Albumin, a single protein of 
molecular weight 69f000 which forms approximately 70^ of 
the total plasma protein concentration, is involved in 
the transport of a number of substances, both essential 
nutrients and compounds such as drugs, and it is important 
in the transport of several elements, in particular, 
calcium and copper.
While there are measurable amounts of several zinc 
metalloenzyrries in plasma, such as lactic dehydrogenase 
and alkaline phosphatase, the concentrations are so low 
that they account for a negligible fraction of the total 
plasma zinc level. Vikbladh showed that almost all of 
the endogenous zinc in plasma is bound to protein and 
that about one third of the bound zinc was firmly 
bound to protein while the remaining two thirds was 
more loosely bound and probably associated with albumin 
(Vikbladh, 1951)* Later work by Vallee and his colleagues 
demonstrated the existence of several zinc-containing* 
fractions among the plasma proteins. Hitnmelhoch and his 
associates isolated three zinc-containing protein
16
fractions, one of which was found to have a molecular 
weight of approximately 120,000 (Himmelhoch et al, 1066). 
However, Paris! and Valle^e identified only two major 
zinc-containing fractions in serum, one of which was 
identified as albumin and the other was found to be a 
zinc metalloprotein containing- 320 - 770yytg zinc per 
gram of protein which had a molecular weight of about 
800,000. They identified this protein as. G^-macro- 
globulin, a protein which is present in relatively large 
amounts in normal serum but of unknown function (Paris!
✓ X
and Vallee, 1970). They suggested that the transport 
proteins for zinc were albumin and ^-macroglobulin 
and th. rx "fc -macroglobulin was a specific transport 
protein for zinc, analogous to transferrin for iron.
Other workers have used thp radioisotope, zinc-65, 
to study the binding of the zinc-65 to the plasma 
proteins i_n vi tro, on the assumption that this procedure 
is analogous to the uptake by plasma of zinc absorbed 
from the gut. Although all studies report binding of 
the major part of the added zinc to albumin there is 
disagreement about which, if any, of the globulins 
bind zinc (Donnes et al, 1962; Suso and Edwards, 1969, 
Prasad and Oberleas. 1970; Bovett and Sullivan, 1970; 
Parisi and Vallee, 1970).
1.9 Recognition of Zinc Deficiency States in Man
Although zinc has been recognised as an essential 
element for man only within the last decade considerable
17
advances have been made in the elucidation of its 
biological role, notably the discovery of a definite 
zinc deficiency state in man and a significant 
relationship between zinc and healing. However these 
discoveries have themselves raised many fundamental 
questions concerning the utilisation and metabolism 
of the element, which become of particular importance 
with the increasing use of zinc as a therapeutic agent.
The most important clinical problem is the recognition 
of latent zinc deficiency, particularly in patients 
with healing wounds. If zinc deficiency is defined 
as a reduction in the body store of available zinc below 
the level necessary for both normal requirements and 
the needs of such processes as tissue repair then the 
recognition of zinc deficiency requires some means 
of estimating this zinc store. To date no single 
parameter has been found which acts as an indicator 
of zinc deficiency. While some workers have suggested 
that patients who respond to zinc therapy have low 
plasma zinc levels (Hallbddk and Lanner, 1972) it has 
been shown that some patients who benefit from zinc 
therapy have plasma levels which are within the 
accepted normal limits (Husain, i969)* While other 
criteria, such as excessive zincuria or deficiency of 
any of the zinc metalloenzymes, might suggest disordered 
zinc metabolism, so far the only reliable criterion for 
zinc deficiency has been a positive response to zinc 
therapy. As a diagnostic test, this is far from
18
ideal., particularly since zinc has been shown to be 
toxic in large doses and the absorption of large 
amounts of the element is known to cause a reduction in 
the intake of other essential minerals. It would seem, 
therefore, that at present our knowledge of the basic 
processes involved in zinc metabolism are inadequate 
and that much further work is needed in this field 
before recognition of zinc deficiency in routine 
clinical work is possible.
1.10 Alms of the Present Work
The aim of the work described in the following 
chapters was to study certain aspects of the dynamics 
of zinc absorption and transport in man. with particular 
reference to the uptake and clearance of the element by 
the plasma components. Since plasrna is the medium by 
which all absorbed zinc is carried to and from the 
tissues the distribution of zinc among the various 
zinc-containing plasma fractions is of special interest, 
as these fractions may reflect the various stages in 
its metabolism. For example, it is likely that newly 
absorbed zinc is associated with different plasma 
components from breakdown products which are to be excreted 
via the kidneys. In particular the existence of a 
specific transport protein for zinc would imply some 
measure of control by plasma of zinc uptake and clearance. 
It has therefore been the intention in the work 
described to develop a method whereby the main zinc- 
containing plasma fractions can be separated from each
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other and their zinc content measured, as simply as 
is consistent with obtaining repeatable results. This 
method has then been used to study the absorption and 
transport of zinc in vivo, mainly in normal subjects, by 
the various fractions. The distribution in plasma of 
both trace amounts of radiozinc and therapeutic doses 
of stable zinc sulphate have been studied and these 
findings correlated with the uptake and clearance of 
zinc from various parts cf the body. As this work is 
in essence a study of the transport of zinc no attempt 
has been made to study the biochemistry of the zinc- 
containing fractions. The degree of separation of 
the plasma fractions sought has been only sufficient for 
analysis of the main zinc-containing fractions and 
study of the variation of the zinc associated with 
each as a function of time. Where specific proteins 
were studied it was in the role of transport media 
for zinc.
In summary, therefore, the intention of the work 
to be described in the following chapters was:-
(a) To study the distribution of endogenous zinc 
among the components of plasma in man and the variation 
of the amounts of zinc bound to the various fractions as 
a function of time, using both trace quantities of 
radiozinc and therapeutic quantities of stable zinc.
(b) To relate these findings to the absorption and 
clearance of zinc by the various tissues of the body.
CHA' tar 2
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CHAPTER 2
STUDY OF THE IN VITRO BINDING OF ZINC-65 
TO PLASMA, USING SEPARATION BY ELECTROPHORESIS 
ON CELLULOSE ACETATE
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2«1 Introduction
A study of the binding of zinc to plasma in vjtro 
is a. useful preliminary to in vivo studies. Addition of 
the element to plasma in vitro allows the binding of 
accurately measured quantities of both zinc and plasma 
to be studied, unaffected by the many variations 
introduced by the jln vivo situation and hence the 
binding capacity of the various plasma components car. 
be investigated in a way which would be impossible 
in vivo. Also it seems reasonable to suppose that, 
provided zinc binding is a passive process unaffected by 
factors external to the plasma, the binding pattern of 
zinc added to plasma in vi tro will be the same as that 
of zinc newly absorbed into plasma from the gast.ro- 
intestinal tract and this metho.d therefore provides a 
simple method of studying the first stage of binding 
in vivo.
The most convenient way of studying the binding 
of added zinc is by the use of a radioactive isotope 
of zinc as a tracer and of the two radioisotopes of 
zinc (see Appendix i), zinc-65 has been used almost 
exclusively in metabolic studies to date. Several 
studies have been published on the binding of zinc-65 
added to plasma in vi tro and while there is general 
agreement that zinc is almost totally bound by the 
plasma proteins and that the major part is bound to 
albumin, there is some disagreement as to whether
22
the globulin traction binds added zinc and, if so, 
which globulins are involved (Dennes et al, 1962;
Suso and Edwards, 1969; Boyett and Sullivan, 1970?
/  V
Prasad and Cberleas, 1970; Parisi and Vallee, 1970).
In these studies the amounts of total zinc (stable 
zinc plus zinc-65) added to the samples of serum and 
plasma vary greatly. Some authors do not specify the 
actual amounts of zinc added in their radioactive 
solutions while others have added amounts which are at 
least equal to that already present in the plasma or 
serum sample.
The aim of the work described below was specifically 
to study the effect of adding increasing amounts of zinc 
(from 0.5 to 1000^ of the endogenous plasma level) on the 
zinc binding pattern. Electrophoresis on cellulose 
acetate strips was chosen as the method of separation 
because it divides the proteins into the classic 
grouping of albumin, 0^ -, and Y-globulins and
provides an inert support medium which is easily stained 
or cut into fractions for counting. High specific 
activity zinc-65 chloride solution was used to enable 
small amounts of total zinc to be added to plasma while 
still retaining adequate zinc—65 activity. Human 
scrum albumin labelled with iodine-131 has been used 
as a marker for the distribution of albumin along 
the strips. Also, since it has been suggested that 
the iron-binding globulin, transferrin, might be
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actively involved in the transport of zinc as well as 
iron (Dennes et a l, 19b2; T3oyett and Sullivan, 1970)
radioiron (iron-59) has been used to label the 
transferrin in plasma and this distribution compared 
with that obtained from zinc-65 added to the same 
sample.
Since in the in vivo situation competition for zinc 
by the plasma proteins occurs in a solution containing 
a. considerable quantity of low molecular weight compounds 
dialysis of the plasma to remove this material prior 
to addition of the zinc limits binding to the proteins. 
However, as the low molecular weight components of 
plasma might not only bind zinc themselves but also 
affect protein binding, the zinc has been added to 
the physiological solution without prior dialysis. 
Dialysis has only been carried out to study the 
proportion of the added zinc which binds to the low 
molecular weight fraction and to determine whether 
the protein-bound zinc is removable by this method.
2.2 Materials and Methods
The zinc-65 was obtained as the chloride in 0.1N 
hydrochloric acid and was diluted to a concentration 
of 100 /xg / ml. Since the specific activity of the
9 i
solution was originally about 100 mCi / mg the diluted 
solution had an activity of 100 ^ xC±./ ml. Since zinc 
chloride tends to precipitate from a neutral solution 
no attempt was made to adjust the pH of the diluted
2 k
solution. Iron-59 as ferric chloride was obtained as 
a solution of specific activity approximately 10 mCi / ml 
and was diluted to a concentration of 1 mg iron per ml
All samples were diluted using double-distilled deionised
All radioactive solutions were obtained from the 
Radiochemical Centre, Amersham.
Plasma samples were obtained from five normal
volunteers, age 25 - 35 and from one patient suffering
from suspected Crohn's disease with associated plasma
protein abnormalities. Venous blood samples were
withdrawn using a disposable syringe and needle and the
samples transferred to vials containing lithium heparin.
The lithium salt of EDTA, lithium sequestrene, is the
anticoagulant usually used for stable zinc measurements
but since it is a powerful chelating agent it was
unsuitable for use in this study. To compare the
plasma zinc levels obtained using containers treated
with heparin and with sequestrene, equal volumes of the
same blood sample were placed in one container
of each type and the samples centrifuged. #The plasma
/
from each was then withdrawn into untreated sterile 
plastic vials. The zinc content of each was measured 
and the values obtained were the same, within the limits 
of experimental error. Blood samples were centrifuged
Human serum albumin labelled with
iodine-131 was diluted to a concentration of 50 juCi / ml
water whose measured zinc content was ^ 2 jjLg / 1 00 ml
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and aliquots of the plasma samples of the required 
volume were transferred to sterile disposable plastic 
vials. Solutions of stable zinc were made up using 
AnalaR grade zinc in hydrochloric acid, diluted to 
the required concentration using double-distilled 
deionised water. Any necessary adjustment of pH 
was made with hydrochloric acid. The zinc solutions 
were added to the plasma samples slowly using a 
disposable polypropylene syringe and a stainless 
steel needle. The samples were incubated for 10 minutes 
at 37°C before separation.
Pure dried human albumin and transferrin 
(Behringwerke, Ltd.) and dried (^-globulins, designated 
Cohn Fraction XV (Miles Laboratories, Inc.) were used 
to increase the natural plasma levels of these proteins 
in some samples.- The required amounts were either 
dissolved in isotonic saline and added to the plasma 
or usually, dissolved directly in the plasma samples.
Electrophoresis was carried out on 2.5 cm x 12 cm 
cellulose acetate strips using a barbitone / sodium 
barbitone buffer. After separation the strips were 
either cut into 2 mm sections along the length of the 
strip or cut along the divisions between the protein 
fractions. The techniques used for electrophoresis 
and for preparation of the cellulose acetate strips 
for counting are described in Appendix II. To reduce 
contamination the electrophoresis apparatus and all
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glassware were soaked in a solution of 50 ml Decon-90 
(Decon Laboratories Ltd) per litre of double-distilled 
deionised water for two hours and washed three times in 
double-distilled deionised water before use. All 
solutions used were made up using Analar grade chemicals 
where possible and in double-distilled deionised water.
Dia3-ysis was carried out using Visking dialysis 
tubing at a temperature of Metal contamination
in the tubing was removed by boiling the cut lengths 
in a 10'-o solution of di-sodium EDTA for 10 minutes, 
washing twice in double-distilled deionised water and 
then boiling for 10 minutes in water. Plasma was 
used in most of the experiments, but, because of the 
fact that heparin’s anticoagulant properties last for 
only a short time serum was used for all dialysis 
experiments.
2*3 Measurement of Zinc Binding to the Low Molecular 
Weight Fraction in Plasma
Zinc-65 chloride solution (2 i) was added to 2 ml 
normal serum and the sample diluted to 5 with 
isotonic saline. The resultant solution was dialysed 
against 500 ml isotonic saline at 4°C for 18 hours.
Two yuCi zinc-65 chloride in 5 ml isotonic saline was 
dialysed against 500 ml isotonic saline at the same 
time. The activity of 2 ml of the dialysate was 
measured in each case and the total activity lost from 
the samples calculated.
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Percentage activity lost by 
zinc-6*5 chloride in saline
Percentage activity lost
by serum %
Therefore, assigning the same rate of dialysis
from both samples
i
Total dialysable activity in
serum 2 x 100 
=58
5.2#
Dialysis can only provide information about the 
low molecular weight compounds as a whole and gives no 
information on the amount of unbound zinc ions existing 
in the sample. Since zinc is a positively charged 
cation excess zinc should separate from the plasma 
proteins on electrophoresis, since they move towards 
the anode, and thus enable an estimate of the free zinc 
to be made. However, when zinc-65 chloride solution 
was added to an equal volume of the barbitone buffer 
and a sample of the solution separated using electrophoresis 
in the buffer solution it was found that the activity 
concentrated in a band towards the anode side of the 
origin, indicating formation of a compound of zinc 
which acquired a net negative charge on applying an 
electric field. The position of this compound was 
approximately midway between the albumin and 
globulin fractions of the plasma proteins. To check, 
therefore, whether any ionic zinc was present in the
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active plasma, 5/>i samples were run using isctonic 
saline as the electrolyte. Although the solution was 
not buffered, stained strips showed that the proteins 
had migrated towards the anode, while the activity of 
a zinc-65 chloride-saline solution was found, as 
expected, at the cathode side of the origin. The mean 
activity of the (unstained) areas containing the 
proteins from a number of strips was compared with the 
mean activity of several 5 /Al samples of the radioactive 
plasma. The values were found to be the same and no 
measurable activity was detected at the cathode side 
of the origin. Since all the added zinc appeared to 
have been bound by the plasma constituents it was 
decided that barbitone buffer could be used in further 
experiments to take advantage of the sharper separation 
obtainable.
2.4 Binding Pattern of Zinc to the Protein Fractions 
An aliquot of 10 yt*-Ci zinc-65 solution in 0. 1 ml 
(0. 1^g zinc) was added to 1 ml plasma. The endogenous 
plasma zinc level was 9 8 / 100 ml and the amount added 
therefore amounted to about lOfo of the total plasma 
zinc level. 5 plasma samples were then separated 
using barbitone buffer and each strip cut into 2 mm 
sections as described in Appendix II. The zinc-65 
activity of each 2 mm strip was plotted against 
distance from the origin, giving the distribution shown 
in Fig. 1, with a large peak coincident with the
albumin fraction and a socond smaller peak apparently 
coincident with the ct^-globulirts. To enable the 
position of this second peak to be assessed more 
accurately, human serum albumin labelled with iodine-131 
was used to outline the distribution of the zinc-65 bound 
to albumin and hence the distribution of the remaining 
activity by subtraction. Fig. 2 shows the distributions 
of both iodine-131 and zinc-65 activities, obtained 
from plasma samples containing both 15 y^Ci zinc-65 and 
10yu.Ci iodine-131 per ml of plasma. It can be seen 
that the mobilities of the iodine-131“ and of the zinc-65 
labelled albumin are in fact measurably different. 
However, though transposed slightly, the zinc-65 curve 
follows the iodine-131 curve well enough to use the 
iodine-131 distribution to calculate the tail of the 
curve of the albumin-bound zinc-65* When this 
distribution is subtracted it leaves a single peak 
coincident with the Ot^-globulins , as shown in Fig. 2.
Solutions of zinc-65 were added to plasma, taken 
from the same subject each time, in amounts such that 
the total quantity of added zinc ranged from 0.5 /*g 
to 1 mg per 100 ml plasma. This covered the range of 
from 0.5 to 1000fs of the endogenous plasma level for 
this subject (98 /*g / 100 ml plasma). 5 J&- samples 
were separated and the distribution of radioactivity 
against distance migrated plotted in each case. In 
all samples studied the distribution gave two peaks
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coincident with the albumin and obulin regions,
A*
though the relative height of the two peaks varied 
with the amount of added zinc. Serum samples containing 
added zinc-65 also gave distributions of zinc-65 
activity having two peaks in the albumin and 
globul.in regions.
5 J* 1 samples of radioactive plasrna containing 20 
added zinc were separated and the strips dried and 
fixed to sheets of X-ray film. The films were left 
in the dark for five days and then developed. Fig,3 
shows one of the autoradiographs obtained, together with 
a stained strip from 5 A-1 plasma without added zinc-65, 
separated at the same time; It can be seen that only 
two bands, coincident with the albumin and ©Cp-globulin 
fractions appear on the autoradiograph.
2.5 Quantitation of Zinc binding in Plasma
Since the method used in this study detects 
binding only in the albumin and Ot^-globulin regions the 
ratio of the area under the albumin peak to that under 
the Ot -globulin peak was used .to quantitate the partition 
of zinc between the protein fractions, for various levels 
of added zinc. The distribution of zinc-65 activity 
was plotted as above and the distribution of iodine-1 31- 
labolled albumin used to estimate the tail of the 
distribution of albumin-bound zinc-65» The total area 
under the albumin peak was then subtracted from the 
total zinc—65 activity to give the area under the 
second peak. Table 1 shows the ratios obtained
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from at least 10 different separations made on plasma 
samples, for 10^ and 25/» added zinc ( l O a n d  25 J**g 
per 100 ml plasma)taken from the same donor but at 
different times. It can be seen that though there is 
considerable variation among the individual values, the 
means do not differ significantly.
Since the separation obtained using electrophoresis 
is highly dependent on such factors as buffer composition, 
ambient temperature and plasma composition, the 
.following method was used to eliminate variation 
introduced by differing experimental conditions, when 
comparing the ratios obtained on addition of 0.5^» 10^,
10O^ b and 1000% of the endogenous plasma zinc level. 
Solutions of zinc-65 were prepared containing the 
required amount of total zinc in 0.1 ml solution, each 
solution having the same pH. 0.1 ml of each solution 
was added to 1 ml aliquots of the same plasma sample 
and samples from the four aliquots were run
together in the same tank, six runs being made in all. 
Since it had already been shown that measurable binding 
occurred only to albumin and the Ot^-globul ins, the 
ratios of albumin— to globulin— bound zinc—65 activities 
should be the same as those for albumin and the
globulins throughout the range. The 5 samples 
were separated so that the maximum separation of albumin 
from globulins was achieved. The activity in each 
fraction was measured and the albumin/globulin zinc-65 
ratios calculated. The results are shown in Table 2.
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They show an increase in albumin/globulin ratio with 
increasing- amount of added zinc. The probability that 
the differences in the mean albumin/globulin ratio for 
each of the distributions occurred by chance was 
calculated using the Student-t test. While differences 
between adjacent individual distribution have varying 
significance, the increase is found consistently 
throughout the whole range.
The binding patterns for zinc-65 for plasma samples 
from different normal donors were compared as follows,
20 yu.Ci zinc-65 solution (equivalent to 20yU»g / 100 ml 
plasma) was added to 1 ml plasma from each of five 
donors and the binding patterns studied. These were all 
found to have the general form of Fig. 1. Since it was 
not possible to run all five samples in the tank at once 
they were compared in groups of two, using four 5 
samples from each aliquot per run, and making every 
attempt to keep the conditions of electrophoresis the 
same throughout. The results are shown in Table 3.
Plasma zinc levels were in the range 85 - 160y*g / 100 ml 
plasma and none of the subjects had evidence of 
pathological conditions which might cause altered zinc 
metabolism. No significant difference could be 
detected between any of the distributions of added 
zinc-65, measured using the albumin/ot ^ -globulin ratios.
2.6 Relationship between Zinc Binding and Protein 
Concentration in Plasma
Since it has been shown that there are two
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distinct fractions which bind zinc and which can be 
separated by electrophoresis it would seem reasonable 
to expect that there will be a relationship between 
the amounts of protein present in each fraction and the 
amount of zinc bound by each of them. To tost this 
assumption the protein concentration of the plasma was 
altered by addition of known amounts of specific protein 
fractions and the binding pattern of zinc-65 added to the 
modified plasma compared with that of the original. This 
approaches the in vivo situation more closely than 
adding zinc-65 to the individual proteins in solution.
The albumin content of one sample was measured and 
an amount of dried human albumin equal to that already 
present in the plasma was dissolved in the sample (thus 
doubling the normal albumin level). 10y{/*Ci zinc-65 
solution was added to 1 ml of this solution and to 1 ml 
of the untreated plasma. Four 5/*l samples of each 
solution were run together as described above. The strips 
were stained using ninhydrin (Appendix II) and cut into 
albumin and globulin fractions. The ratio of albumin / 
globulin zinc-65 activities was then found for each strip 
and the mean values calculated. The ratios were found 
to be (1.73 _+ 0.20) for the untreated plasma and 
(3.20 + 0.08) for the sample containing tv/ice the normal 
level of albumin, an increase of approximately a 
factor of two, suggesting that for albumin the amount of 
zinc bound is proportional to the quantity of the
3^
protein present.
Since the CC2 —globulin fraction is heterogeneous, 
this group could contain one or more proteins capable 
of binding zinc (for the purpose of the present study 
albumin has been considered as a homogeneous fraction). 
Hence it is necessary to increase the O^-globulin 
fraction as a whole, rather than using a single protein. 
This was done in an approximate way by assuming a normal 
total Ot-globuli.n level of 800 mg / 100 m.1 in the plasma 
sample and adding this: concentration to 1 ml plasma and 
thus approximately doubling the quantity of CC-globulins 
in the sample. Since the added protein contains 
appreciable amounts of the other fractions, particularly 
albumin, the ratios obtained do not accurately reflect 
the change in protein concentration. However, when 
10/*C i. of zinc-65 was added to each 1 ml sample (modified 
and original plasma) and the mean albumin/globulin zinc—up 
ratio calculated for eight 5 samples, values of 
(2.8 ±0,7) for the normal plasma and (2.0 0.5) for the
plasma containing the additional oC-globulins were 
obtained, showing a significant increase in binding to 
the 0^-gl obulins when the tf— gl obulin level was 
increased.
To test the hypothesis that transferrin is a 
transport protein for zinc as well as for iron (Dennes 
et al, 1962; Boyett and Sullivan, 1970), zinc-65 and 
iron-59 were added to the same plasma sample. The amount
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of ii-on added was chosen so that the total iron- 
binding capacity was not exceeded and hence all the 
iron added would bind to transferrin, producing a 
single peak in the ft^-globulin region. 10yt/»Ci zinc-65
samples separated. The cellulose acetate strips were 
cut into 2 mm sections and the activities of each 
isotope plotted, giving the graph of Fig. k. This shows 
that at normal levels the binding of zinc to transferrin 
is too small to be measured using this technique and is 
negligible compared with the binding to the other 
fractions. The experiment was repeated using plasma 
from a second normal donor and similar results were 
obtained. However when the transferrin level of one 
Pi asma sample was raised to approximately four times 
the endogenous level (by dissolving the required amount 
of the dried protein in the plasma) and 10 ^u.Ci zinc-65 
added to 1 ml plasma, measurable binding in the 
|3-globulin region was obtained.
One plasma sample was obtained from a patient with 
severe malabsorption thought to be due to Crohn’s 
disease and whose plasma protein levels were grossly 
abnormal. The binding pattern of zinc-65 to the 
plasma was studied and it was found that the pattern 
was noticeably different from the normal one, with 
a measurable peak in the -globulin region, besides the 
albumin and Ol^-globulin peaks found in healthy subjects.
and 5 yU-0i iron-59 were added to 1 ml plasma and
3 6
2.7 Effect of Dialysis on Prot.oin-Bound Zinc in Serum,
containing no active material over a period of two 
weeks showed that zinc-65 was lost continuously through 
the membrane. Electrophoresis of samples of the active 
serum before and after dialysis and of the originally
was distributed as in Fig. 1 in each caise. 0.25y^Ci 
zinc-65 was added to 1.5 nil serum and the active serum 
dialysed against 2.5 ml of the same serum for five
sample and dialysed against 2.5 ml serum under 
identical conditions. The activity of the originally 
inactive serum sampi.es was measured at intervals during 
this period and the gain of activity plotted against 
time for each sample, shown in Fig. 5« While no 
activity was gained from the sample containing iron-59 
the zinc-65 was gradually lost from the other sample, 
suggesting a weaker binding of zinc to both protein 
fractions compared with the strong binding of iron 
to transferrin.
2.8 Discus sion
The present study has shown binding of added zinc 
to two protein fractions, albumin and the 0^-globulins, 
when the proteins are separated using electrophoresis 
cn cellulose acetate strips. Only those two fractions
Dialysis of 1 ml serum cont * ~ ‘ zinc-65
(0.02 added zinc) against 2 ml of the same serum
inactive serum after dialysis showed that the zinc
days added to a second 1«5 ml
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bound measurable quantities of zinc, even when the 
amount of added zinc was ten times the normal level in 
plasma, suggesting that the capacity of the plasma 
proteins for zinc ions is very high, and unlikely to 
be exceeded even by therapeutic doses of zinc.
Although only albumin and the O^-globulins bind measurable 
amounts of the added zinc in a range of from 0.5 - 1000$ 
of the normal level, the relative amounts bound to each 
vary with the amount of zinc added, from almost equal 
partition between the two fractions at the lower end of 
the range to almost two thirds binding to albumin at the 
upper end. This ratio is also dependent on the amounts 
of each protein present in the sample, though the 
variations in the plasma protein levels found in normal 
subjects were presumably too small to affect, the ratio, 
since no difference in the ratios obtained from a group 
of normal subjects could be detected. However in one 
case where the plasma protein distribution was grossly 
abnormal a difference in zinc binding was detected,
The binding of zinc to two fractions, demonstrated 
using protein separation by electrophoresis on cellulose 
acetate, is consistent with the results of other studies 
which’ have used various forms of electrophoresis, all 
of which have shown binding to both albumin and to the 
globulins, the greatest affinity for zinc being shown 
by the cL — globulins (Dennes et al, 1962; Prasad and 
Oberleas, 1970, Boyett and Sullivan, 1970).
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The degree of separation achievable by electrophoresis 
is dependent on the support medium used and greater 
separation of the proteins can be obtained using support 
media such as starch and acrylamide gels which combine 
electrophoretic separation with molecular sieve effects. 
Dennes, Tupper and Vormall used filter paper as the 
support medium in their study of binding of zinc-65 to 
the plasma proteins in both rabbits and in human plasma 
in vitro. They showed that, when zinc-65 was added to 
human plasma the isotope bound to the albumin and to all 
of the globulin fractions, the oC-globulins showing the 
greatest affinity among the globulins and the Y-gl^ulins 
least. Prasad and Cberleas used starch gel and they 
also found that zinc-65 added to human serum in vitro 
bound to both albumin and globulin fractions and that 
the o(-globulins bound the major part of the globulin 
zinc-65. Boyett and Sullivan used an acrylic polymer 
as the support medium and found that zinc-65 added 
to human serum bound to both albumin and to a fraction 
containing mainly oC^-macroglobulin and transferrin, 
and, in some cases, to immunoglobulin—G. They found 
that when zinc-65 was added to serum samples from 
patients suffering from hepatic cirrhosis who had 
low serum zinc levels, the percentage of added zinc-65 
bound by the albumin fraction was significantly lower 
than in normal controls. They postulated that the 
binding of zinc—65 to plasma samples in vi tro could
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be used as an indicator of the manner in which the 
endogenous zinc in plasma is bound to the proteins, • 
and they calculated the amount of stable zinc 
associated with each protein fraction from the 
percentage of the added radiozinc found in each 
fraction and the total serum zinc level. While it is of 
interest that they obtained maximum globulin binding 
in a fracti on containing ot2~macroglobul in, their 
assumption that trace amounts of zinc-65 can be 
used to measure endogenous binding is open to question. 
It assumes, firstly, that added zinc will bind to all 
the zinc-containing proteins in serum and hence that 
alJ zinc-containing proteins obtain the zinc from 
ionic zinc absorbed into plasma, and, secondly, that 
binding of added zinc will reflect.the partition of
V
zinc among the proteins which already exists in the 
sample. It would seem much more likely tha t thi s 
method would indicate the capacity of the proteins 
concerned for zinc, rather than the amounts already 
•sound to them.
In the present study the only globulin fraction 
found to contain measurable zinc-65 activity was the 
^ 2~Sl°bulins, However this fraction was located by 
plotting the distribution of zinc—65 activity along 
the cellulose acetate strip, which gave two Gaussian 
distributions with peaks coincident with the albumin 
and ot2-eiobu 7 in regions, A method which measures 
only the radioactivity associated with the protein
^0
fractions as a whole would detect measurable activity 
from the major binding proteins in adjacent fractions 
also, since the protein distributions are continuous, 
which would explain the finding of smaller amounts of 
zinc-65 in both the “ and |3 —globulin fractions,
Boyett and Sullivan, who found that added zinc was 
bound by albumin, and a fraction which contained both 
Ot^-macroglobul in and transferrin, suggested that 
transferrin might be actively involved in zinc transport 
by plasma for this reason (Boyett and Sullivan, 1970). 
However the present work has shown that, when radioactive 
iron-59 is used to label the transferrin in plasma, no 
measurable activity associated with added zinc-65 could 
be found in the area of the iron-binding peak. This 
suggests that the zinc-65 in Boyett and Sullivan's 
second peak was bound only to 0^  ^ -macroglobulin.
The pattern of zinc binding obtained in this study
/
agrees with that obtained by Parisi and Vallee for the 
partition of the endogenous zinc among the plasma 
proteins, with about two thirds of the zinc associated 
with albumin and one third with one of the oC^-globulins, 
the zinc metalloprotein, O^-macroglobulin (Parisi and 
Vallee, 1970). However it is significant that those 
authors who have used methods of protein separation 
other than electrophoresis have not detected binding 
of zinc-65 to any other protein than albumin, when 
the isotope was added to the sample in vi tro. Tn
particular, Parisi and Vallee found that zinc-65 
added in vitro did not bind to the O^-macroglobulin 
fraction, but. only to albumin, using chromatography 
on Sephadox gel as the method of separation. Similar 
results were obtained by Suso and Edwards using the 
sarne method of protein separation (Suso and Edwards, 
1969)* it is possible that the electric field applied 
during electrophoretic separation affects the binding 
of added zinc in some way, and this is the more likely 
since the binding of zinc to albumin is known to be 
weak (Vikbladh, 1951 » Parisi and Vallee,1970). 
Comparison of the results obtained in the present work 
with separation using a chromatography technique is 
therefore essential, especially since electrophoresis 
on cellulose acetate strips is not' suitable for the 
separation of large volumes and hence useless for 
separating samples labelled with zinc-65 hu vivo, where 
the low activities of the plasma samples necessitate 
separation of relatively large volumes.
2,9 Conclusions
From the results of the work described above it can 
be concluded that:-
(a) Zinc-6 5 added to plasma in. vl tro is bound almost, 
entirely by two protein fractions, axbumir and the 
O^-globu 1 ins, and this is true over a wide range of 
levels of added zinc, from 0.5 to 1000< of the normal 
plasma zinc level.
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(b) The ratio of amount of added zinc bound to albumin 
to amount bound to O^-globulins varied with the amount 
of zinc added, a larger proportion of the zinc being 
bound by albumin for large quantities of added zinc, 
though these values are affected by gross variations
in the concentrations of the particular proteins.
(c) The proportions of added zinc-65 binding to the two 
fractions are similar to those found for the partition 
of endogenous zinc between the two fractions, found by 
Parisi and Vallee, though complementary studies using 
another method of protein, separation are necessary before 
the significance of this finding can be assessed.
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3♦1 Roguirsments for Separation of Plasma Samples 
Labelled with Zinc in Vivo 
While the addition of zinc to plasma in vi tro can 
give useful preliminary information on plasma protein 
binding the ultimate aim of any study on the transport 
of a particular element by plasma must be to examine the 
binding pattern obtained when it is introduced into the 
plasma in vivo, either by studying the binding of the 
endogenous stable element in plasma or the binding of a 
trace quantity of a radioisotope of the element 
administered in vivo. However since the levels of both 
stable and radioactive zinc will be low it is essential 
to be able to separate samples of several millilitres in 
volume to obtain a sufficient concentration of zinc in 
the protein fractions. Electrophoresis using cellulose 
acetate strips is therefore unsuitable for either 
study. The purpose of the work described below was 
therefore to develop a technique which would provide 
reliable separation into known fractions of sufficiently 
high concentration whose protein content could be 
accurately assessed. The technique was then used to 
study the binding of zinc—65 added in vi tro to the plasma 
proteins and the results obtained have been compared 
with those previously reported using electrophoresis on 
cellulose acetate strips.
There are several methods which can be used to 
fractionate the required volume of plasma, notably 
preparative electrophoresis, chromatography using
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ion-exchange cellulose and mo3.ecn.lar' sd ove chromatogranhv 
using cross-linked dextran gels. However the first two 
methods present particular difficulties in the 
measurement of the stable zinc levels in the protein 
fractions. The possible redistribution of the zinc 
caused by electrophoresis has been discussed in Chapter 2. 
Chromatography on ion-exchange cellulose requires elution 
of the proteins by a solution of gradually increasing 
pfl and concentration. While this may not affect the 
binding of zinc to the plasma components these fractions 
are eluted in a solution of varying composition and 
concentration, which creates problems in the accurate 
assessment of the background level in the fractions when 
measuring the stable zinc concentration. The most 
suitable method therefore appeared to be chromatography 
using cross-linked dextran gels.
3*2 Chromatography Using Sephadex Gels
Water-soaked cross-linked dextrans form gels which 
act as molecular sieves for molecules within a certain 
size range, whose upper and lower limit depends on the 
degree of cross-linkage of the dextran monomers.
Although strictly the separation is in order of molecular 
size, it is generally true that this is also the order 
of molecular weights, and it is found that the elution 
volume for a particular molecule is approximately 
proportional to the logarithm of its molecular weight.
Chromatography on cross-linked dextrans is
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particularly suitable for separation of the zinc-binding 
plasma proteins for the following- reasons
(a) The separation is a passive procedure depending 
only on size and not on reaction of the sample molecules 
with the gel. The possibility of the zinc binding being 
altered by the separation procedure is therefore 
minimi sed.
(b) Almost complete sample recovery is obtained and 
hence quantitation and standardisation of the procedure 
is readily achieved.
(c) Since the separation is a function of molecular 
weight, good separation of the two proteins known to 
bind zinc, namely albumin (molecular weight 69»000) 
and cd^-rnacroglobulin (molecular weight approximately 
800,000) can be achieved using this method.
Sephadex G200, which fractionates in the molecular 
weight range 800,000 - 5»000 is particularly suitable 
for separation of the plasma proteins and this grade was 
used in the preliminary studies described in this 
chapter. A column k6 cm x 2.6 -cm diameter was used 
and elution carried out using a 0.1 M Tris(hydroxymethyl)- 
methylamine / hydrochloric acid (Tris—HCl) buffer, 
pH 8.0, made up in a 1M solution of sodium chloride.
The method used to prepare the gel and the separation 
procedure are described in Appendix III.
By this technique the separated sample emerges as a 
continuous flow from the column and the fractions
k f
consist of equal volumes of the eluted solution* Each 
fraction contains a number of proteins in varying 
concentration, the concentration of a particular 
protein in any fraction being a function of the elution 
volume of that fraction. The total protein content of 
the fractions was assessed using ultraviolet 
spectrophotometry.
3•3 Measurement of Total Protein Concentration
Since protein solutions absorb ultraviolet light 
strongly, with maximum absorption at wavelength 280 nm, 
measurement of the absorption of l:i ght of this 
wavelength by the sample gives a useful indication of 
the protein concentration of the column fractions. The 
measurements were carried out as described in Appendix TV. 
The method is not suitable for quantitative evaluation, 
however. When the variation in absorbance at 280 r.n 
with concentration was measured for serum diluted with 
Tris-HCl buffer and for albumin and transferrin 
dissolved in the same buffer, it was found that albumin 
has a lower absorbance at this wavelength than the 
same concentration of either transferrin or whole serum. 
Since the relative absorbances of the proteins vary in 
a non-linear manner with concentration attempts to 
estimate total protein concentration from ultraviolet 
absorption measurements are of little value for solutions 
containing a number of different proteins. However these 
measurements do provide a useful qualitative estimate of
the separation, since the distribution shows three 
separate peaks, the first representing the high 
molecular weight fraction (around 800,000) the second 
being composed mainly of the 7S gamma globulins and the 
third consisting mainly of albumin. The three peaks 
act as useful markers and provide a guide for more 
detailed analyses. Fig. 6 shows the variation of 
absorbance with elution volume for plasma samples of 
3 ml, 5 ml and 10 ml, when separated into 6 ml fractions 
3.  ^ Distribution of the Proteins among the Column 
Fracti ons
Cellulose acetate electrophoresis and 
immunoelectrophoresis of the column fractions were c?rri 
out to. determine the distribution of the individual 
proteins among the fractions. A sample of pooled normal 
serum (6 ml) was separated into 6 ml fractions using 
Tris-ITCl buffer and a flow rate of 21.6 ml / hr. The 
absorbance at 280 nm was measured for each fraction 
and Fraction 1 was taken to be the first containing 
measurable protein concentration. The maxima for the 
three protein peaks occurred at fractions 3* 8 and 13.
5 ^  samples of fractions 1 - 1 7  were then separated by 
electrophoresis on cellulose acetate strips and 2 
samples separated using immunoelectrophoresis in agar 
gel. The methods used are described in Appendix I.
Where difficulties in identifying the major individual 
arcs in the immunoelectrophoresis slides arose they
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were identified using monospecific antisera. If the 
proteins are considered as occurring in three groups, 
corresponding to the three peaks in the protein 
distribution, then the first group consists of fractions 
1 - 5  and contain the proteins with molecular weight in 
excess of 500,000. The major proteins are immunoglobulin-H, 
O^-macrogiobulin anc} gt^-haptoglobin, which, although it 
has a molecular weight of 160,000, is atypical, and 
appears to have a much greater molecular weight when 
separated using Sephadex gel. The second group (fractions 
6 - 1l) consists of the proteins in the molecular weight 
range 500,000 - 100,000 and the main constituents are 
iminunoglobulin-G, caeruloplasmin and significant 
quantities of albumin. The third group contains mainly 
albumin and transferrin. The immunoelectrophoresis 
slides showed that group III and, to a lesser extent, 
group II, contain a considerable number of other proteins 
which are present in lower concentrations. Fig. 7 
compares the stained strips from cellulose acetate 
electrophoresis and the immunoelectrophoresis slides for 
the two samples with maximum protein concentration in 
group I with those having maximum concentration in group 
III. together with serum samples. It can be seen that 
while those in group III contain a fairly large number 
of proteins, group I contains only significant amounts 
°f * -globulins, identified as d 2-macroglobulin and 
^-haptoglobin by immunoelectrophoresis.
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3.5 Quantitative Estimation of Individual Protein 
Concentrations 
Immunoelectrophoresis can identify the individual 
proteins contained in each fraction but can give no 
information on their relative concentrations. Since it 
has been shown that all the fractions contain a nijmber 
of proteins in varying concentration single radial 
diffusion in agar gel containing monospecific antisera 
to the major serum proteins was used to measure the 
concentration of these proteins. Although agar plates 
incorporating antiserum are available commercially these 
are expensive and not sufficiently flexible to cope with 
a wide range of concentrations. Accordingly, the plates 
were made up when required using the necessary specific 
antisera. The technique used is described in Appendix V.
The most reliable method for quantitation of 
radial immunodiffusion is that described by Mancini, 
Carbonara and Heremans (Mancini et al, 1965)» where the 
antigen samples are left to diffuse in the gel until 
no further precipitation of antigen-antibody complex 
occurs. Mancini and his associates found that when 
diffusion is complete there is a linear relationship 
between the area of the precipitin rings and the 
concentration of the antigen in the sample. In the 
present study it was found that the concentration 
could be described sufficiently accurately by an 
exponential function of the diameter, for varying times 
°f diffusion.
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A sample of serum was diluted to half strength with 
Tris —HC1 buffer. Half of this sample (called 100^ 
concentration) was further diluted with an equal volume 
of buffer and the process repeated six times, giving 
concentrations of 100°o, 50?*, 25/*', 12.5';", 6.2 5/-, 3.13?,
1.56% and 0.7Sfo, Three plates, area 8 cm x 16 cm, were 
made up incorporating antiserum to human albumin in 
the gel and 2 y^ l samples of serum at the required 
dilution placed in the wells. The diameters of the 
precipitin rings were measured at 17 hours, ^1 hours and 
65 hours, A least squares fit to both an exponential 
function of the diameter and to a linear function of the 
square of the diameter (i.e. to the area) was calculated 
for each plate. It was found that an exponential function 
gave a much better fit to the experimental points than 
a linear function for each of the time intervals 
chosen. The calculated exponential curves, together 
with the experimental points, are shown in Fig. 8.
An exponential function of this form was therefore 
used for all subsequent estimations of protein 
concentration. Four standards consisting of known 
dilutions of serum or plasma were included in each 
plate and the equation of the standard curve plotted 
using a least squares fit to an exponential funct.il on.
One sample containing a known concentration of the 
particular protein was included when absolute 
measurements of protein concentration were required.
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The concentrations of several of the major proteins 
in the column fractions were then measured. The proteins 
were chosen such that their molecular weights covered 
the range of the plasma proteins and also so that the 
separation achieved of proteins of similar molecular 
weights could be assessed (for example, of albumin and 
transferrin.
The proteins studied were:>
Molecular Weight 
Albumin 69,000
Transferrin 90,000
Caeruloplasmin 160,000
Immunoglobulin-G 160,000
Haptoglobin 160,000
(separates as if of molecular 
weight 500,000)
OL 2~macroSlol3ulin 820,000
Immunoglobulin-M 1,000,000
Plates were made up using the appropriate specific 
anti sera and the concentrations' measured in those 
fractions shown to contain measurable quantities of the 
particular protein from the immunoelectrophoresis slides. 
The results are shown in Fig. 9, together with the 
absorbance at 280 nm of the fractions. To enable 
the distribution of the other proteins to be included 
only the lover half of the albumin peak has been shown. 
The protein distributions show the wide range of
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concentrations of the individual proteins and particularly 
that even a small percentage of the total albumin 
content, which is present in many of the fractions, 
accounts for a significant proportion of the protein 
content of that fraction. However the fractions 
containing the proteins of high molecular weight, and, 
in particular, those containing oC^-macroglobulin, 
contain a negligible amount of albumin. If the relative 
positions of the peaks of the individual proteins 
are considered, rather than the amounts of protein 
present, it can be seen that separation of the protein 
peaks is achieved, even for proteins of similar 
molecular weight such as albumin and transferrin.
3.6 Measurement of Albumin Concentration
Since there is substantial.evidence that the major 
part of the plasma zinc is bound to albumin it is 
particularly important in a study of this kind to be 
able to assess accurately the concentration of albumin 
in each of the fractions, especially since it is present 
in such excess over any of the other proteins. Also 
separation using gel chromatography has the disadvantage 
that albumin is poorly separated from a large number 
of other proteins and any binding of zinc to these 
proteins in fractions containing appreciable amounts 
of albumin will tend to bo masked by it and will be 
detectable by its distortion of the shape of the 
albumin-bound zinc distribution rather than as a
separate peak. Separation froin the greater binding to 
albumin is only possible if the albumin concentration 
in each fraction can be estimated accurately.
As with the other proteins radial immunodiffusion 
is the most accurate method available for albumin
estimation. However there are several disadvantages to
this method, particularly for samples of high albumin
concentration. If the concentration of antiserum in
the gel is adjusted to allow measurement of a large
range of concentrations, samples with high concentration
produce precipitin rings which are large and difficult
to see and therefore difficult to measure.
A more rapid estimation of albumin concentration 
can be obtained by utilising the marked affinity of 
albumin for certain dyes. In particular, methyl orange 
is bound almost completely by the albumin in serum or 
plasma and produces graded colour changes depending on 
the amount of albumin present. These changes can be 
measured using a spectrophotometer and the amount of 
albumin calculated from a calibration curve. The 
technique used is described in Appendix IV. The 
variation of absorbance at 5h0 nm for a solution of 
pure albumin dissolved in buffer and for diluted serum 
containing a known amount of albumin was studied. It 
was found that each curve could be described accurately 
by an exponential function, but that the curves 
obtained for the two samples were not coincident.
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This is due to the existence in serum and plasma of 
other proteins with a slight affinity for the dye and 
of pigments such as bilirubin which affect the absorbance 
in proportion to their concentration. Hence in 
measurements of albumin levels in fractions from serum 
and plasma samples a range of dilutions of the serum or 
plasma to be studied was used to derive the standard 
curve, the equation of which was calculated using a 
least squares fit to an exponential function. ^he 
•presence of other proteins in the fractions with low 
albumin content gives a slightly overestimated result 
for the albumin level in these fractions but this was 
not found to be significant. When compared with the 
results obtained using immunoelectrophoresis this method 
was found to be of comparable accuracy for albumin 
measurements and was therefore used except where 
absolute measurements were required.
3.7 Determination of Optimum Sample Size
Since the ultimate aim of the separation procedure 
is to relate the zinc level in the separated fractions 
with their protein content, it is important to obtain 
good separation of the proteins while retaining maximum 
protein c o n c e n t r a t i o n , Accordingly, plasma samples of
2.5 ml, 5 ml and 10 ml were separated and the albumin 
concentrations measured using methyl orange reagent.
The variation of concentration with eluted volume is 
plotted in Fig. 10 for each case. If the width
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of the al bum in curve at ha] f its height is used as a 
measure of the sharpness of the peaks (and hence as 
a measurement of the separation obtainable) tiie values 
are 16.8 , 15*0 and 16.8 for the curves for 2,5 ml,
5 ml and 10 ml respectively. Although the sharpness of 
the peaks also depends on the evenness of the application 
of the sample onto the drained gel bed it can be seen 
that there is no measurable loss of resolution with this 
size of column in using 10 ml rather than smaller samples 
and that cutting down the sample size to less than 
5 ml only reduces the protein concentration withoiit a 
corresponding gain in resolution.
3•8 Addition of Zinc-65 to Plasma and Serum in Vitro
High specific activity zinc-65 chloride solution 
(100 mCi / ing) was diluted using double-dist.illed 
deionised water to a concentration of 0.01 0 i / ml.
This solution was added to serum or plasma in a 
concentration of 0.1 ml per ml plasma or serum. In the 
work described below this is referred to as "trace 
amounts” of zinc and added less than 1 zinc per
100 ml serum or plasma.
A trace quantity of zinc-65 was added to a 4 ml 
sample of plasma from a normal donor, together with 
a trace amount of iodine-131-labelled human serum albumin, 
and the sample incubated at 37°C Tor 30 minutes.
The sample was then separated info 6 ml fractions using 
a column of Sephadex G200. The ainc-65 and iodine— 1 pi
activities in the fractions and the absorbance of 
light at 280 nm were measured. The zinc-65 and iodine-131 
activities are plotted as a percentage of the maximum 
value in Fig. 11. It can be seen that, though there 
is slight binding to the higher molecular weight proteins, 
the major proportion of the zinc-65 activity is 
coincident with the albumin fraction, whose distribution 
is outlined by the iodine-131 distribution. In 
particular there is little binding to fractions 1 - 5» 
which contain the Ct^-macroglobulin of the plasma.
Comparison of the binding patterns of varying 
quantities of added zinc was carried out as follows. 
Amounts of zinc, containing zinc-65, equivalent to 
addition of 0.1 jjg / 100 ml, $0 fjg / 100 ml and 
200 jig / 100 ml plasma, were added -to aliquots of
2.5 ml plasma from a single donor and each sample 
incubated at 37°C for 20 minutes. The samples were 
then separated into 3»7 rnl fractions using a column 
of Sephadex G200. The zinc-65 activity and the 
albumin level (measured using the absorption at 5^0 nm. 
in methyl orange reagent) were measured for each fraction 
for each of the three separations. The distribution 
for trace amounts of zinc—65 was as in Fig. 11 and the 
distributions for 50 jj,g and 200 jj.g / 100 ml are shown 
in Fig. 12. It can be seen that the zinc-65 and 
albumin distributions are coincident, vrithin the limits 
of experimental error, in all three cases. These results
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suggest thnt albumin binds virtually all the added zinc, 
even when the plasma level is raised to twice the 
endogenous level.
When a trace amount of zinc-65 vas added to serum 
a similar binding pattern was obtained, with almost 
all the added zinc associated with the albumin fraction.
These results are apparently in disagreement with 
those previously discussed in Chapter 2, obtained 
using electrophoretic separation on cellulose acetate 
strips, where an appreciable pronortion (about one 
third) of the zinc-65 activity was associated with the 
C^-globulin fraction. These results could be reconciled, 
however, if the molecular weight of the O^-globulin 
fraction which binds the added zinc was very similar 
to that of albumin, since it would then coincide with 
albumin on separation using gel chromatography. To 
investigate this possibility, 8 x 5  y^ l samples of 
plasma, labelled with 20 A Ci zinc-65 per ml, were 
separated using electrophoresis .on cellulose acetate.
The Ot-globulin fractions were cut out of each strip 
and the proteins washed using Tris—HC1 buffer into 
a plastic vial. This eluate was made up to 4 ml and 
separated into 6 ml fractions using a column of G200 
and the zinc-65 activity measured over the molecular 
weight range of the plasma proteins. Since the 
protein level in the fractions was too low to be 
measured in the usual way the void volume of the
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column was measured (Appendix III) and the molecular 
weight range of the plasma proteins estimated from this 
value. The activity in each of the fractions is 
plotted in Fig. 13. This shows measurable activity 
over the whole range of the plasma proteins, with a 
small peak in the high molecular weight region 
coincident with the exclusion limit of the column.
As previous separation of whole plasma samples labelled 
with zinc-65 in vi tro have shown a concentration of 
more than 90?° of the activity in the albumin region, it 
can be seen that the separation of the cC-globulin 
fraction produced by electrophoresis does not provide 
a second zinc-binding fraction with Q/Lg—globulin 
mobility and of molecular weight similar to albumin, 
but rather zinc labelling throughout the proteins of 
higher molecular weight.
3*9 Discussion
It has been shown that a column of Sephadex G200, 
k6 cm x 2.6 cm diameter, can provide adequate separation 
of the major proteins of serum or plasma, for samples . 
of up to 10 ml volume, providing separation of such 
closely spaced proteins as albumin and transferrin, with 
a dilution to about a quarter of the total plasma level 
in the fractions containing maximum concentration of 
the protein. The method therefore provides adequate 
separation without too great sample dilution, even for 
relative!?/ lar£?e sample volumes.
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Separation of pla.srna samples to which zinc-65 has
been added in vi tro gives a distribution of zinc-65
activity with a single large peak coincident with that
of the albumin distribution. It is significant that
there is no appreciable binding in the high molecular
weight range (fractions 1 - 5)> which contain the
Ot^-macroglobulin in the sample, since this protein is
known to be a zinc metalloprotein. These.resuits agree
/•
with those obtained by Parisi and Vallee using 
chromatography on Sephadex G100 (Parisi and Vallee, 1970). 
This binding pattern was obtained for amounts of added 
zinc from 1 - 200$ of the average endogenous level 
of 100ytfig / 100 ml plasma.
Cellulose acetate electrophoresis separation, cn the 
other hand, gives two distinct .peaks in the distribution 
of protein bound zinc-65» one coincident with albumin 
and the other with the O^-globulins. When the 
G^-globulin fraction thus labelled is separated using
a column of Sephadex G200 the zinc-65 activity is found
throughout the whole molecular weight range of the
proteins, and not only in the albumin region. These
results support the hypothesis put forward in Chapter 2 
that the electric field applied during electrophoresis 
causes redistribution of the bound zinc among the 
protein fractions.
These results show the important part which can 
be played by the method of protein separation chosen in
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studying: the binding of trace elements to proteins.
Hence the results obtained, from both in vj tro and 
in vi vo experiments, may only be valid within the frame 
of reference defined by the method of protein 
separation chosen. The usefulness of any particular 
method will therefore depend on its ability to 
differentiate between certain states, for example, the 
ability to detect differences in plasma zinc binding 
caused b}r particular pathological conditions which 
nffcct the plasma zinc concentration. It is also 
essential that the method gives similar and repeatable 
results on plasma samples from patients with normal 
zinc metabolism. The suitability of a particular method 
will therefore only be determined after study of both 
normal and abnormal plasma or serum labelled with zinc 
in vivo, either by studying the distribution of 
endogenous zinc or in vivo labelling by zinc-65•
3*10 Conclusions
(a) Chromatography using Sephadex G200 gives good 
separation of plasma or serum samples up to 10 ml, with 
acceptable sample dilution. The method is therefore 
suitable for use in the study of endogenous zinc binding 
and of zinc-65 introduced into plasma in vivo.
(b) Separation of plasma or serum containing zinc, 
with zinc-65, added to plasma in vj ^ ro in amounts from 
1 - 200$ of the average endogenous plasma zinc level 
gives a zinc-65 distribution with a single peak
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coincident with the albumin distribution, in contrast
with the distribution obtained after separation usinf;
electrophoresis on cellulose acetate, which gave a
second peak coincident with the o^-globulins, well
as that in the albumin region. It is therefore apparent
that the zinc-containing 0^-macroglobulin described
/
by Parisi and Vallee is produced only vivo » since 
this protein is well separated from albumin using 
gel chromatography.
CHAPTER '4
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4.1 1ntroductjon
Measurements on the binding of zinc to plasma 
in vitro have shown that the major protein involved in 
binding exogenous zinc is albumin and that this is 
probably a fairly weak bond, easily broken by external 
forces. Provided in vivo binding of zinc is a passive 
process uninfluenced by factors only present in the 
body, it can be assumed that the in vi tro binding 
pattern will be the same as that for newly absorbed zinc, 
that is, zinc released from the dietary constituents 
in the gastro-intestinal tract and absorbed intc the 
plasma for transport to the organs and tissues. The 
endogenous zinc in plasma, on the other hand, has several 
possible componentsj-
(a) Newly absorbed zinc.
(b) Intermediate metabolites containing zinc - 
substances such as zinc-containing proteins which 
have been manufactured by the organs for use 
elsewhere in the body and which are being transported 
there by plasma.
(c) Excretion products, produced by tissue 
breakdown, whose zinc is in a form which can be 
excreted via the kidneys.
The binding pattern of the stable zinc to .the 
plasma constituents is therefore an equilibrium pattern 
and, in a hcmeostatically controlled system is probably 
fairly constant for a particular individual. Tt is a
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purely static picture, giving no information about 
the fate of a particular zinc-containing fraction* 
However, it does present a composite pattern containing 
all the physiologically important zinc-containing 
components. This makes it. particularly suitable as 
a means of comparing plasma or serum samples, both 
normal and abnormal (from patients with abnormal zinc 
metabolism. Also when studies on the binding of stable 
zinc in plasma are combined with studies using 
radioactive zinc, useful information can be obtained 
on the kinetics of the varioxis fractions.
After the initial studies of Vikbladh (Vikbladh,
1951) showed that serum zinc exists as two fractions,
one tightly bound and the other fairly loosely bound
and identifiable with albumin, the problem has been
/
studied in greater detail, particularly by Yallee and 
his associates (Himnelhoch et al, 1966; Parisi and
Vallee, 1970). The protein fractions appear to contain 
several zinc-containing proteins, none of which can be 
identified with known zinc metalloenzymes. Parisi 
and Vallee showed that the zinc present in normal 
pooled human serum has tivo main components, one loosely 
bound to albumin and the other firmly attached to 
O^-macrcglobulin, which they showed to be a zinc 
metalloprbtein, containing between 3^0 to 770 jLig zinc 
per g protein, in a number of (^^“tndGrDglobuliii 
preparations.
While little work has been reported on the stable
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zinc content of the low molecular weight components 
(probably because of the small quantity) it is generally 
recognised that a small percentage of the plasma zinc 
is present in this fraction, probably bound to 
amino acids.
Tt has been shown previously that chromatography
using Sephadex gel allows separation of plasma samples
into fractions which are sufficiently concentrated to
make measurement of the stable zinc content of the
fractions feasible. The method also allows clear
separation of albumin from Ot ^ -macroglobulin. The aim
of the present work has been to study the stable zinc
binding using gel chromatography in serum and plasma
from normal subjects and to establish whether the
✓
pattern obtained by Parisi and Vallee is found in 
individual samples of plasma. The relative amounts of 
zinc bound to each of the protein fractions has been 
determined, in both normal controls and in patients 
with suspected zinc deficiency, and a method developed 
for measuring the relative amounts of zinc bound to the 
protein fractions in plasma which is rapid and simple 
to perform.
^.2 Measurement of Trace Amounts of Stable Zinc
Early colorimetric methods of zinc estimation using 
reagents such as dithizone, which form a coloured complex 
with the zinc, in solution and whose colour can be 
used to estimate the amount of zinc present, have been
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largely superseded by methods which make use of the 
fundamental properties of the zinc atom. Two methods 
of thi s type are in current use to measure trace 
quantities of stable zinc. The first, activation 
analysis, uses irradiation of the sample by thermal 
neutrons, converting a proportion of the stable zinc 
atoms to zinc-65* Measurement of the zinc-65 activity 
in the irradiated sample enables the amount of stable 
zinc originally present to be calculated. This method 
|s particularly useful for samples in solid form.
However, for liquid samples atomic absorption spectromeTry 
is more suitable. This method measures the absorption 
of light by atoms in the ground state in a sample 
which has been vapourised in a flame. Conventional 
emission spectrometry does not provide a sufficient 
number of excited .atoms to make the method sensitive 
enough for use in trace element analysis, but use of 
the absorption of light by the more numerous unexcited 
atoms increases the sensitivity to an extent which 
makes accurate measurement of the zinc levels in 
biological fluids possible. The sensitivity of the 
method is virtually the same as for activation analysis 
- about 0,01 ppm or, in the case of plasma or serum, 
approximately 1 jj-g / 100 ml. Atomic absorption 
spectrometry has therefore been used to measure the 
zinc content of the plasma and serum samples, and of 
the fractions from the Sephadex columns.
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The normal range of values f'or plasma zinc levels 
is 80 — 120jj,g / 100 ml. Normal serum values are 
reported to be about 16^ higher (TIalsted and Smith, 1970) 
due to release of zinc on platelet disintegration. 
Abnormal levels to date have been reported as usually 
lower than the normal range and low plasma zinc values 
have been found to be a feature of a variety of 
pathological conditions, from myocardial infarction to 
hepatic cirrhosis. To be applicable over the whole 
range of plasma zinc levels, the method used to measure 
the stable zinc binding should be sensitive enough 
to measure the zinc content of fractions from both 
normal and abnormal plasma. It has been shown previously 
that there is no advantage to be gained in sharpness 
of separation in using samples .of less than 5 nil.
Samples of this volume give a dilution to approximately 
a quarter of the plasma level for individual proteins 
in the fraction with maximum concentration of the 
protein. It should therefore be possible to measure 
at least the major protein-bound components, even in 
samples with very low plasma zinc levels, provided 
background contamination can be kept to a minimum.
A Perkin Elmer atomic absorption spectrometer 
(Model ^03) using acetylene as fuel and air as oxidant 
was used for all the stable zinc measurements. Zinc 
was measured at a wavelength of 213*8 nm and samples 
were diluted to quarter strength using propanol, to
reduce variations in sample viscosity. The method is 
described in Appendix VI.
^ .3 Removal of Contamination
One of the major problems involved in trace element 
analysis is that of sample contamination by small 
quantities of the element on glassware, in reagents, etc 
The number of intermediate stages in the sample 
preparation was therefore reduced to a minimum and 
Pi astic disposable containers used where possible.
Blood samples were withdrawn into plastic vials and 
the plasma or serum removed after centrifugation using 
a disposable plastic syringe. Because of the powerful 
chelating activity of lithium EDTA, heparin was used 
as an anticoagulant for all plasma samples where protein 
bound zinc was to be studied. It has been shown 
previously (Chapter 2) that no significant increase in 
pi asma zinc level resulted from the use of heparin.
Water supplies used for both rinsing glassware and 
for making up solutions were first double-distilled 
then deionised until the resistivity was greater than 
3 Kflcm. No zinc could be detected in the water after 
this procedure. All reagents used were of the highest 
purity obtainable ( A m  star"^ grade when obtaxucibls a..d 
failing that AnalaR)•
Measurements of the zinc level of the Tris—HC1 
buffer in 1M NaCl solution gave values of approximately 
12 f+S / 100 ml. When the zinc content of the individual
* British Drug Houses
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components of the buffer were measured it was found that 
a 1M sodium chloride solution gave the same value.
The sodium chloride solution was then passed through a 
46 cm x 2.6 cm column of Chelex-100 chelating resin 
(Bio-Rad Laboratories, Ltd) to remove the contaminating 
zinc. However this resulted in only marginal improvement. 
As Chelex-100 had been found capable of removing 
even tightly bound zinc from compounds it- was assumed 
that the high sodium content of the solution increased 
the background in the atomic absorption measurements. 
Accordingly, the amount of sodium chloride in the 
buffer was reduced to 0.1M, which gave a total zinc 
level in the buffer of 0 - 2  yug / 100 ml. This 
reduction was found to have no measurable effect 
on the Ln vi tro binding of zinc-65 to plasma.
However albumin is known to have an increased tendency 
to form polymers in a solution of low ionic strength 
and appreciable amounts of albumin dimer and higher 
polymers in the sample result in measurable amounts 
of albumin across the major part of the plasma 
protein distribution. The albumin distribution 
obtained using 0.1M NaCl-buffer solution as eluant 
was compared with that obtained from 1M NaCl-buffer 
solution* No measurable increase in tailing of 
the protein could be detected.
The Sephadex gel, which itself contains appreciable 
amounts of zinc, was washed using several volumes of
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of the buffer until the zinc level in the eluant from 
the column was equal to that of the original buffer.
The glass columns were decontaminated by soaking 
them in a 2°. solution of Decon-90 at elevated 
temperature for several hours and rinsing several 
times with double-distilled deionised water. The 
plastic tubing connecting the buffer reservoir, the 
column and the fraction collector were decontaminated by 
punning a 2^ > solution of Decon-90 through the system for 
several hours, followed by several rinses of double­
distilled deionised water. Disposable plastic vials 
were used to collect the column fractions.
4.4 Separation Using Sephadex G200
Volumes of serum and plasma were separated into 
6 ml fractions using a 46 cm x-2.6 cm diameter column 
of Sephadex G200 using a Tris-HCl buffer, pH 8.0, in 
0.1M sodium chloride solution as eluant. Approximately 
half of each sample was poured into a second similar 
vial, for protein measurement, etc. and the zinc level 
of the solution in the original vial measured, thus 
reducing the chance of contamination in the sample.
The absorbance at 280 nm and the albumin level, 
calculated using the absorption of the solution in 
methyl orange reagent, vrere measured for each of 
the fractions from the column. Fig* 14 shows the 
distribution of stable zinc in the fractions obtained 
on separation of a 6 ml plasma sample from a normal
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donor, together with the albumin distribution. It can 
be seen that the zinc distribution has two distinct 
peaks, one roughly coincident with albumin and the 
other in the region of the exclusion limit for the gel, 
that is, in the molecular weight range 1,000,000 - 800,000. 
The protein fractions in this region contain mainly 
immunoglobulin-M, haptoglobin and ^-macroglobulin. 
Quantitative immunodiffusion measurements of the levels 
of the three proteins in the relevant fractions were 
carried out and the individual protein distributions 
plotted. Only the distribution for O^-macroglobulin 
conformed to that of the second peak, as shown in 
Fig. 14. Since extensive work has been carried out to 
show that this protein does contain zinc it was concluded 
that the peak in the zinc distribution is due to that 
associated with this protein. Assuming that the zinc is 
associated with only the two components represented by 
the two peaks and calculating the areas under the two 
peaks, the amount bound to albumin was found to be 70% 
of the total endogenous zinc level of 90j&g / 100 ml 
plasma and that to O^-macroglobulin 30$,
The separation was repeated using a second sample of 
plasma taken at a later date from the same donor. A 
similar binding pattern was obtained, with 75$ the 
plasma zinc bound to albumin and 25$ to OL ^ -macroglobulin.
'A 7.5 ml sample of serum, again from the same 
subject, was separated into 6 ml fractions and the 
stable zinc content, absorbance at 280 nm and albumin
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levels measured. As for the plasma samples, the zinc 
distribution had two peaks coincident with the 
distributions of # ^-macroglobulin and albumin. No 
obvious difference between the distributions of zinc 
in serum and in plasma could be detected. The 
percentages bound to the two fractions for the serum 
sample were 23$ bound to 0C^-macroglobulin and 77$ 
bound to albumin. A trace amount of zinc-65 was added 
to 2.5 nil of the same serum and the sample separated 
into 6 ml fractions under the same experimental 
conditions. The distributions of endogenous stable 
zinc and added zinc-65 for the two serum samples are 
shown in Fig. 15« It can be seen that the single peak 
in the distribution for the added zinc-65 is coincident 
with the larger of the two peaks in the endogenous 
distribution but no measurable zinc-65 activity vras 
found in the O^-macroglobulin region.
Plasma samples from two other normal subjects were 
separated in the same way. Both gave zinc distributions 
of the same general shape as that obtained for the 
first subject, with two peaks coincident with albumin 
and cC ^ -macroglobulin. The percentages of zinc bound 
to albumin and to 06 2-macroglobulin were 75$ and 25$ 
for one subject and 67$ and 33$ for the other.
In all the samples studied the total plasma zinc 
concentration was found to be associated with the 
plasma proteins. Measurements made of the zinc levels
Ih
in the fractions containing the lower molecular 
weight components in plasma gave values which were 
indistinguishable from background levels.
4•5 Separation Using Sephadex G-75 and G100
The separation procedure outlined above has been 
designed to give maximum separation of the plasma 
proteins throughout the whole molecular weight spectrum.
, However, it is not particularly suitable .for comparing 
the results obtained from a number of samples, since 
the procedure is a relatively lengthy one (about 
12 hours) and if excessive dilution of the protein 
fractions is to be avoided, requires large blood 
samples (about 12 ml). Also the use of large volumes 
of buffer and a large column inevitably increase the 
background zinc level and the chance of contamination in 
the fraction. Since the distribution of stable zinc 
aincng the plasma proteins is concentrated in two regions, 
widely separated in molecular weight, use of a grade 
of Sephadex gel whose exclusion limit occurs for a 
lower molecular weight should bring the two peaks 
closer together, but still separable, assuming that 
the zinc is entirely bound to Ct^-macroglobulin and to 
albumin, or to groups of proteins whose molecular weight 
is very similar to these proteins.
In theory, adequate separation is achieved when 
one fraction is obtained which has measurable amounts of 
one of the proteins and none of the other. The zinc
75
in that fraction is therefore associated with only 
one protein and, if the amount of the protein in the 
fraction is expressed as a percentage of the total plasma 
level, the total amount of zinc associated with the 
protein can be calculated. The amount of zinc bound to 
the second protein can then be found by subtraction.
Sephadex G-75 fractionates in the molecular weight 
range 80,000 - 3>000 and therefore most of the plasma 
proteins are excluded from the gel and are eluted 
together at a volume approximately equal to the void 
volume of the column. However albumin is within the 
fractionation range of the gel and is therefore 
separated from the proteins, including 0^  ^ -macroglobulin, 
which are excluded from the gel.
An initial trial was carried out using an 18.5 cm x
1.6 cm diameter column of Sephadex G75» packed and 
equilibrated with Tris-HCl buffer in 0.1M sodium chloride 
solution as described in Appendix III. Samples of 
serum were obtained from six normal donors, five male 
and one female, in the age range 20 - 35, and 2 ml 
aliquots were separated into 2.4 ml fractions at a flow 
rate of 14.6 ml / hour. It was found that 95$ of the 
proteins were concentrated into four fractions, with 
only a small proportion of the heavier proteins, 
Ot^-macrogiobulin in particular, in the second two 
fractions, which contained most of the albumin. The 
total serum zinc level, the stable zinc content of the
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fractions, the albumin distribution (measured using the 
absorption by the fraction of light at 5^0 nm in methyl 
orange reagent) and the absorbance at 280 nm of the 
fractions were measured in each case. A typical 
separation is given in Fig. 16 , showing the absorbance 
at 280 nm, the stable zinc concentration and the albumin 
level in the fractions. Using the fraction containing 
maximum albumin concentration and assuming that the 
concentration of 0^^-macroglobulin in this fraction 
was negligible in comparison with the albumin, the 
total stable zinc bound to the albumin was calculated, 
and the amount of zinc bound to the oC^-macroglobulin 
found by subtraction. The results are summarised in 
Table h. The percentages bound to albumin varied between 
5^$ and 81 7 0, with an average value of 68.7^« Again, 
no measurable zinc levels could be detected in those 
fractions containing the lower molecular weight 
plasma constituents for any of the samples studied.
While these initial studies produced encouraging 
results, with concentrations of stable zinc in the 
appropriate fractions which were satisfactorily above 
background level, the close proximity of the albumin 
and O^p-raacroglobulin peaks on separation using 
Sephadex G75 means that theOL2-macroglobulin-rich 
fractions always contain appreciable amounts of 
albumin and thus the calculation relies on the albumin 
fractions alone. Improved results would be obtained if
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the separation was extended so that fractions containing 
g-rnacroglobulin, but no albumin, could be obtained.
The amounts of zinc bound to each of the proteins could 
then be estimated independently, instead of using 
subtraction from the total plasma zinc level. This 
would provide a check on the results, since the sum of 
the amounts bound to each protein should be the total 
plasma zinc level, if only albumin and O^-macroglobulin 
bind zinc.
Sephadex G100 has a fractionation range from 
100,000 to 4,000 and therefore oC^-macroglobulin j_s again 
eluted at approximately the void volume for the column, 
together with other heavier proteins such as the 
V-globuli.ns which are not thought to contain significant 
amounts of zinc. Albumin is within the fractionation 
range of the gel but because of the higher exclusion 
limit of G100, is better separated from the excluded 
proteins than is possible using G75« It was therefore 
decided to use the same size of column with G100 as the 
separating medium. Again, 2 ml samples were used, 
separated into 2.4 m3, fractions using Tris-HCl buffer 
in 0.1M sodium chloride as eluant. An initial trial 
was carried out, using two samples of pooled serum from 
six normal subjects (each sample coming from a different 
group of donors) and calJed Serum I and Serum II.
These samples were sepa.rated as above and the levels 
of -macroglobulin measured using radial immunodiffusion
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and of albumin, measured using the binding to methyl 
orange, and the total serum zinc and the zinc level in 
each of the fractions. The distributions obtained for 
each of the samples were similar and the distributions 
for Serum I are shown in Fig. 17• The proteins were 
concentrated in six fractions in this case and it can be 
seen that the first two contain virtually no albumin, 
while the last two contain no measurable levels of 
OC^-macroglobulin. Using these pairs of fractions to 
calculate the percentage of zinc bound to Ot^-macroglobulin 
and to albumin gave values of 32$ bound to 
O^-macroglobulin ancj 63$ to albumin and of 33$ to 
O^-macroglobulin and 70$ to albumin for Serum I and 
Serum II respectively. Hence the results obtained from 
each of the protein fractions are reasonably consistent, 
adding up to approximately 100$ in each case, and also 
the percentages obtained for the two sera are very 
similar - as would be expected from pooled samples of 
normal serum.
Plasma samples were then obtained from six normal 
subjects and 2 ml aliquots separated using G100 into 
2.k ml fractions. For each fraction measurements were 
made of Oi^-rnacroglobulin and albumin concentrations, as 
well as the zinc content. The endogenous zinc level 
of the plasma was also measured in each case. The 
results are summarised in Table 5. The percentages of 
the total plasma zinc bound to o£^-macroglobulin were in
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the range 25 - 32$ and to albumin in the range 68 - 75^- 
The average values vere 29$ bound to C^-macroglobulin 
and 71$ bound to albumin.
Plasma samples were obtained from two patients 
suffering from pustular psoriasis, who were found to 
have plasma zinc levels which were lower than those of 
any of the normal controls (78 and 84 yug / 100 ml). 
Aliquots of 2 ml were separated into fractions as above, 
using Sephadex G100, and the percentage of zinc bound 
to the two proteins calculated. Values of 42$ and 45$ 
bound to oC^-macroglobulin and 58$ and 55$ bound to 
albumin were obtained and therefore in both cases the 
proportion of the zinc bound to albumin was lower 
than for any of the normal controls.
A single sample was obtained from a patient found 
to have the nephrotic syndrome, with a plasma albumin 
level of approximately 50$ the normal value. The 
plasma zinc level was found to be significantly lower 
than normal (64 yu,g / 100 ml) and, on separation of a 
2 ml aliquot of plasma using G100, the percentages 
bound to g^-macroglobulin and albumin were found to 
be 39$ and 61$ respectively.
A 6 mi sample of pooled normal serum was shaken 
briefly with an equal volume of Chelex-100 chelating 
resin, which had boen previously adjusted to pH 7*4.
The sample was centrifuged and the supernatant separated 
using a 46 cm x 2.6 cm column of Sephadex G200. The
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distribution of stable zinc in the protein fractions
showed that most of the zinc was removed from the
albumin region but that the peak in the -macroglobulin
region was little reduced, giving strong support to
the hypothesis that the binding to albumin is much
weaker than that to od^-macroglobulin. However it
was found that when the sample was passed through a
small column of Chelex-100, the zinc could be removed
almost entirely from both fractions.
k •6 Pi scus sion
In all samples studied the pattern of the endogenous
stable zinc binding showed that almost all the zinc is
bound to two proteins, or groups of proteins, one
having a molecular weight in the region of 800,000
where the zinc has the same distribution as jthe
cC^-macroglobulin in the sample, and the other with a
molecular weight of approximately 70>000, which is
almost certainly albumin. These findings agree with
/
the work of Parisi and Vallee who showed that in pooled 
normal serum the major part of the serum zinc was 
bound to two proteins, albumin and a zinc metalloprotein 
which combined with trypsin to produce a compound with 
esterase activity. As cL^-macro globulin is the only 
protein in serum found to react in this way it was 
concluded that the zinc inetalloprotein was identical 
with -macro globulin, a finding which was confirmed 
using immunological methods. The purified
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-macroglobulin preparations obtained were found to
contain amounts of zinc in the range 320 - 770y*g / g
/ .
protein (Parisi and Vallee, 1970). In view of the 
agreement obtained with their work in the present studies 
it has not been considered necessary to attempt further 
purification of the high molecular weight fraction in 
an attempt to obtain pure Ot^-macroglobulin, especially 
since the distribution of zinc in these fractions was 
coincident with the distribution of 0^-macroglobulin.
Values for the proportions of zinc bound to each 
protein in normal pooled serum were found to be about 
one third of the total serum zinc bound to
Ot^-macroglobulin and two thirds to albumin, which agrees
with the zinc content of the protein given by Parisi 
/
and Vallee. No significant difference could be detected 
between the binding patterns for zinc in serum and in 
plasma. The amounts of zinc bound to the two proteins 
in samples of plasma from normal individual subjects 
fell within a fairly narrow range, with between 25$ and 
32$ of the total plasma zinc bound to O^-macroglobulin 
and between 68$ and 75$ bound to albumin. No measurable 
amounts of zinc were found in the low molecular weight 
plasma components. Two plasma samples from patients 
suffering from pustular psoriasis, with low plasma 
zinc levels, gave percentages of 55$ 58$ of the
plasma zinc bound to albumin, values which are lower 
than any of those obtained from normal subjects, though
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the plasma albumin levels in these samples were within 
normal limits.
Comparison of the binding- pattern for trace amounts 
of zinc-6p added to serum ijti vitro with the pattern of 
the endogenous zinc in the same serum showed that while 
a zinc-containing O^-macroglobulin fraction is clearly 
demonstrated in all distributions of the endogenous 
zinc, in both normal and abnormal samples, this 
protein show little tendency to bind zinc in vitro.
The albumin peak, on the other hand, appears in both 
the endogenous binding pattern and in the pattern for 
zinc added to serum in vitro. This binding to albumin 
is almost certainly a weaker bond than that to 
& ^ -macroglobulin, since chelation removes the zinc 
in the albumin fraction in preference to the zinc bound 
to O^-macroglobulin.
It would therefore appear that zinc newly absorbed 
into the blood via the gastro-intestinal tract is 
bound initially to albumin and that the zinc in the 
C^-macroglobulin fraction is a product of a later 
metabolic reaction. This does not exclude the 
possibility that the O^-macroglobulin is a transport 
protein for zinc, since the protein could bind zinc 
at a specific site within the body, rather than 
immediately in the plasma, but later give up its zinc 
at some other site. Alternatively, the protein might 
be an enzyme whose function is as yet undiscovered.
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If this is the case it would be expected that the 
ratio of protein-bound zinc to protein concentration 
would be constant, since the protein will only exist 
in a form containing a given number of zinc atoms per 
molecule. In a transport protein sites must be 
available in the molecule for binding absorbed zinc 
and hence the ratio of weight of bound zinc to weight 
of protein is not necessarily constant. It has been 
found that about one third of the total zinc in plasma 
is bound to ^-macroglobulin. Taking an average normal 
plasma zinc level of 100yuug / 100 ml and an average 
O^-macroglobulin concentration of 300 »v^ g / 100 ml
(Schultze and Heremans, 1966) gives a very approximate 
value of 1 atom of zinc per molecule of G^-macroglobulin. 
However further studies on the.fate of the zinc bound to 
each of the proteins are necessary before this point 
can be elucidated. 
h . 7 Conclusions
(a) In all samples of serum and plasma studied, the 
zinc content was found to be associated with two 
protein fractions, one of which was identified as 
O^-macroglobulin and the other as albumin. In samples 
from normal subjects no measurable levels of zinc were 
found in the low molecular weight fractions.
(b) The average values for the proportions bound to 
each of the two fractions, in normal plasma or serum, 
were found to lie within a narrow range, with about
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one third of the total plasma zinc bound to
a/
-macrog]obulxn and two thirds bound to albumin, but 
the percentage bound to albumin was reduced in plasma 
samples from two patients suffering from psoriasis.
(c) Since the oC^-rnacroglobulin fraction does not 
appear to bind zinc added to the sample in vitro it 
is probable that zinc binds to the protein either at 
the site of protein production or by metabolic reaction 
in the body.
\
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5•1 Introduction
It has been established that there are two major 
protein components which bind zinc in serum or plasma. 
One of these components binds zinc added to plasma 
in vitro, and the other more tightly bound fraction is 
only found in the pattern of endogenous protein-bound 
zinc. This suggests that the first fraction, almost 
certainly mainly albumin, is the transport medium for 
zinc initially absorbed into the system through the 
^astro-intestinal tract. Since the other fraction, 
a zinc metalloprotein which has been identified as 
Q6^-macroglobulin, does not bind zinc in vitro. All thar 
can be inferred from its presence in the endogenous 
pattern is that the protein binds zinc only jjn vivo 
and the previous studies provide no information on 
the clearance of zinc from either fraction.
To obtain this information, in vivo labelling of 
the proteins is necessary and zinc-65 provides a 
convenient tracer for this purpose. The isotope 
can be administered either intravenously or orally.
While intravenous administration has the advantage that 
all of the administered dose is absorbed, the rate of 
clearance from the plasma is very rapid and there is 
the possibility that, since the zinc-65 has not passed 
through the gastro-intestinal wall it may not 
parallel the physiological process of zinc absorption.
An oral dose of zinc-65 as the chloride in 100 ml
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water was therefore used in this study.
Since zinc is known to have a long biological 
half-life and the radioisotope itself has a half-life 
of several hundred days, zinc-65 is a considerable radiatioi 
hazard in large doses and must be used with extreme 
care in clinical trials. Permission was obtained from 
the Isotope Advisory Panel of the Medical Research 
Council for the administration of 5JjSi zinc-65 
to normal subjects as an oral dose.
The aim of the work described below was to study
the uptake and clearance of zinc-65, particularly in
normal subjects, but also in patients suffering from
varicose ulcers, and to study the variation with time of
the amounts of zinc bound to albumin and to
O^-macroglobulin. Gel chromatography on Sephadex G200
was used to separate the proteins into fractions
whose activity could then be measured.
5*2 Materials and Methods
The dose administered was 5 /^ i  zinc-65 as the
chloride in 100 ml water, obtained by dilution of
a solution of zinc-65 chloride in 0.1N hydrochloric
acid (Radiochemical Centre, Amersham). The dose was
equivalent to about 20 //.G zinc.
/
20 ml. blood samples were withdrawn using a disposable 
polypropylene syringe and stainless steel needle.
These were taken before administration of the dose and 
at intervals of approximately half an hour for the
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first few hours, then at progressively longer intervals 
during the day. After the first day blood samples 
were taken at intervals of several days, then at longer 
intervals for a period of about 12 months. The blood 
samples were centrifuged immediately after withdrawal 
and the plasma drawn off using a polypropylene syringe.
The red blood cells were washed three times in isotonic 
saline and retained for counting. After counting, the 
samples were separated using a h6 cm x 2.6 cm column of 
Sephadex. G200 using a Tris-lICl buffer, pH 8.0, in 1M 
sodium chloride solution. To avoid possible contamination 
of the later samples by activity from the earlier more 
active samples the Sephadex gel was rinsed with a 
volume of the buffer solution at least equal to that of 
the column after each separation and the gel replaced 
after at most four separations had been carried out.
Where the total plasma activity was low the fractions 
were pooled and concentrated either by evaporation 
in a refrigerator or by freeze-drying the pooled fractions 
and reconstitution to a suitable volume with isotonic 
saline•
The samples were counted using a Tracerlab 
Gammaguard 150 automatic gamma counter. Each of the 
plasma samples and plasma protein fractions was counted 
for several hours. To ensure that no drift in the 
counter settings occurred during counting each sample 
in the group to be counted was counted for 500 second
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intervals and a standard, consisting of of the dose 
administered, and several background samples, were 
included in each group. The counts were repeated until 
a sufficient time had elapsed. The mean and standard 
deviations for the background and standard counts were 
then calculated. Provided that the standard deviation 
did not differ significantly from the theoretical value 
of the square root of the mean counts in each case, 
constant conditions for counting were assumed and the 
mean values taken as the background and standard counts. 
This was found to be true in all cases in practice. The 
average sample counts were calculated and the counts 
expressed as a percentage of the dose administered 
per litre of plasma.
5•3 Uptake and Clearance of Zinc-65 in Plasma of Normal 
Subjects
Samples from two normal subjects (female) were 
studied. These subjects had plasma zinc levels of 
86 and 88y^g / 100 ml, with normal values for 
total protein, haemoglobin and albumin, and 
^p-macroglobulin levels. The dose was administered in 
the morning, several hours after a light breakfast.
Fig.18 shows the uptake and clearance of the 
zinc-65 in plasma for the two subjects. It can be 
seen that both curves have a similar shape, with very 
rapid uptake in the first half hour, reaching a 
maximum after about 1-J- hours, then declining steadily.
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The level appears to stabilise to an almost constant 
level after about six days, with a very slow decline 
for a period of about 30 days. After 3 months the 
zinc-65 level has dropped below background. The 
curves show that the maximum plasma level for subject C 
is significantly greater than for subject E, with a more 
rapid clearance in the first few hours - the difference 
between the plasma levels for the two subjects is 
approximately 0.80$ of the dose at the maxima, but 
only about 0 .15$ after 2k hours..
Plasma samples taken at times 1, 1.5* 2, 3* 4, 7 
and 25 hours and 3 and 6 days from subject C were 
separated into 6 ml fractions using volumes of 7 - 1 2  ml. 
The activity of the later samples was found to be too 
low to give significant results for most of the 
separated fractions. The plasma samples taken at 
2 hours and 4 hours were counted as 6 ml fractions. The 
fractions from samples at 1 hour, 1.5 hours and 3 hours 
were pooled in groups of two, into 12 ml fractions, 
taking the first fraction as the first which contained 
a measurable quantity of protein, measured using the 
absorption of light at 280 nm. The pooled fractions 
were then concentrated by freeze drying. The fractions 
from the later samples were pooled into larger volumes, 
depending on the activity of the fractions. The 
absorbance at 280 nm was measured for each of the 
column fractions and the albumin content of the pooled 
and concentrated fractions measured by absorbance in
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methyl orange reagent at 540 nm.
Sample volumes of 7«5 - 10 ml from subject E were 
used and the samples for the times 35 minutes - 
3 days were separated. Those samples having maximum 
activity ( 1^- - 2 hours) were separated into 6 ml 
fractions and those with less activity, though well 
above background (up to 7 hours) were separated into 
9 ml fractions. Each of the 6 and 9 ml fractions were 
then counted without further concentration. The samples 
taken after 1 day and 3 days were separated into 9 ml 
fractions, which were then pooled in pairs, again 
taking as the first that sample first showing a measurable 
amount of protein. The pooled samples were then 
concentrated by freeze-drying and reconstituted in o ml 
isotonic saline. The albumin content of each 
unconcentrated fraction was found by measuring the 
absorbance at 540 nm in methyl orange reagent. The 
absorbance at 280 nm was also measured to give an 
estimate of the total protein level in each fraction.
Figs. 19 and 20 show the distribution of zinc-65 
activity among the protein fractions at 2 hours and 
25 hours after ingestion of the tracer dose for subject 
C and Figs. 21 and 22 show the distribution of activity 
at 1.5 and 4.4 hours for subject E. All the distributicas 
obtained from plasma samples obtained from both 
subjects show a fairly similar pattern. In the early 
plasma samples (those with maximum activity) there is a
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large peak in the albumin region, but in each case 
there is also measurable activity in the high 
molecular weight region, though initially this is only 
a small proportion of the total activity. As the 
activity contained in this region was only slightly 
above the background level it was difficult to measure 
and therefore estimates of the percentage of the total 
activity which appears in this high molecular weight 
fraction are inevitably subject to a high error.
However all of the earlier samples from both subjects 
show a slight but definite peak in this region, which 
coincides with theO^ ^ -macroglobulin distribution.
This finding can be contrasted with the binding 
of zinc added to plasma in vitro, where no significant 
binding in the 0C2 -macroglobulin region could be 
demonstrated. However, comparing the distribution of 
the earlier plasma samples with that for the stable 
zinc distribution for the same subject it is found 
that the distributions have similar shapes, with 
two peaks, one coincident with albumin and the other 
with Q^-macroglobulin. The distributions of stable 
zinc and zinc-65 hours) in plasma are shown in Fig 23» 
for subject C, expressed as a percentage of the 
maximum value in each case. It can be seen that, 
allowing for differences in the separation, the two 
sets of peaks are coincident, but that the zinc-65 
bound to 0^9-macroglobulin is a smaller percentage of
the total level than the stable zinc bound to that 
protein. As the two peaks are distinct in the earlier, 
more active samples the total activity bound to each 
protein can be calculated from the area under the peak 
as a percentage of the total dose administered. In the 
later samples where the reduction in total plasma 
activity has necessitated pooling several of the 
protein fractions no obvious peaks can be detected but, 
knowing the distribution of -macroglobulin and of 
qlbumin in the samples the activity associated with each 
protein can be calculated. The variation of the zinc-65 
activity of both protein fractions with time is 
compared with the total plasma activity over a period 
of about 2h hours, in Fig. 2k for subject C and in 
Fig. 25 for subject E. It can be seen that the uptake 
and clearance of zinc-65 by albumin is fairly rapid 
and follows the shape of the plasma curve. However, 
after a rapid initial uptake, the amount of the dose 
bound to -macroglobulin remains virtually constant 
over this period in both cases. At maximum zinc-65 
level the percentages of the total plasma activity bound 
to albumin and toOC2»macroglobulin were 89$ and 11$ for 
subject C and 89$ and 11$ for subject E. After 2k hours 
the percentages were 72$ and 28$ and 78$ and 22$ 
respectively. The latter values are similar to the 
percentages of the endogenous zinc levels associated 
with the two proteins, which were 75$ bound to albumin
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and 25$ bound to O^-macroglobulin Tor subject C and also 
75$ bound to albumin and 25$ bound to 0 ^ —macroglobuiin 
for subject E.
The percentages bound to each protein are therefore 
similar in each case, even though the total plasma 
zinc-65 levels at the maximum vary by approximately a 
factor of two. The levels of albumin and O^-macroglobulin 
present in the plasma from each subject were found to 
differ by less than 20$ of the mean, suggesting that the 
amounts of zinc bound by each fraction do not apparently 
depend on the amounts of protein present and that the 
*2 -macroglobulin fraction binds a definite percentage 
of the absorbed zinc, rather than a constant amount.
As the amount of zinc bound to the protein increases 
with increasing absorbed zinc and the amount of protein 
present is fairly constant this implies a variable ratio 
of zinc to protein.
5.4 Uptake and Clearance of Zinc-65 by Plasma in 
Patients suffering from Varicose Ulcers 
An oral dose of 5 zinc-65 chloride was
administered to two patients suffering from varicose 
ulcers (one male, one female). The dose was given just 
before the patients started on a course of zinc 
sulphate therapy. The zinc-65 chloride was added to 
200 ml water in which 220 ml zinc sulphate had been 
dissolved. Plasma samples were taken at intervals of 
it Tt 3» and 6 hours and then at 48 hour
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intervals for a week. The zinc-65 activity and the 
stable zinc level were measured for each sample. The 
clearance curves for zinc-65 (expressed as percentage 
dose per litre plasma) and for stable zinc are shown 
in Figs. 26 and 27*. It can be seen that the maximum 
levels for zinc—65 activity in plasma are of the same 
order as those obtained for subject E, but much less 
than those of subject C, though the maximum level 
occurs at approximately the same time after ingestion 
of the dose in all four cases. Also the clearance 
of the stable zinc follows the zinc-65 fairly closely, 
as expected.
Because of the low activity and the small sample 
volume it was not usually possible to separate individual 
samples. Hence the samples having' maximum activity 
were pooled and separated into 6 ml fractions using 
a 46 cm x 2.6 cm column of Sephadex G200. In one 
case (patient S.G.) the samples from days 2 - 6  were 
pooled and separated in the same way. The 6 ml fractions 
from each separation were each pooled into three groups. 
Group 1 contained the high molecular weight proteins 
(with molecular weights greater than approximately 
200,000), Group 2 the fractions for molecular weights 
approximately 200,000 - 100,00 and Group 3 the proteins 
in the molecular weight range 100,000 - 50»000» Hence
♦reproduced by permission of Dr. R.G. Bessent 
and Dr. S.L. Husain
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Group 1 contained most of the Ot^-macroglobulin and 
Group 3 most of the albumin. The grouped fractions 
were concentrated by evaporation then freeze-dried 
and reconstituted in 6 ml isotonic saline, then Counted 
for several hours as described. Since the middle 
group (Group 2) contains appreciable amounts of 
albumin and Q^-macroglobulin the levels of each 
protein were measured for each grouped fraction.
Relative albumin levels were estimated by adding trace 
amounts of human serum albumin labelled with iodine-131 
to the serum samples before separation and the iodine-131 
activity in each of the grouped fractions measured.
The concentrations of ot2 -macroglobulin were estimated 
by radial immunodiffusion. Since Group 1 contains 
negligible amounts of albumin and Group 3 no 
O^-macroglobulin, the total amounts bound to each 
protein could be calculated. This was found to account 
for all the activity in Group 2.
It was found that in the three plasma samples 
separated the percentage of the total activity found 
in the Od^-macroglobulin region was greater than for the 
normal controls at similar times. At maximum plasma 
activity (1 - 2 hours) the percentage of the total 
zinc—65 activity bound to 0^^—macroglobulin was 46$ 
for patient S.G. (male) and 73$ for patient A.R. (female), 
while that obtained for both normal subjects was 11$.
For patient S.G. the aggregated samples for days 2,4
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and 6 gave a much higher percentage of the zinc-65 
activity bound to GC^-macroglobulin, an increase of from 
46^ o to 80^ 0. However, since both patients were give 
220 mg zinc sulphate (equivalent to 50 mg Zn++) the 
zinc-65 acts as a tracer for a therapeutic dose of 
zinc rather than as a tracer for dietary zinc intake.
5•5 Discussion
When zinc-65 is absorbed from a tracer dose ^iven 
orally it is found that, in plasma samples separated 
using gel chromatography, zinc is bound to both the 
O^-macroglobulin and albumin fractions in all samples.
For samples taken up to 2 hours after ingestion of the 
dose from subjects with apparently normal zinc metabolism 
the percentage bound to C*C2-macroglobulin was approximately 
11$ of the total but this gradually increased to about 
25$ of the total zinc-65 level after 24 hours. After 
an initial rapid uptake the amount of zinc bound by 
this protein remained constant throughout this period.
The level of the albumin-bound zinc-65» however, 
dropped rapidly during this time, the clearance of 
zinc having roughly the same shape as the plasma curve.
While the finding of a constant level of zinc bound
to 0^  macroglobulin Would support the hypothesis that
this is a metalloprotein which only exists in a form 
containing a constant number of zinc atoms per 
molecule of protein, it was found that, in two cases 
having virtually equal amounts of the protein present,
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as measured by radial immunodiffusion, that che amounts 
of zinc-65 binding to the protein were different in 
each case, one having more than double the amount of 
zinc bound to this protein than was found in the second 
case (subjects C and E)• However some caution is 
necessary in the interpretation of these results since 
although the same dose of zinc-65 was administered in 
each case it is virtually impossible to ensure that the 
same amount of total zinc (largely stable zinc) is 
administered. If the specific activity of the dose is 
reduced due to contamination of the sample by stable 
zinc, either externally or by zinc-containing compounds 
already present in the gastro-intestinal tract, the 
total amount of zinc bound to a particular fraction 
may only appear to have been reduced when the zinc-65 
binding alone is used as a measurement of total zinc 
binding.
When zinc-65 was administered with a 220 mg dose of 
zinc sulphate to two patients with suspected zinc 
deficiency the percentage of the absorbed zinc in plasma 
which was bound to oC2 -macroglobulin was found to be 
greater than in either of the two normal subjects.
Since the total zinc administered and absorbed in these 
patients was much greater than the trace amounts given 
to the normal subjects the differences in the binding 
ratios could be due to either a difference in the 
binding pattern of large amounts of zinc (in these cases
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the plasma zinc level increased to more than twice 
the original level) or to abnormalities in zinc 
metabolism. However experiments on the absorption of 
therapeutic doses of zinc by normal subjects (to be 
described in a later chapter) will allow comparison of 
normals with these patients with suspected zinc 
deficiency•
The binding of newly absorbed zinc—65 in vivo to 
G^-macroglobulin differs from the results obtained when 
zinc-65 is added to plasma ±n vitro t when only binding 
to albumin could be detected. It would appear, therefore, 
that there is some factor present in the in vivo 
situation which acts as a catalyst for the incorporation 
of zinc into the protein. It is perhaps significant 
that the plasma, obtained from samples of peripheral 
venous blood, has already passed through the liver, 
known to be a site of O^-macroglobulin synthesis 
(Prunier et al, 1964).
The varying ratio with time of zinc bound to albumin 
to zinc bound to C/^-macroglobulin is an indication of 
the more rapid clearance of zinc from albumin, a 
result which is not surprising in view of the much 
w'caker binding of zinc to the protein compared with 
that to the metalloprotein, O^-macroglobulin. This 
rapid clearance, together with the virtually constant 
level of the zinc-65 bound to 0^2-macroglobulin, supports 
the hypothesis that albumin is the primary transport
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protein for absorbed zinc. If this is the case it 
would be expected that the clearance of zinc from 
albumin would be related to the uptake of zinc by 
the organs and tissues. These results are described 
in the following chapter.
5.6 Conclusions
(a) When zinc-65 is absorbed into plasma from an oral 
dose the maximum plasma level occurs after one to two 
hours, declining rapidly during the first 2k hours 
then more slowly over a period of several weeks.
(b) Newly absorbed zinc-65 in plasma binds to both 
the albumin and ^ ’2"rnacr0Sl0^ulin fractions, in contrast 
to zinc added to plasma in vitro where only binding
to albumin could be detected. In normal subjects the 
percentage of the total plasma . zinc-65 level bound to 
the -macroglobulin fraction in samples obtained during 
the first 2 hours after administration of the dose 
was less than half that obtained for the endogenous zinc 
bound to this protein. However after 2k hours the 
percentage of the zinc-65 bound to the protein had 
risen to that of the endogenous zinc.
(c) The amount of zinc bound to ^-macroglobulin was 
found to be fairly constant over the first 2k hours.
The level of zinc bound to albumin decreased much more 
rapidly, having the same shape as the plasma clearance 
curve•
(d) In patients suffering from varicose ulcers who 
were given a dose of 5 M-Ci zinc—65 in a solution
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containing 220 mg zinc sulphate the peak plasma level 
was found to be of the same order as those obtained 
for the normal subjects given only trace amounts of 
zinc. However the percentage of zinc bound to 
0^  ^ -macroglobulin comparable times was found to be
much greater than for the normal controls, and further 
experiments on the absorption of therapeutic doses of 
zinc in normal subjects are necessary to determine 
whether this is caused by absorption of large amounts 
*of zinc or is due to abnormalities in zinc metabolism 
in these patients,
(e) The results of the experiments described above 
suggest that albumin is the primary transport protein 
for newly absorbed zinc. If C^-macroglobulin has a 
role in zinc transport it would appear to release zinc 
only slowly to the tissues.
CHAPTER 6
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CHAPTER 6
RELATIONSHIP BETWEEN THE CLEARANCE OF 
ZINC FROM THE PLASMA PROTEINS AND THE 
UPTAKE AND CLEARANCE BY THE TISSUES
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6.1 Introduction
It has been shown that zinc absorbed from an oral 
dose into plasma is bound to both fractions, albumin 
and Q^-macroglobulin, even in the first hour after 
administration of the zinc. During the first 2k hours 
the amount of zinc bound to O^-macroglobulin remains 
virtually constant, while the albumin level drops 
rapidly. As plasma is the medium which transports 
absorbed zinc to the organs and tissues this would 
suggest that the zinc which is weakly bound to albumin 
is easily removed by the tissues and is therefore the 
primary transport protein for newly absorbed zinc.
A transport protein can be defined as a protein 
which combines with the absorbed substance and carries 
it in combination to the tissues, where it then gives 
up the substance and itself returns to its original, 
form, free to once more act as a transport medium for the 
substance. It therefore follows that, for a true 
transport protein, the half-life of the transported 
substance bound to the protein is much shorter than 
that of the protein itself. If albumin is indeed the 
main zinc transport protein the half-life of the zinc 
bound to albumin will be less than the biological 
half-life of the protein itself. However this 
information cannot be obtained from the oral clearance 
curve alone•
Although oral absorption is the most physiological
104
means of administering the element this advantage 
which absorption via the gastro-intestinal tract gives 
also causes problems in the interpretation of the 
plasma clearance curves. With oral absorption the
clearance curve is complicated by the existence of 
two components, one the clearance of the zinc from 
plasma to the tissues and the other the gradual passage 
of the element through the gastro-intestinal tract into 
plasma. If the form of the intravenous clearance curve 
is known it is possible to compare the half-life of 
albumin-bound zinc with that*of albumin alone. Since 
the plasma clearance curve from an oral dose is the 
product of the two functions, the clearance of zinc 
from plasma to the tissues and the transit function 
for zinc passing through the gastro-intestinal mucosa, 
if the oral and intravenous plasma clearance curves 
are known for the same subject it is possible to 
derive the shape of the transit function.
As zinc is lost from a transport protein a 
corresponding increase in the tissue levels should occur. 
By comparing the uptake of the tissues with the 
clearance from the plasma protein fractions it should 
be possible to gain some insight into the functions of 
the two fractions.
The aims of the work described below were, therefore:-
(a) To study the clearance of an intravenous dose of 
zinc-65 from plasma and to use this and the oral
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clearance curves already obtained to derive the transit 
function for the passage of zinc through the gut wall.
(b) To compare the uptake of the tissues with the 
clearance of zinc from the two protein fractions and 
hence to obtain information about the possible functions 
of the two fractions.
6.2 Plasma Clearance from an Intravenous Tracer Dose 
of Zinc-65
Injection of a single bolus of tracer for the 
measurement of plasma clearance suffers from an 
important disadvantage. After the injection diffusion 
of the bolus occurs until the plasma is uniformly 
labelled with the tracer. However this diffusion 
requires a finite time to reach equilibrium and, with 
substances which are known to be cleared very rapidly 
from plasma, such as zinc, a significant fraction of 
the tracer may have disappeared before equilibrium has 
been reached. A clearance curve containing a significant 
number of samples withdrawn before equilibrium has 
been attained will therefore not be truly representative 
of the physiological disappearance. This difficulty 
can be largely overcome by using intravenous infusion 
of the substance over a period of time, since a uniform 
equilibrium concentration of the substance can then be 
built up in the plasma. When the infusion is stopped 
the clearance from plasma can be measured as usual, 
but since uniform labelling has been achieved, the
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problems associated with instantaneous administration 
are avoided. This method has therefore been used in the 
measurement of the zinc-65 clearance from plasma.
The total dose administered in each case was 0 .kj&Cl 
zinc-65 as the chloride. The radioactive solution was 
autoclaved and added to bottles containing standard 
solutions of sterile isotonic saline. The total stable 
zinc content of the active solution was measured and 
found to be 20 jjmg / 100 ml. A second infusion of 
isotonic saline was used in conjunction with a two-way 
tap to allow blood samples to be withdrawn easily as 
required. Disposable transfusion sets were used to 
connect each reservoir to a polythene cannula inserted 
into the vein. To obtain a constant rate of infusion 
for the radioactive solution a peristaltic pump was 
used to control the rate of flow. The flow rate 
was chosen so that the required volume was administered 
over a period of from one to three hours. The flow rate 
of the non-active saline infusion was controlled 
using the valve of the transfusion set and was kept to 
the minimum level necessary to maintain a steady flow.
Blood samples were withdrawn by stopping the 
infusion, clearing the tap of saline and withdrawing 
10 ml blood samples using a polypropylene syringe 
into disposable plastic vials. These were then 
centrifuged immediately and the plasma removed into 
vials for counting. Samples were taken at intervals
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during the infusion of zinc and for a period of 4 hours 
afterwards.
The samples were counted using a Wallac DEC EM GTL 2,c~ J 
automatic gamma counter. Since the plasma activity was 
very low each sample was counted for one hour'intervals, 
the counts being repeated several times. Known volumes 
of the infusion solution, made up to the same volume as 
the samples, used as standards, and backgrounds were 
counted each time and the stability of the counter 
.settings assessed as described in Chapter 5»
The clearance curves for administration of zinc-65 
were obtained for three subjects, one male (subject K) 
and two female (subjects M and C). In the first two 
cases (subjects M and K) 0.4 jj.Q>i zinc-65 in 100 ml 
solution was infused for a period of one hour at a 
flow rate of 100 ml / hour. In the third case (subject 
C) 0.4 yUCi zinc-65 in 120 ml saline was infused for a 
period of three hours, at a flow rate of 40 ml / hour.
Figs. 28, 29 and 30 show the uptake and clearance
of zinc-65 from plasma for the three subjects, 
expressed as a percentage of the maximum level for 
subjects M and K and as a percentage of the total dose 
administered for subject C. It can be seen that when 
infusion is stopped in each case the zinc-65 level 
drops very rapidly to an almost constant level and 
remains virtually unchanged over a period of several 
hours. The half-lives for the initial disappearance of
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zinc-65 were found to be 18 minutes, 14 minutes and 
18 minutes for subjects M, K and C respectively.
6.3 The Role of Albumin in Zinc Transport.
It has been shown previously that the initial 
rapid clearance of an oral dose of zinc-65 from plasma 
is due almost entirely to loss from the albumin fraction. 
If the oral clearance from plasma is considered as the 
product of the two functions, the transit function 
which describes the passage of the tracer through the 
vails of the gastro-intestinal tract and the intravenous 
plasma clearance, the first of these causes a rise in 
plasma tracer level while the disappearance of the tracer 
from plasma must result solely from the second function. 
Therefore the same conditions for disappearance of the 
tracer can be assumed for both intravenous and oral 
clearance, and it follows that since zinc has been 
shown to be lost mainly from the albumin fraction for 
oral clearance this is also true for the disappearance 
from an intravenous dose. Hence the initial clearance 
from albumin occurs very rapidly, with a half-life of 
less than 20 minutes in the three cases studied.
There are two factors which influence the 
disappearance of albumin itself from plasma. The first 
is the gradual breakdown of the protein with time, that 
is, the actual disappearance of albumin itself from 
the body, and various estimates of its biological 
half-life have been made. These have given values in
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the range 14 - 20 days (Steinfeld, 1960; Cohen et al,
1961 ; Talceda and Reeve, 19^3)* However a more rapid 
clearance from plasma occurs due to the gradual mixing 
of the intravascular protein with that contained in 
the extravascular tissue spaces. While this diffusion 
through vessel walls appears to take place for most 
proteins the rate of diffusion has been studied in 
detail for albumin using iodine-131-labelled albumin.
It has been shown that the half-life for this process 
'is approximately 8 hours (Cohen et al, 1961; Takeda 
and Reeve, 19^3)* However since the half-life of zinc 
bound to albumin is, in its initial clearance, less 
than 20 minutes, this value is much less than either 
the biological half-life of the protein or the half- 
life for mixing of intravascular and extravascular 
protein. It would appear, therefore, that albumin is 
a true transport protein for zinc.
6,4 Comparison of the Intravenous and Oral Clearance 
Curve s
Comparison of the intravenous disappearance curves 
of Figs 28 - 30 with those obtained for the clearance 
of an oral dose of zinc-65, shown in Fig. 18, shows 
that the clearance f± ou< an o ral dose occurs over a much, 
longer time interval than the intravenous disappearance. 
Both curves (oral and intravenous) are made up of a more 
rapidly decaying initial disappearance, followed by 
a much slower decline. However the initial disappearance
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of* the intravenous clearance curve takes place in 
approximately an hour but this stage occupies almost 
2k hours for the oral clearance curve. Because of this 
rapid clearance of the intravenous dose the shape of the 
oral clearance is defined mainly by that of the transfer 
through the gut wall..
When any two of the three functions, the oral 
clearance curve, the intravenous curve and the transit 
function through the gut wall are known the third can 
be derived, since the three functions are related 
mathematically. The oral clearance curve is the 
convolution of the transit function and the intravenous 
curve. Hence 
At time t,
r
c(t) = I g(t-T).f(t) dT 
JO
where
c(t).= oral clearance function 
g(t) = intravenous clearance function 
f(t) = transit function through gut 
In one subject (subject C) both c(t) and g(t) 
have been determined. By using a series expansion 
for c(t) in terms of g(t) and f(t) and a small, chosen 
finite time interval, At, successive values of f(t) 
have been determined using a digital computer. The 
method is described in detail in Appendix VII. The 
method can only give an approximation for f(t), since 
it relies on the choice of finite time intervals and
the form of* the function f(t) depends on the interval 
chosen for the calculation. The results for time 
intervals fat = 0 .125, 0.25 and 0.5 hour are shown in 
Fig. 31 for the derived transit function. All three 
curves are similar in shape to the oral plasma clearance 
curve, with an initial sharp rise to a peak value and 
a slower decline. The oral plasma curve and the 
transit function for^t = 0.125 hour are compared in Fig. 
32. It can be seen that the rapid disappearance of the 
absorbed zinc from plasma has the effect that the sharp 
peak in the gut transfer function is considerably- 
reduced in height in the oral plasma clearance curve.
6.5 Relationship between Plasma Clearance and Tissue 
Uptake of Zinc
Absorbed zinc appears first in plasma, by which it 
is transported throughout the body. Disappearance of 
zinc from plasma must imply either excretion or uptake 
by the tissues. Previous studies have shown that the
major part of the absorbed zinc is retained in the
/
body for long periods and excreted only slowly, the 
whole body half-life being of the order of several 
hundred days (Spencer et al, 19^5 5 Newton and Holmes,
19665 Husain and Bessent, 1971)* Zinc is therefore 
absorbed by the body tissues and retained there for some 
time.
On the whole, uptake by the tissues of a radioactive 
tracer is less easily measured than that for plasma since
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it is impossible to count the area of interest isolated 
from the surrounding tissues. Because of their own 
activity the surrounding areas produce a high 
background count whose exact value cannot be measured, 
and this makes quantitation of the results difficult. 
Exceptions to this are the red cell activity, since the 
cells can be extracted for counting, and the whole body 
count, which is a composite measurement from all the 
tissues and therefore not subject to interference of 
this type. The absorption and clearance of zinc-65 
from erythrocytes, whole body, liver and muscle were 
measured for the two normal subjects given an oral dose 
of 5 zinc-65* Red cell activity was measured using
a Tracerlab "Garamaguard 150" automatic gamma counter.
The cells were washed three times in isotonic saline and 
the washed cells counted for 500 second intervals, for 
a total time of several hours, as described for the 
plasma samples. Red cells were counted from all the 
blood samples, with the exception of a few samples 
taken during the first few hours.
Whole body counts were measured using a shadow 
shield whole body monitor (Warner-Oliver type), using 
two 12.5 cm diameter sodium iodide crystals. Scans of 
1000 seconds were carried out in each case and the 
results compared with a 5yUCi zinc-65 standard each 
time. Counts were made a few hours after administration 
of the dose (to enable the counts equivalent to 100$
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absorption to be measured) and thereafter at intervals 
of several weeks.
Tissue counts were measured using a Selo scanner 
with 12,5 cm diameter sodium iodide crystal. Liver 
counts were carried out with the subject angled in such 
a way that as little as possible of the surrounding 
organs contributed to the count. The position of the 
scanner is shown in Fig.33* At the position chosen only 
a small fraction of the stomach and the upper part of the 
small intestine is seen by the scanner, which is of 
particular importance for counts made in the first few 
hours after administration of the dose. Counts were 
also made of muscle, in areas (thigh and forearm) where 
contribution from adjacent tissues would be minimal.
Liver counts were made as shown in Fig. 33 at a position 
centred 5 cm above the lower costal margin, at a set 
distance from the body. Counts of the thigh were made 
at a point halfway between hip and knee. Counts of 
right forearm were made approximately 8 cm down from 
the elbow. Calculation of the variation of liver 
activity expressed as a percentage of the administered 
dose was carried out using a phantom. The phantom 
consisted of a liver—shaped thin polythene mould filled 
with a 2^ agar solution into which a known amount of 
zinc-63 had been mixed. The liquid agar was poured into 
the mould and allowed to set before use. Agar gel has 
the advantage that it is of a similar consistency to
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tissue and therefore absorption of the activity by 
the oiass of the gel should be of the same order as 
that occurring in the liver. The muscle counts were 
calibrated in an approximate way using a 1 litre 
polythene bottle filled with water and containing ^ 
zinc-65•
The clearance curves for red cells and whole body 
are shown in Figs. 34 and 35 f01, subjects C and. E, 
expressed as a percentage of the total dose administerei 
*in each case. It can be seen that the curves for the 
two subjects are similar in general shape in each case. 
Figs. 36 and 37 show the curves for liver and for muscls 
for subject E. A collimator was used in the earlier 
tissue measurements for subject C, but due to a fault 
the measurements were not sufficiently accurate for 
quantitation. Later measurements were calibrated using
the liver and muscle phantoms. However the shape of
the curves was approximately the same as for subject E, 
with maximum values attained at about the same times in 
each case.
It can be seen that uptake by liver is rapid, with 
a peak in the first 2k hours, followed by a much slower 
decline. The uptake by red cells is slower, with a
maximum after about 10 days and a slow decline
thereafter over a period of several hundred days.
The muscle activity, however, increases only slowly, 
reaching a maximum about 50 days after administration
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of the tracer, long after the maxima in liver, red cell 
and plasma curves. The whole body counts show a gradual 
decline over a period of several hundred days.
6.6 Mathematical Analysis of the Clearance Curves
The curves for uptake and clearance of zinc-65 in 
plasma, red cells, whole body, liver and muscle can be 
analysed into a series of exponential functions using 
an exponential stripping technique, where the final 
points on the curve are used to derive the equation of 
an exponential function using a least squares fit to the 
points. This equation is then used to derive the 
contribution made to earlier values by the exponential 
function and, by subtraction, the points on the next 
exponential function derived. This process can be 
continued to derive a series of exponentials, depending 
on the data available.
( i ) P1 a s m a_ C ury e
This can be analysed into two exponential functions, 
with reasonably good fit.
If the plasma activity, is given by
* a  “ ^ t  a * - k t  / aA , — A « 0 + A « G • • • • ( ! )t o o ' 7
where A and b are constants and the half-life,T-, , 
o y
is given by:-
ln 0.5
b = -- ---
Tjl 
2
Analysis of the curves obtained for subjects C and.
*
In = natural logarithm
(2 )
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E gives values
T 1
t
Ao
1
Tjl
2
c E
0 . 9 2 0 . 5 0 /o dose / 1
1 A 1 . 2
12 A hours
-cfrC\i.o 0 . 18 rfo dose / 1
0 . 0 3 3 0 . 0 4 0
21 17 days
(ii) Red_ Cell_Curve
After the maximum, the clearance curve decays as a 
two exponential function of the form of equation (1). 
The values obtained from the curves for subjects C 
and E were:-
C E
Ao 2 . 6 1 . 2
b 0 . 0 4  1 0 . 0 5 8
Ti
T
17 12
•
A o 0 . 5 0 0 . 2 7
b' 0 .0 0 2 4 0 . 0 0 2 0
Ti
T
286 3^7
(iii) ¥hole] hody__curve
cells
days
cells
In each case the data gives a good fit to a single
exponential, given by the equation
-bt= A . e o (3)
The values obtained were:-
11?
E
36 G]o dose 
0.0021 
•331 days
A 86o
b 0.0022
tJl 316
2
(iv) Liver curve
Accurate results were obtained only for subject E.
The values obtained gave a good fit to a double exponential 
of the form of equation (1).
E
Aq 8.1 fo dose
b 0.091
7.6 days 
5*7 dose
0.006b
108 days
(v) Mu s_cle^curve_s
This can be analysed into two exponential functions,
/
2
an initial gain of zinc-65 activity of the form:-
A; = A^.d - .-*)  (k)
and a single exponential of the form of equation (1)
//
after the maximum. If Tt and T 1 are the half-lives for
T  2
these functions the values obtained for subject E were:-
T,
T
T±
2
Thigh Forearm
15 12 days
198 101 days
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6.7 Calculation of Zinc Content Usin^ the Occupancy 
Principle
The Occupancy Principle, derived by Orr and 
Gillespie from Bergner1s analysis of tracer dynamics 
(Orr and Gillespie, 1968; Bergner, 1964), gives, for 
a steady state system, a relationship between the amount 
of a particular substance in any defined part of the 
system (the capacity), the flow rate of the substance 
through the system, and the occupancy of a tracer for 
the substance administered at the input to the system.
The occupancy, Q , is defined as the total integral
with respect to time, of the tracer fraction f(t) present
in that part of the system at any time, that is:-
Q  = ff(t) dt ............... (5)
aThe Occupancy Principle states that the occupancy, U , 
divided by the capacity, C, is equal to the reciprocal 
of the flow rate, F:-
6  1
—  = —   (6)
C F
Also, since the flow rate is a constant for the 
system the occupancies and capacities for the various 
components of the system are related by the equation:-
©1 0 2  e n
“    (7)• • •
c ,  c 0 c1 2  n
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The body approximates to such a steady state system, 
with a constant intake of essential nutrients and trace 
elements orally from the diet. Hence if the occupancy 
of any chosen part of the system for an orally 
administered tracer for a substance can be measured the 
Occupancy Principle can be used to calculate the total 
stable content of the substance on that part of the 
system, provided either the flow rate or the occupancy 
and capacity of any other part of the system are known.
Both plasma and red blood cells provide conveniently 
accessible components of the system for occupancy 
calculations, as samples can be withdrawn for counting, 
uninfluenced by other parts of the system. Also the 
stable content of the substance of interest can often 
be measured accurately in both plasma and red cells. If 
the occupancy is known for any other defined part of 
the system the capacity can therefore be calculated 
using either the plasma or red cell values.
In the present series of experiments the variation 
of the level of the orally administered tracer dose of 
zinc-65 has been measured for whole body, liver and 
muscle, as well as for plasma and red blood cells.
The variation of the plasma zinc—65 activity with time 
can be described by an equation of the form of equation 
(1). The plasma occupancy is, therefore:-
o
A* -bt\ ,. + A ,e ) dt 
o 7
For subjects C and E, therefore
C E
0  1 = 7.9 x 10“2 4.8 x 10"2 daysplasma J
(for t litre)
Similarly, the variation of red cell zinc-65 activity 
with time is also described by equation (l) and hence th 
red cell occupancy is also given by equation (8), 
together with a small fraction contributed by the area 
under the curve in the first 10 days, which can be 
neglected compared with the other contribution.
The values obtained for the two subjects, C and E were:- 
For 1 litre packed cells
C E
0 RBC 2.7 1.5 days
Since the disappearance of zinc from plasma is 
very rapid and the levels in the samples used for the 
calculation of the second exponential function very near 
background, measurement of any plasma occupancy 1emainin 
after about 50 days is impossible with the counting 
system used. However, with the exception of only the 
first few hours, the zinc-65 activity of the erythrocyxe 
is also greater than that of the plasma and this 
activity is measurable over a period of several hundred 
days. The red cell occupancy can therefore be estimated 
with greater accuracy. Knowing the plasma and red cell
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stable zinc concentrations the equationA 9"  plasma _ RBC
C Cplasma RBC
can be used to predict the plasma occupancy.
Plasma zinc 
Red cell zinc
eRBC
: . d ,plasma
C and E ,
-2 -2
2.7
0 . 172
S / 1 
S / 1 
days 
days
In each case the value for the plasma occupancy is 
smaller than that predicted from the red cell curve.
This suggests that there is a significant part of the 
plasma clearance curve which is below the limits of 
measurement. If the plasma activity at time t = 35 days 
is taken as the first point on a final exponential 
decay then an approximate estimate of the half-life of 
this curve can be made, since the remaining occupancy
^predicted “ Measured = ••••(lO)
This gives values of T-i of 86 days for subject C and 
97 days for subject E, suggesting that there is a 
third slowly decaying component in the plasma zinc—63 
clearance curve with a half-life of approximately 
100 days.
The red cell occupancy and capacity can also be 
used to calculate the whole body and liver capacities
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using equation (?).
The whole body occupancy,
e
For subjects C and E,
, ,  = A / b  .......  (11)whole body o' v 7
c E
390 172 days
2.0 1 . 4 g zinc
Q
^whole body 
•• Cwhole body
The liver occupancy is given by an equation of* the form 
of equation (8). Hence for subject E,
6,.n . = 9.8 daysliver J
and C_. = 0.079 6 zincliver . 0
Using the final values of the zinc-65 liver clearance
curve, which were the only usable data obtained for
subject C, and assuming the same values as subject E for
the half-lives of the two components of the clearance
curve gave an approximate value for the liver
occupancy for subject C
Q , . = 2k•1 daysliver
and C_. = 0.123 g zincliver
6.8 Discussion
The clearance curves obtained on administering an 
intravenous tracer dose of zinc to three normal subjects 
have shown that about 75/^  the absorbed dose 
disappears into tissue very rapidly, the half-life for 
initial disappearance being of the order of 16 minutes. 
These results agree with those obtained by other workers 
(Prasad et al, 1963; Spencer et al, 1965; Sullivan and
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Heaney, 1970), though of these only Prasad and his 
colleagues studied zinc clearance in normal controls*
The rapidity of the initial clearance from plasma means 
that though.as much as 86/0 of an oral dose of zinc-65 
can be absorbed (subject C) there is never more than 
kfo of the dose in the total plasma volume. Using the 
oral and intravenous plasma clearance curves obtained 
at different times for one normal subject the shape of 
the transfer function for zinc through the 
gastro-intestinal wall was determined. This function 
was found to rise rapidly to a peak, then decay more 
slowly, suggesting that while metimum uptake occurs 
almost immediately after administration of the dose zinc 
uptake is not limited to a small section of the gut but 
can occur over a considerable length. While it is 
obviously impossible to locate the exact section of the 
gut involved the rapid rise to a maximum within a short, 
time would suggest uptake from the upper part of the 
small intestine, possibly in the duodenum or even in 
the stomach.
The initial rapid clearance of zinc from plasma is 
paralleled by a similar rise in the zinc-65 activity in 
the liver. In subject E it was found by extrapolation 
of the calculated clearance curve that at maximum 
about 25$ of the absorbed dose was concentrated in the 
liver. After 2k hours the activity starts to decline, 
initially with a half-life of about 8 days. This is
1 2k
accompanied by a rise in the activity of muscle, the rise 
having a half*—life of the same order as the decline in 
the liver. This strongly suggests transfer of zinc 
stored in the liver to the muscle mass. Comparing the 
half-lives for the initial decline in the liver activity 
and the rise in muscle activity with that of the decline 
in activity in plasma during this period it is found 
that all three half-lives are of the same order of 
magnitude, allowing for the considerable experimental 
error which is unavoidable in these results. This 
would suggest equilibrium between liver, plasma and 
muscle during this phase and represents rapid transfer 
of zinc from its initial store in the liver to the muscle 
mass by plasma.
These results agree with the whole body profile 
scan curves of Newton and Holmes for a subject who had 
accidentally absorbed an amount of zinc-65 into the lungs 
(Newton and Holmes, 1966). They showed that there was 
an initial large concentration of zinc-65 in the liver 
region and that this steadily declined during a period 
of about 100 days to the level of the surrounding soft 
tissue. There is agreement also with the post-mortem 
measurements of Spencer and her colleagues (Spencer et 
al, 1965) who showed that the zinc-65 concentration in 
the liver was highest in the first few days after 
administration of the dose, with a gradual decline over 
70 days and that the zinc content of muscle, initially 
much lower than liver, rose to bout the same value as
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in the liver after 70 days.
The existence of a second component in the liver 
clearance curve, with a half-life of the order of 100 days, 
shows that the total zinc-65 absorbed into the liver is 
not transferred in this way. This value for the half- 
life is similar to the decline in muscle activity and 
the final decay in plasma activity predicted from the 
occupancy values, suggesting that the zinc in muscle, 
liver and plasma are in equilibrium at this stage and 
form an exchangeable pool of zinc. Since these 
half-lives are not the same as the whole body values 
this would imply that the zinc is being deposited 
elsewhere in the body, though it is possible that if the 
final measurements in liver and muscle (which are very 
near the limits of measurement•after about 200 days) 
could be continued for longer periods and the final 
exponential calculated more accurately, that values of 
the same order as the whole body half-life would be 
obtained.
In red blood cells the zinc-65 level rose to a peak 
10 days after administration of the dose, falling 
thereafter as a double exponential clearance, the first 
part having a half-life of about 15 days and the second 
part a half-life which in each case is similar to the 
values obtained for the whole body curve (about 300 days), 
suggesting that the greater part of the zinc-65 uptake 
by the erythrocytes is not exchangeable except within
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the red cell pool.
The whole bod}r curves, plotted over a period of about 
400 days, show a steady monoexponential clearance of 
the zinc-65 from the body, with half-lives of 31 6 and 
331 days in the two subjects studied. These values are 
in agreement with those of other workers (Graig and 
Seigel, 1960; Spencer et al, 1965; Newton and Holmes, 
1966) all of whom reported values for whole body half- 
lives of several hundred days.
The rapid transfer of a large part of the zinc-65 
absorbed into plasma to the liver is in agreement with 
the change in the relative concentrations of zinc-65 
bound to the two plasma protein fractions discussed in 
the previous chapter. In the first few hours after 
swallowing the dose, the plasma zinc-65 level is largely 
due to zinc newly absorbed from the gut, but this zinc 
is removed very rapidly, probably to the liver, once in 
plasma. It was found that in the first few hours the 
greater part of the plasma zinc-65 was bound to albumin 
though there was a measurable quantity (about 11$) bound 
to O^-macroglobulin, anci that the level of the albumin- 
bound zinc fell until after 2k hours the equilibrium 
partition obtained for the endogenous zinc had been 
attained for the zinc-65. These findings suggest that 
newly absorbed zinc is bound to albumin and that a 
large proportion of the albumin-bound zinc is removed 
by the liver which then gradually releases a part of the
absorbed zinc firmly bound to cC^-macroglobulin, This 
interpretation is reinforced by the results obtained 
when zinc-65 was added to plasma in vitro, vhen binding 
only to the albumin fraction could be detected. The 
liver is alsp known to be a site of O^-macroglobulin 
production. That the zinc-65 remains associated with 
these two proteins in plasma and does not exist for 
an appreciable period in another form is shown by 
the Occupancy Principle. Rearrangement of equation (7 ) 
Shows that the ratio of the occupancy of any other 
zinc-containing plasma component to that of the total 
plasma zinc is equal to the ratio of their capacities. 
Hence since measurable zinc could only be detected 
in the albumin and O^-macroglobulin fractions the 
capacity of any other component in plasma is very small 
compared with the total plasma value and therefore the 
occupancy is also small.
Calculation of the stable zinc content of the body 
for each of the two normal subjects using the Occupancy 
Principle gave values of 2.0 g and 1.4 g. These results 
give excellent agreement x^ith those of Widdowson, McCance 
and Spray (Widdowson et al, 1961) who measured the
total body zinc content of whole cadavers using 
conventional chemical methods and who found whole body 
zinc values in the range 1,4 — 2.2 g for adults. The 
values calculated for the total zinc content of the 
liver also agree well with the results of these workers.
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The Occupancy Principle, therefore, which to date 
offers the only method for estimating total body zinc 
in vivo, gives results which are very similar to those 
obtained by detailed analytical techniques. Assuming 
that the liver mass is approximately 3% of the total 
body mass the stable zinc values for the liver (0.12 g 
and 0.08 g) are approximately 6/d of the whole body 
zinc levels, suggesting that while there is an initial 
concentration of at least 25^ of the absorbed zinc in 
*the liver there is no long-term concentration of zinc 
by the organ. These results agree with the stable 
zinc values obtained for samples of normal liver by 
activation analysis which show that the stable zinc 
concentration in liver and muscle are similar.
6.9 Conclusions
It has been shown that:-
(a) The greater part of a tracer dose of zinc-65 
administered intravenously to normal controls is cleared 
very rapidly from plasma, with a half-life of less than 
20 minutes. The derived transit function, which 
describes the passage of zinc through the wall of the 
gastro-intestinal tract rises sharply to a peak within 
half an hour after admini stra.tion of the zinc then 
declines more slowly, indicating early absorption of 
zinc through the gut, possibly in the stomach or 
duodenum.
(b) The initial plasma clearance, shown previously to 
be due to loss of zinc from the albumin-bound
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fraction, coincides with uptake of zinc by the liver, 
suggesting that newly absorbed zinc is bound to albumin 
and transported to the liver. There a fraction of the 
zinc is firmly bound to O^-macroglobulin and this 
process continues until equilibrium binding of zinc to 
albumin and to -macroglobulin is achieved.
(c) Comparison of the clearance curves for liver, plasna 
and muscle shows that, in the first 50 days after 
ingestion of the dose the zinc-65 activity in muscle 
rises gradually, the half-lives for the decline in 
liver and plasma zinc-65 activity being similar to that 
of the corresponding increase in muscle, suggesting 
rapid transfer of zinc from liver to muscle by plasma 
during this phase. This is followed by a much slower 
decline in activity in all three compartments, suggesting 
exchange of zinc among them.
(d) Calculation of the amount of zinc contained in 
the body using the Occupancy Principle gave values of
1.4 and 2.0 g for the two normal subjects studied, 
equivalent to an average concentration of 0.028 g / kg 
body weight. The amount of zinc contained in the 
liver was about 6$> of the whole body value.
CHAPTER
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7.1 Introduction and Purpose of the Study
The work described in the previous chapters has 
shown that the endogenous protein-bound zinc in plasma 
is associated with two protein fractions, which have 
been identified as albumin and O^-macroglobulin. ^ 
trace quantity of zinc newly absorbed into plasma from 
the gastro-intestinal tract is bound mainly by albumin 
but this level drops rapidly until after 24 hours the 
equilibrium binding ratio of the endogenous distribution 
has been achieved. Thus albumin is a transport protein 
for zinc. The results given in the last chapter suggest 
that zinc is bound to O^-macroglobulin in the liver and 
the virtually constant level of zinc-65 associated with 
the protein during the first 24 hours after administration 
of the dose indicates that any clearance of zinc from 
the protein to the tissues is much slower than the 
initial clearance of the zinc from albumin. However it 
has been shown that during the phase when transfer of 
zinc from liver to muscle occurs an appreciable 
percentage of the total plasma zinc-65 is bound to 
°^-macroglobulin, an contrast to the first initial 
rapid transfer from plasma to liver, which apparently 
involves only the albumin fraction. It would therefore 
seem that the zinc bound to O^-macroglobulin is in 
some way involved in the gradual transfer of zinc 
stored in the liver to the muscle mass but the precise 
nature of its role in this process is not clear. In
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particular it is not known whether the protein 
actually transports zinc, that is, whether the zinc 
bound to 0^^-macroglobulin is released and incorporated 
into the tissues or whether it is in some way involved 
in control of the transport of the element by albumin.
As discussed in Chapter h it is not possible to 
obtain such information from a study of the endogenous 
distribution of zinc among the plasma proteins, since 
this is a steady state distribution. However it is 
known that after ingestion of 220 mg zinc sulphate the 
plasma zinc level rises in some cases to as much as 
twice the endogenous level and that this level returns 
to the normal value within a few hours (Chapter 5)«
Study of the change in distribution of the zinc between 
the protein fractions should show whether the 
0^,-macroglobulin - bound zinc is significantly increased 
in cases where the plasma zinc level shows a pronounced 
rise and whether the variation in the amount of zinc 
bound to the protein follows the rapid rise and fall of 
the plasma zinc level, without an accompanying change 
in the plasma O^-macroglobulin concentration.
The aim of the work described below was therefore to 
study the variation of total plasma zinc level with 
time after ingestion of a single therapeutic dose of 
zinc sulphate, mainly in normal controls, but also in 
patients with suspected disorders of zinc metabolism, 
and also to study the effect of continued administration
133
of the zinc sulphate over e period of several days on 
the total plasma zinc level, the distribution of zinc 
among the proteins and on the urinary output of zinc.
7.1 Methods
A single gelatine capsule containing 220 mg zinc 
sulphate B.P. was swallowed by six normal volunteers, 
four male and two female, aged between 25 and 35 years, 
none of whom were suffering from any pathological 
condition known to be associated with altered zinc 
metabolism. The capsules were taken approximately 
hours after a light meal (since the subjects all 
took part in the study during a normal working day it 
was not thought advisable for them to take the capsules 
in the fasted state because of the possibility of 
gastric upset). In one case capsules were taken for 
a period of 5 days and after the first capsule, were 
taken immediately after meals. In this case 2k hour 
urine collections were made before and during these 
five days and then at intervals afterwards until the 
urine zinc level had returned to normal. Two patients 
suffering from pustular psoriasis also participated in 
the study.
Blood samples (l0 ml) were obtained from all subjects 
before swallowing the capsules and in most cases at 
intervals of -J, 1-5-* 3 and 6 hours afterwards. Samples
were withdrawn into heparinised plastic containers, 
centrifuged immediately and the plasma removed into
untreated plastic vials. An aliquot (1 ml) was reserved 
for plasma zinc estimation and, in the samples chosen 
for separation, 2 ml was passed through a column of 
Sephadex G100, 18.5 cm x 1.6 cm, using Tris-RCl buffer 
in 0.1M sodium chloride solution as eluant and 
collected in 2.4 ml fractions as described in Appendix XII, 
In the single case studied for several days 20 ml blood 
samples were withdrawn at 1^- hours and after 5 days and 
plasma samples of approximately 6 ml were separated into 
6 ml fractions using a 46 cm x 2.6 cm column of 
Sephadex G200, to enable more detailed analysis of the 
protein distribution to be made. Blood samples were 
taken from the two patients suffering from psoriasis 
before and 2 hours after taking the capsule.
Plasma zinc levels were measured by atomic 
absorption spectrometry, albumin levels by measurement 
of the absorption of light at 5^0 nm by the sample in 
methyl orange reagent and O^-macroglobulin levels by 
single radial diffusion. For both albumin and 
^j-macroglobulin measurements dilutions of the original 
plasma were used as standards in each case and the 
protein level in the plasma samples measured by 
comparison with a reference serum containing a known 
amount of both proteins.
Urine samples were collected in 2.5 1 polythene 
bottles containing thymol. The volume of each 24 
hour collection was measured and the zinc level 
estimated by atomic absorption spectrometry.
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7•3 Variation of Plasma Zinc Level with Time in 
Normal Subjects 
Fig, 38 shows the variation of plasma zinc level 
with time for the normal volunteers studied. It can 
be seen that there is a wide range of variation of zinc 
levels in the six subjects, both initially and at various 
times after ingestion of the capsule. The largest rise 
was found in the two female subjects (C and E), where 
the plasma level rose to approximately double the 
original level after about 1-^ hours. Maximum increases 
in plasma zinc level in the range 0 — 61$ were found in 
the other four male subjects and in the case of subject 0 
no significant increase in zinc level was found in any 
of the samples measured. In subject J the initial plasna 
zinc level was found to be higher than the final value 
six hours later, though there was a significant rise in 
plasma zinc level after 1-f hours. Maximum values were 
usually obtained about hours after administration of 
the capsule, though this value occurred somewhat 
earlier for subject K,
7 ,k Comparison of Distribution of Protein-Bound Zinc 
before and after Ingestion of Zinc 
Fig, 39 compares the distribution of endogenous 
zinc among the plasma proteins (T = 0) with that 
obtained from plasma at the time of maximum increase 
in plasma zinc level (T = hours), separated using 
Sephadex G200. It can be seen that both distributions
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have exactly the same shape, with peaks :in the albumin
and c^-macroglobulin regions, but that both albumin-
and Ov,-macroglobulin-bound zinc levels are increased
when the zinc level is raised. If the area under each
of the peaks is measured in each case the ratios of
zinc bound to albumin to zinc bound to O^-macroglobulin
are 3 *0:1 and 3 *2:1 for the endogenous zinc and for the
zinc absorbed from the capsule respectively, showing an
increase in the zinc bound to both protein fractions to 
*
approximately double the normal level.
Plasma samples (2 ml) taken from each of the normal 
volunteers before swallowing the capsule and 1^ - hours 
after were separated using a column of Sephadex G100.
From measurements of the zinc concentration in each 
fraction and of the albumin and 0^ 2”macro£l°t>ulin 
concentrations of the fractions the total amounts of 
zinc bound to the two proteins were calculated, as 
discussed in Chapter 4. Table 6 compares the percentages 
of zinc bound to albumin and to 0^-macroglobulin for 
plasma samples from the six normal volunteers at time 
T = 0 and T = 1-jr hours. Also included are the values 
obtained from the two patients with psoriasis before 
and two hours after swallowing the zinc capsule, 
separated in the same manner. It can be seen that 
both protein fractions are increased in approximately 
the same proportion in all cases, though there is a 
slightly larger proportion of the zinc bound to albumin
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after two hours in the two patients, J.G. and R.G.
Plasma samples, taken from those subjects where the 
plasma zinc level of the last sample taken had dropped 
to almost the original level, were also separated in 
this way and the results (from subjects C, K, R and j) 
are given in Table 6 . In two subjects (C and j) 
the percentage of the total zinc bound to the Oi^-macro- 
globulin fraction is significantly higher at this time 
but, in the case of subject R, where the plasma zinc 
level had returned to the original value after six hours, 
the same percentage of the total plasma zinc was found 
associated with each of the proteins for the samples 
taken at times T = 0 and 6 hours.
To determine whether the increase in O^-macroglobulin 
bound zinc was accompanied by an increase in the 
concentration of the protein the G^-macroglobulin 
levels were measured for all the plasma samples obtained 
from subjects C and E during the first 5 hours. No 
change in C^-macroglobulin level with time could be 
detected in either case. The O^-macroglobulin levels 
in the plasma samples from all eight subjects were 
measured by radial immunodiffusion. The values obtained 
are given in Table 7* It can be seen that, while the 
results are too few to be statistically significant, 
the O^-macroglobulin levels tend to be higher in those 
whose zinc level showed the greatest increase on 
taking the capsule.
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A plasma sample was obtained from subject C after 
taking throe zinc sulphate capsules daily for five 
days. The sample was taken one hour after swallowing 
the last capsule. The plasma zinc level was found to be
6 ml fractions using a 46 cm x 2.6 cm column of 
Sephadex G200 and the zinc level in each of the fractions 
measured. The distribution was found to be similar in 
shape to both the endogenous zinc distribution and to 
that obtained for the sample taken 1-jr hours after 
swallowing the first capsule of the fifteen, shown in 
Fig. 39* Measurement of the areas under each of the 
peaks gave values for the percentages of the total 
plasma zinc bound to albumin and to O^^-macroglobulin 
of 70$ and 30$ respectively.
A plasma sample was taken 24 hours after swallowing 
the last capsule and the zinc level measured. It was 
found that the value was 106 ytfg / 100 ml, which is
significantly greater than the initial plasma level of
2.4 ml fraction using the small column of G100 and the 
percentage of the total zinc bound to each of the two
134 ^ Ag / 100 ml, a value intermediate to the value 
obtained 1y hours after taking the first capsule and
the initial plasma zinc level
respectively). 6 ml of the sample were separated into
proteins calculated, giving values of 3^$ bound to 
^-macroglobulin and 66$ bound to albumin.
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Fig. hO shows the variation in urine zinc levels 
with time for subject C during the five days of the 
experiment and for several days afterwards. The urine 
zinc level rose during the first day and continued to 
rise in the following period until the urine level 
was about double the initial value. On stopping the 
capsules the zinc level fell gradually to the original 
value after a time of about 11 days from the beginning 
of the experiment.
In the present work the variation of plasma zinc 
level with time after an oral dose of 50 mg zinc 
has been measured for subjects C and E. In both cases 
the response to an oral tracer dose of zinc-65» 
equivalent to approximately 20JU-g zinc has already been 
described. Fig. compares the variation of plasma zinc
and zinc-65 levels with time for the two cases. The 
graphs show that, while both stable and radioactive 
zinc levels reach a peak at between and 2 hours after 
administration of the zinc there is a more rapid 
clearance of the extra stable zinc from plasma, with a 
a return to the original stable level in a few hours.
The curves also show that both stable and radioactive 
zinc are cleared more slowly from plasma in subject S 
thaji in subject C. ^
7*5 Discussion
The graphs of variation of plasma zinc level with 
time after ingestion of a single 220 mg capsule of zinc
1*10
obtained from six normal volunteers show that, in the 
majority of cases, a significant rise in the plasma zinc 
level occurs, with a maximum at between \ and 2 hours 
after taking the capsule and with a rapid decline to 
almost the normal level within a few hours. A rise 
in plasma zinc level to more than double the original 
level was found in two cases, but in one case no 
significant increase in the plasma level over a period 
of 6 hours could be detected. It is therefore evident 
that there is a wide variation in the amount of zinc 
absorbed even in subjects with no known disorders 
associated with altered zinc metabolism. Also, when 
the capsules were given orally three times daily for 
5 days it was found that the plasma zinc level did not 
increase continually during this time. Measurement 
of the plasma level 1 hour after taking a capsule on the 
fifth day gave a zinc level (1 g / 100 ml)
between the initial value obtained before the first
rapid return of the plasma zinc level to almost the 
original level a few hours after swallowing a single 
capsule. If there is a six hour interval on average 
betwreen swallowing the capsules taken three times 
daily the plasma zinc level will have returned to 
almost the oi’iginal level before swallowing the next
capsule was taken and the maximum value obtained 1v hours
after taking the first capsule (9^ and 100 ml
respectively). This result is consistent with the
capsule causes a further rise in the plasma level.
These results agree with those obtained by Hallbddk 
and Lanner (Hallbttdk and Lanner, 1972) who found that 
the plasma level of patients on 220 mg zinc sulphate 
three times daily, measured after overnight fasting 
and before taking a capsule rose only very slowly to 
a maximum level of approxima tely 150^ g  / 100 ml and 
that this rise was significant only in cases \vhere the 
initial plasma zinc was lower than 1 1 0 /  100 ml. 
Abdulla et al (Abdulla et al, 1973)» who obtained a 
similar result, interpreted this finding to mean that 
only small amounts of zinc were absorbed into the body 
during this time. However considerable absorption of 
zinc could have occurred in these cases, since the plas 
zinc would have returned to the equilibrium value after 
taking the capsule at the time when the measurements 
were made•
Administration of a tracer dose of zinc-65 to 
two normal volunteers gave maximum levels in plasma 
of about 2$ of the absorbed dose per litre of plasma, 
calculated from the zinc-65 levels in plasma and whole 
body. If, to give a rough guide, this is taken to be 
the case for the absorption of stable zinc, then an 
increase of 100 yjlg zinc per 100 ml plasma at maximum 
is equivalent to absorption of 50 nig zinc, that is, 
virtually the whole of the administered dose. After 
5 days i.e. 15 capsules the total absorption is
\hz
therefore 750 mg. The total urinary excretion from 
these 15 capsules was calculated to be about 10 mg for 
subject C and assuming that the faecal excretion 
of absorbed zinc is roughly five times the urinary level 
(Husain and Bessent, 1971) this gives a total excretion 
of about 60 mg during this time, an amount equivalent 
to less than 10^ o of the amount absorbed. If it is 
assumed that the tracer and therapeutic absorbed dose 
follow the same metabolic path, this quantity would be 
retained for long periods in the body. Hence, if therapy 
is carried out for several weeks, as is the case for 
patients on oral zinc sulphate supplements for 
conditions such as varicose ulcers the amount of zinc 
deposited in the body could be increased to several 
times the pre-therapy level.
Greaves and Skillen have shown that prolonged zinc 
therapy has no effect on parameters such as haemoglobin 
level, platelet and white cell counts, plasma urea and 
bilirubin concentrations and on serum L.D.H., isoenzyme 
patterns, which have been found to be a sensitive index 
of liver function, and in particular, on the levels of 
the main zinc metalloenzymes in plasma, alkaline 
phosphatase and lactic dehydrogenase, even after four 
months on zinc therapy and though significant increases 
in plasma zinc level were found in 67> of the patients 
studied (Greaves and Skillen, 1970). This lack of 
change in the levels of the zinc metalloenzymes even 
after prolonged absorption of significant amounts
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of zinc suggests that though zinc is retained in the 
body the greater part of it is stored.
It has been shown that, when the pla.sma zinc level 
rises following ingestion of a single dose of zinc 
sulphate, the distribution of zinc among the plasma 
proteins has a similar shape to that obtained for 
endogenous zinc, with two peaks, one coincident with 
O^-macroglobulin and the other with albumin. Measuremen 
of the percentages of the total zinc bound to each 
fraction in the sample having maximum zinc level shows 
that zinc absorbed into plasma is shared between the 
o^-macrog.lobulin and the albumin fractions in the same 
ratio as the endogenous zinc (approximately 1:3)* This 
has been shown to be true for a group of normal subjects 
but in two patients suffering from psoriasis, a conditio 
thought to be associated with disordered zinc metabolism 
there was a slight increase in the proportion of the tot 
plasma zinc bound to albumin in the plasma samples 
obtained 2 hours after swallowing a capsule of zinc 
sulphate. After about 6 hours, when the plasma level 
has dropped to almost the original level the amount of 
zinc bound to both albumin and ^-macroglobulin falls 
again. In some cases a slightly higher concentration of 
zinc is found in the O^-macroglobulin fraction but in 
others the original level is regained and no difference 
could be detected between the distribution patterns for 
zinc for the pre-dose plasma sample and that obtained
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6 hours after taking the capsule. As no change could 1= 
detected in the concentration of 0*2-macroglobulin in 
plasma during this period it can be seen that 
<*2 -macroglobulin acts as a true carrier for zinc, since 
it loses zinc to the body tissues without itself being 
broken down. O^-macroglobulin is therefore a transport 
protein for zinc.
After taking three zinc capsules daily for 5 days
the distribution of zinc among the plasma proteins was 
%
found to be the same as in the earlier samples and the 
proportions bound to the two*proteins were 70$ to 
albumin and 30$ to O^-macroglobulin• A further sample 
obtained on the sixth day, 24 hours after taking the 
final capsule, gave percentages of 66$ bound to albumin 
and 34$ bound to O^-macroglobulin. There is thus a 
gradual slight increase in the proportion of the plasma 
zinc bound to O^-macroglobulin during this period in
this subject but further work is necessary before the
significance of this finding can be assessed.
The results obtained in the work described above 
agree with those obtained from separation of plasma 
samples from patients given an oral dose of 220 mg 
zinc sulphate, together with 5 yuCi zinc-65» described 
in Chapter 5. It was found that, in the plasma samples 
with maximum zinc—65 level, a much higher proportion of 
the plasma zinc-65 activity was associated with the
O^-macroglobulin fraction (about 50$) than that found iar
1^5
plasma samples obtained when a tracer dose of zinc-65
alone was administered, when the value was only 11^ of
the total. Hence loading the plasma with zinc appears
to cause a more rapid rise in the amount of zinc bound
to the O^-macroglobulin fraction. It has been suggested
(Chapter 6 ) that this fraction is connected in some way
with the uptake of zinc by muscle and it is possible
that this increase in the zinc bound to the protein
causes the greater part of the zinc absorbed from 
♦
therapeutic doses to be transported to muscle and stored 
there. In this connection it is of interest that 
evidence has been produced that O^-macroglobulin is one 
of the few plasma proteins to be synthesised by muscle 
(Prunier et al, 1964).
The concentration of O^-niacroglobulin in plasma is 
therefore not an indication of the amount of zinc bound 
to this protein, since this level can vary according to the 
amount of zinc ingested. This finding agrees with the 
results of McBean and his colleagues (McBean et al, 1972) 
who found that patients with suspected zinc deficiency 
had plasma ^ ^-macroglobulin levels which did not differ 
significantly from those of normal controls.
7.6 Conclusions
The experiments described above have shown that:-
(a) Y7hen a single dose of zinc (50 mg) was administered 
orally to six normal subjects and to two patients 
suffering from psoriasis the plasma zinc level rose
1 k6
significantly in all but one case, the increases being
in the range 0 - 110'^  of the original level, but fell
to almost the initial value after approximately six
hours. After taking 150 mg zinc per day for a period of
five days the plasma level showed the same response to
a single dose of zinc, with only an increase of 10x of
the original level found in a plasma sample taken 2h hours
after administration of the last capsule of zinc.
(b) When the distribution of zinc among the plasma 
%
proteins was studied for the plasma samples with 
maximum zinc level it was found that the excess zinc 
was associated with the albumin and Q^-macroglobulin 
fractions, distributed between the fractions in the ratio 
of albumin / O^-macroglobulin zinc of 3^1, the same 
ratio obtained for the endogenous plasma distribution.
When the amount of zinc bound to the two fractions was 
determined for the plasma samples taken six hours 
after swallowing the capsule, the level of the zinc bound 
to O^-macroglobulin kac* fallen, in some cases to the 
level obtained for the initial plasma sample. Since 
no change in the concentration of O^-macroglobulin 
could be found the protein must be capable of binding 
zinc and later releasing it to the tissues without 
itself being destroyed, ^-raacroglobulin is therefore 
a true transport protein for zinc.
CHAPTER 8
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8.1 Review of Results Obtained
Initial studies were carried out on the binding of 
trace amounts of zinc-65 added to plasma in vitro , 
using protein separation by electrophoresis on cellulose 
acetate strips. It was found, both by counting transverse 
sections of the strips and by autoradiography of whole 
strips, that all the zinc-65 was associated with two 
protein fractions, albumin and the O^-globulins. This 
was found to be true for a range of amounts of added zinc, 
from 0.5 - 1000$ of the endogenous plasma level, though 
there was a slightly larger proportion of the added zinc 
associated with the O^-globulins the lower end of the 
range. As this method was only capable of analysing 
small quantities of plasma it was riot suitable for use 
in the major part of the work, on the study of the 
binding pattern of both endogenous zinc in plasma and 
the variation of the binding pattern with time of 
zinc-65 absorbed into plasma from tracer doses 
administered in vivo.
Chromatography on Sephadex cross-linked dextran 
gels was chosen as the most suitable method, one reason 
being that it is particularly suitable for separation 
of the two main proteins thought to bind most of the 
endogenous zinc in plasma, identified by Parisi and 
Vallee as albumin and O^-macroglobulin which are w’cll 
separated using the higher grades of Sephadex gels 
(G100 - G200). It was found that there was no
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significant binding to O^-macroglobulin of zinc-65 
added to plasma in vitro. Zinc-65t added with amounts 
of stable zinc in the range 0.1 ~ 200$ of the endogenous 
plasma zinc level was found almost totally concentrated 
in a peak coincident with the albumin distribution, 
confirming the results of Parisi and Vallee that zinc 
is bound to O^-macroglobulin only in vivo.
When samples of plasma and serum were separated
using a column of Sephadex G200 the distribution of 
*
stable zinc among the protein fractions was found to 
have two distinct peaks coincident with the distributions 
of albumin and O^-macroglobulin. At least 95$ of the 
total plasma level was contained in these fractions, 
with about a quarter of this bound to O^-macroglobulin 
and the other three quarters to albumin. Analysis of 
several plasma samples from six normal volunteers 
gave values for the percentage of the total plasma 
zinc bound to ^-macroglobulin in the range 25 - 32$.
In two samples from patients suffering from psoriasis 
the percentages were slightly higher, 45$ and 48$.
When the binding pattern of zinc-65 in plasma 
samples taken at varying times after administration of 
an oral tracer dose was studied in two normal subjects 
it was found that in the first few hours after 
administration of the dose about 90$ of the zinc—65 in 
Pi asma was bound to albumin. The zinc—65 level bound to 
macroglobulin remained constant over a period of
150
2k hours but the albumin-bound zinc-65 level dropped 
until the ratio of* binding to the two proteins had 
reached the equilibrium value found for the endogenous 
zinc.
Intravenous clearance curves were measured in 
normal controls using tracer doses of zinc-65 and it 
was found that clearance of zinc from plasma was very 
rapid, with about 75^ of the plasma zinc-65 being 
cleared into tissue with a half-life of about 20 minutes. 
When the curves showing the variation of absorbed 
zinc-65 with time for both oral and intravenous 
administration of zinc-65 were compared in one subject 
the shape of the transfer function for zinc crossing the 
gastro-intestinal tract was found to rise to a sharp 
peak within half an hour after administration of the 
zinc and then decline more slowly, showing that 
the major part of the zinc is incorporated in the upper 
part of the gastro-intestinal tract, possibly in the 
stomach or duodenum.
When the uptake and clearance curves from the 
orally administered dose of zinc-65 were measured for 
erythrocytes, whole body, liver and muscle it was found 
that the whole body curves showed a single exponential 
decline with a half-life of about 300 days in the two 
subjects studied. While the zinc-65 activity of the 
liver rose rapidly to a maximum after about 2k hours 
the activity in erythrocyes and in muscle rose more
slowly to a maximum, the erythrocyte peak occurring
about 10 days after administration of the tracer and
that of muscle after about 50 days. Analysis of the
curves as a series of exponential functions showed that,
after the initial 2k hour period, the fall in the
zinc-65 level in plasma occurs at roughly the same rate
as both the fall in activity of the liver and the
corresponding rise in the activity in muscle, a
correlation strongly suggestive of rapid transfer of 
%
zinc from liver to muscle by plasma during this period.
When 50 mg doses of stable zinc were given orally 
to six normal volunteers it was found that the plasma 
zinc rose to a maximum value between \ and 2 hours after 
administration of the zinc in all but one case but that 
this level had fallen again to almost the normal value 
within six hours. In one case, when 150 mg zinc was 
taken for five days, a similar response to a single 
capsule was found on the fifth day as on the first and 
the plasma zinc level, measured 2k hours after the final 
capsule, showed an increase of about 10$ above the initi 
level.
On separation of plasma samples at the maximum zinc 
level using Sephadex gel it was found that the excess 
zinc was bound with a distribution similar to that of 
the endogenous zinc in plasma, with two peaks in the 
°^-macroglobulin and albumin regions. Measurement of 
the percentage of the total plasma zinc bound to each 
protein fraction showed that the zinc is shared between
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them in the same ratio as the endogenous zinc, a rise in 
the amount of zinc bound to ^-raacroglobulin of as much 
as 100^ of the original level, with no accompanying 
change in the concentration of the protein in plasrna.
As the O^-macroglobulin-bound zinc level had dropped 
significantly within a few hours, in some cases back 
to the original level, O^-macroglobulin has the 
properties of a zinc transport protein.
Calculation of the zinc content of the total body 
mass using the Occupancy Principle gave values of 2.0 g 
and 1.4 g zinc, which agree well with the results of 
previous chemical studies using cadavers. Similarly, 
calculation of the total zinc content of the liver gave 
values of 0.12 g and 0.08 g zinc, results which also 
agree very well with those from chemical analyses.
8.2 Relationship between the Zinc-Binding Proteins
While there are apparent differences in the binding 
pattern obtained when zinc-65 is added to plasma or serum 
depending on the method of protein separation used, and 
thought to be due to redistribution of the added zinc 
during electrophoretic separation, separation of these 
samples using Sephadex gel produces a zinc-65 distribution 
in which almost all the activity is concentrated in the 
area of the albumin peak. On the other hand, the 
dd stribution of the endogenous zinc in plasma or serum 
obtained using the same separation technique has two 
peaks, one coincident with that obtained for the
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in vitro zinc-65 distribution and a second peak which 
coincides with that of the Q^-macroglobulin. While 
there is considerable evidence that albumin and 
O^-macroglob.ulin are the two proteins which bind the 
major part of the zinc in plasma the possibility that 
other proteins are also involved which are 
indistinguishable from either of these proteins on 
separation using cross-linked dextran gels does not 
affect the results of the present work. This has been 
concerned with an analysis of the change in the levels 
of zinc bound to the high and low molecular weight 
protein fractions and does not depend on properties of 
either protein, apart from in the identification of their 
position. Again, while it is of interest that the 
distribution obtained on separation of plasma samples 
labelled with zinc-65 in vitro using electrophoresis on 
cellulose acetate resembles the endogenous distribution 
obtained using Sephadex gel rather than that obtained 
when zinc is added to plasma in vitro« these differences 
do not affect the results of later in vivo studies, since 
these have all been carried out using the same method 
of separation using Sephadex gel and the results 
compared accordingly.
The finding that only one fraction binds zinc in vitro 
suggests that newly absorbed zinc is initially bound by 
this fraction since, in the absence of factors present 
in plasma only in vivo, zinc ions added to plasma
15^
in vitro should bind to the proteins in the same way as 
zinc entering from the gastro-intestinal tract. 
Comparisons of the binding obtained using increasing 
amounts of zinc have shown that, on addition of amounts 
equivalent to several times the endogenous plasma zinc 
level, all the extra zinc binds to the same protein 
fraction as trace amounts of zinc. It is therefore 
probable that even large amounts of zinc absorbed from 
orally ingested doses of zinc can be cleared by plasma 
to the tissues.
Clearance curves obtained for tracer doses of 
zinc-65 administered intravenously have shown that, once 
absorbed, the major part of the zinc in plasma is cleared 
very rapidly. However the oral curves are modified by 
the slower process whereby the orally ingested zinc 
crosses the gastro-intestinal tract. This means that 
during the first few hours after swallowing a tracer dose 
of zinc-65 a large proportion of the zinc-65 in plasma 
has just entered the plasma, but that because of the 
rapid clearance there has been a considerable amount of 
the zinc-65 previously removed from plasma into the 
tissues. On separation of plasma samples taken during 
this time it is found that even only an hour after 
swallowing the dose there is appreciable binding to the 
O^-macroglobulin fraction, though the major part of the 
zinc is bound to albumin, suggesting that the zinc 
cleared from plasma is rapidly incorporated into the
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O^-macroglobulin fraction and that the larger amount
bound to albumin is mainly newly absorbed zinc-65. This
interpretation is reinforced by the finding that a
considerable percentage of the newly absorbed zinc is
taken up by the liver, which is known to be capable
of producing the protein. Absorption into the liver
from plasma stops when the ratio of zinc-65 bound to
albumin to that bound to.O^-macroglobulin has reached
the equilibrium value found for the endogenous zinc.
%
8.3 Relationship between O^-macroglobulin and Tissue 
Uptake of Zinc 
For the first 2k hours after administration zinc-65 
is cleared preferentially into the liver and though during 
this time measurable amounts of zinc-65 can be detected 
in muscle there is a gradual increase in activity for 
about 50 days while after 2k hours the zinc-65 activity 
in the liver starts to decline. This increase in muscle 
activity is too great to be provided solely from the 
Pi asma zinc pool, since during this time the average 
total zinc-65 content is only about 0.5$ of the 
administered dose. The liver, on the other hand, 
contains about 16$ of the dose after 2k hours but only 
k% at the time of peak zinc-65 activity in muscle. It 
therefore seems fairly certain that the increase in 
zinc-65 level in muscle is derived largely from the liver. 
Corroborative evidence is provided by the finding that 
the half-lives for the decline in zinc-65 activity of
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liver and plasma are the same as that for the gain in 
activity of muscle during this period.
Uptake of zinc-65 by liver occurs only while the 
percentage of the total plasma zinc-65 bound to albumin 
is greater than the equilibrium value. Uptake by muscle, 
however, is appreciable only when there is measurable 
binding of zinc-65 to the O^-macroglobulin fraction.
This would suggest that Otp-rriacroglobulin-bound zinc is 
particularly important in this transfer.
8.4 Effectiveness of Zinc Therapy
It is apparent that large amounts of zinc can be 
absorbed from therapeutic doses but the rapid clearance 
of absorbed zinc into the tissues makes study of the 
resultant change in plasma level difficult if only stable 
zinc is given. In particular it is not possible to 
study the uptake and clearance by liver and muscle of 
zinc absorbed from therapeutic doses unless zinc-65 is 
administered with the dose. It has been shown that 
relatively large amounts of zinc added to plasma in vitro 
are bound in the same way as trace amounts, suggesting 
that most of this zinc will be transported to the tissues 
in the same way as the much smaller quantities absorbed 
from the diet. However the preliminary studies descnoed 
in the present work have shown some evidence of more 
rapid clearance of zinc from an oral dose, since 
approximately 30$ of the peak zinc-65 level was found in 
plasma 2k hours after oral administration of a tracer
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dose of zinc-65, but onJ.y 10fj of the peak increase in 
stable zinc level was found in plasma 5 hours after 
a therapeutic dose. This more rapid clearance of the 
absorbed zinc is accompanied by a much faster rise in 
the proportion of the total plasma zinc bound to 
C/^-macroglobulin • While if the tracer excretion pattern 
is maintained, very little of the absorbed zinc from 
a therapeutic dose is excreted during the first few' days 
it is not clear at present whether the absorbed zinc is 
used immediately by the tissues or whether it is merely 
stored within the body.
These results are obviously of importance when the 
use of zinc therapy in routine clinical practice is 
considered, particularly in cases where the regime is 
continued for long periods. While the considerable 
number of clinical trials of zinc sulphate therapy 
carried out to date have in the main shown no adverse 
effects on the patients to whom the zinc was administered, 
the present work has highlighted the need for more basic 
information on the uptake and clearance of therapeutic 
zinc by the organs and tissues and of the excretion of 
these amounts both in normal controls and in patients 
suffering from conditions thought to bear some 
relationship to zinc deficiency. These can then be 
compared with the results obtained'from tracer doses of 
zinc and any differences assessed. A study of the levels 
of some of the more readily estimated zinc metalloenzymes
1 5 8
(such as the carbonic anhydrase level in erythrocytes) 
would give valuable information about the utilisation of 
the absorbed zinc*
8*5 Conclu sions
In the introduction to this work the main aims were 
stated as being the study of the distribution of zinc 
among the components of plasma both in the steady state, 
as given by the binding of the endogenous zinc, and as 
a function of time, studied by measuring the variation 
in the binding pattern of zinc-65 in plasma from a tracer 
dose given orally, and to correlate these results with 
the uptake and clearance of zinc by the tissues. It has 
been found that zinc, like many other trace elements, 
possesses a sensitive and sophisticated mechanism for 
its uptake and control in plasma and that one of the 
zinc transport proteins, O^-macroglobulinf is apparently 
specific for the element. Both the transport proteins, 
albumin and O^-macroglobulin, transport zinc to the 
tissues but it seems that the relative levels of zinc 
bound to these two proteins act as a control for the 
destination of the zinc in plasma, excess zinc on albumin 
being deposited in the liver and this zinc then 
transferred tc the muscle tissue. V7hlie these results 
are necessarily of a preliminary nature they suggest fumre 
areas for research into the functions of an element whies: 
is not only essential for the maintenance and repair of 
the body tissues but may also provide benefit in
therapeutic closes 
healing problems.
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1APPENDIX I
PROPERTIES OF ZINC
1.1 Properties of Zinc
1.2 Principal Radioisotopes of Zinc
21.1 Properties of Zinc
Atomic Weight 65.38
Atomic Number 30
Periodic Classification IIB
Electron Distribution 2 - 8 - 1 8 - 2
Density 7.14 g / ml at 20°C
Melting Point 419.5°C
Boiling Point 907°C
Electrode Potential -0.762 V at 25°C
1.2 Principal Radioisotopes of Zinc
There are two radioisotopes of zinc which are 
readily available, zinc-65 and zinc-69m.
Isotope . Type of Half-life Gamma Energy
Decay (MeV)
zinc-65 + 2^5 days 0.51
1 . 1 1
zinc-69m isomeric 13.8 hours 0.44
transition
zinc-69 52 minutes
3APPENDIX II
TECHNIQUES FOR PROTEIN 
SEPARATION USING ELECTROPHORESIS
II. 1 Technique fox Electrophoresis
on Cellulose Acetate Strips
II.2 Technique for
Immunoelectrophoresis
\k
II.1 Technique for Electrophoresis on Cellulose 
Acetate Strips 
Electrophoresis was carried out on 12 cm x 2.5 cm 
cellulose acetate strips (Oxoid, Ltd.) using a 0.05M 
barbitone / sodium barbitone buffer, pH 8.6, containing 
5 ml / 1 of a solution of 0. 1$ thymol in isopropanol as 
antibacterial agent. The buffer was made up using 
double-distilled deionised water. samples were
applied in a uniform line at a position about one third 
of the strip length from the cathode. Separation was 
carried out using a constant current of 0.6 mA / cm 
strip width for one hour and usually of eight 5 
samples per run. After separation the strips were either 
stained using a 0.5$ solution of Ponceau-S in 3$ 
trichloracetic acid and washed in 5$ acetic acid, then 
in water, or, since the staining procedure removed the 
zinc from the strips, prepared for counting in either of 
the following ways:-
(a) The strips were dried and cut longitudinally into 
three sections in the ratio tJ of the total width and 
the outer sections stained using Ponceau-S to locate the 
protein bands. The middle section was cut crosswise 
into 2 mm wide strips, each of which was then counted.
The position of each strip was marked on the stained 
portions to enable its activity to be related to the 
protein fraction concerned.
(b) It was found that a solution of ninhydrin in
5butanol did not remove the zinc-65 activity from 
the fractions as did the staining procedure using 
Ponceau-S and hence this solution could be used to 
locate the protein fractions, which could then be cut 
out and counted. The cellulose acetate strips were 
sprayed with a 0 .05$ solution of ninhydrin in butanol 
using an aerosol spray (British Drug Houses, Ltd.) and 
dried at 100°C to develop the stain. The strips were 
then cut into individual protein fractions through the 
midpoint of the unstained area between the fractions.
The fractions were then counted.
Samples were counted in plastic containers using 
a well counter with a two inch thallium-activated 
sodium iodide crystal at an energy corresponding to 
the major ^ f-peak for the particular isotope. The time 
for which the samples were counted varied according to 
the activity of the samples and was the time required 
for at least 50 counts above background to be obtained.
In practice this was in the range 100 - 800 seconds.
II.2 Technique for Immunoelectrophoresis
Samples were separated using a 0.1M sodium barbitone / 
sodium acetate buffer, pH 8.6, as electrolyte. The agar 
solution was made up using Ionagar No.2 (Oxoid, Ltd.) 
in quarter strength buffer at a concentration of 20 g / 1. 
The agar solution was heated for one hour at 100°C in 
a water bath and then allowed to solidify. The gel 
was kept at 4°C until required, when it was reheated to
660°C before use. A layer of the gel was then poured 
on to eight 10 cm x 2.5 cm glass slides positioned, in 
a holder and the gel allowed to solidify. Two wells 
and one trough were cut in each slide and the gel in 
them removed by suction. 2jjA. samples were placed 
each well and electrophoresis carried out at a constant 
current of 36 mA for 1y - 1ir hours.
The troughs were then filled with the required 
antiserum, either goat antiserum to human serum or 
the appropriate monospecific antiserum (Hyland).
The slides were placed in a diffusion chamber and 
left for 16 hours to allow diffusion of the antiserum. 
They were then washed in isotonic saline for 48 hours 
to remove excess protein then in distilled water for 
2k hours to remove the salt. A fresh layer of liquid 
agar was poured onto the slides and when this had 
solidified the slides were placed in an incubator at 
37°C to allow the gel to dry out. When dry the slides 
were stained using triple protein stain in 2$ 
trichloracetic acid, washed in 2$ acetic acid and 
covered.
III. 1 
III. 2
APPENDIX III
/
METHOD FOR PROTEIN SEPARATION 
USING SEPHADEX GELS
Column Preparation 
Sample Separation
8111.1 Column Preparation
The required quantity of dry gel grains was added 
to a volume of the eluting buffer approximately twice 
the expected volume of the swollen gel. The gel was 
heated in a water bath for at least 5 hours to swell 
the grains and remove the air bubbles. The gel was then 
allowed to cool to room temperature. The column was 
filled about one third full of buffer and the swollen 
gel poured gradually into the column down a glass rod.
The gel was then allowed to pack by allowing the buffer 
to run from the column, fresh gel being added continually 
from the top. When the column was full and no further 
packing observed a volume of buffer at least equal to 
the bed volume of the column was pumped through at the 
the rate of flow used in the protein fractionation 
experiments. Uniformity of packing was checked by 
visual inspection of the gel bed and in some cases by 
passing a sample of Blue Dextran (Pharmacia, Ltd.,
Uppsala) dissolved in buffer through the column. This 
procedure also enabled the void volume of the column to 
be measured.
111.2 Sample Separation
Three grades of Sephadex gel, G75» GiGO and G2G0 
(Pharmacia, Ltd.), were used in the work described. Two 
column sizes, h6 cm x 2.6 cm diameter and 18.5 cm x 1.6 cm 
diameter were used in the experiments (Pharmacia, Ltd.), 
depending on the grade of gel used and the degree of
9separation required. Samples were separated by pumping 
the eluant buffer through the column at a constant flow 
rate using a peristaltic pump (Chromapump, Baird and 
Tatlock, Ltd.). The flow rates normally used were 
1k.h and 21.6 ml / hour. The fractions from the column 
were collected automatically using a Chroinafrac fraction 
collector set to deliver a constant volume. Fraction 
volumes were in the range 2.U - 9 ml, depending in the 
sample volume and the size of column used.
The buffer used in all the experiments was 
Tris(hydroxymethyl)-methylamine - hydrochloric acid,
0.1M, pH 8.0. To ensure a sufficiently high ionic 
strength the buffer was made up in a solution of sodium 
chloride whose concentration was in the range 0.1 - 
1.0M. This ensures that the ionic strength of the 
eluted protein fractions is constant and that possible 
adsorption of proteins onto the gel, which can occur 
at low ionic strength, is minimised.
The sample was applied to the drained gel bed using 
a disposable polypropylene syringe. To ensure 
evenness of application and to remove any precipitate 
some samples were applied to the gel surface using a 
plastic sample applicator faced with fine nylon mesh 
but where the stable zinc content of the fractions 
was to be measured the sample was applied directly on 
the grained gel bed to avoid contamination of the sample. 
The fractions from the column were collected in 10 ml
1 0
disposable plastic vials.
After each sample fractionation a volume of buffer 
at least equal to the bed volume of the column was 
pumped through before re-use and the gel was discarded 
after at most six separations had been performed and 
replaced with unused gel.
IV.
IV.
1 1
APPENDIX IV
ESTIMATION OF TOTAL PROTEIN AND ALBUMIN 
LEVELS USING SPECTROMETRIC METHODS
Measurement of Protein Content 
by Absorption of Light at 280 nm 
Measurement of Albumin Concentration 
in Methyl.Orange Reagent
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A Pye—Unicam SP500 spectrophotometer was used for 
all measurements
IV.1 Measurement of Protein Content by Absorption of 
Light at 280 nm
0.1 ml of the sample to be measured was diluted with 
Tris-HCl buffer in a 1 cm x 1 cm x 5 cm quartz cuvette.
A similar cuvette containing 2.1 ml of the buffer was 
used as a reference. The absorbance of the reference 
solution was adjusted to read zero at a wavelength of 
280 mn and the absorbance of the samples measured as the 
increase in absorbance above this level.
I V .2 Measurement of Albumin Concentration in Methyl 
Orange Reagent 
A stock solution was made up from 1 1 0 .055M 
Citrate buffer, pH 3 • 5 and 0 .16jo methyl orange solution 
in water. Using each solution in the temperature range 
2 k° - 29°C, the methyl orange solution -was added to the 
buffer in 5 ml aliquots and stirred. The spectrometer 
was set to read zero for distilled water and after 
each addition the absorbance of 2.1 ml of the resultant 
solution was compared with that of the same volume of 
water at 5^ +0 nm. When the absorbance of the solution 
was in the range 0.?9 - 0.82 the solution was ready for 
use and was stored at ^°C until required.
The albumin content of the samples was measured by 
adding 0.1 ml of the sample to 2 ml methyl orange / 
buffer solution at approximately 2 J°C in a
TYPICAL EXAMPLES OF ALBUMIN 
STANDARD CURVES
Absorbance = Absorbance of 0.1 ml standard solution 
in 2 ml methyl orange reagent
(i ) Purified human serum albumin dissolved in Tris-HCl 
buffer
Albumin Concentration 
(g / 100 ml)
Absorbance at 
540 nm
o•-3" o. 15
2.0 0.23
1 .0 0.36
0.5 0.48
0.25 0.59
(i i ) Normal plasma diluted using Tris-HCl buffer
Albumin Concentration 
(g / 100 m l )
Absorbance at 
5 4 0 nm
5 .10 0.090
2.55 0.125
1 .02 0.205
0.25 0.470
0.06 0.630
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1 cm x 1 cm x 5 cm quartz cuvette and the absorbance 
measured. Distilled water in a similar cuvette was 
used to define the reference zero point. Standard 
curves were derived using the absorbance of known 
amounts of human albumin (Behringwerke, Ltd.) dissolved 
in Tris-HCl buffer and of serum of known albumin 
concentration diluted with buffer. The two curves 
were found to be slightly different due to the presence 
of other substances with a slight affinity for methyl 
orange and of bilirubin in serum. However it was 
found that both sets of results gave a good fit to 
an exponential curve of the form:-
bxC = Ae where A, b = constants
C = concentration of 
albumin 
x = absorbance at 5^0 nin 
The standard curve was derived using a least 
squares fit to an exponential function and the albumin 
concentration of the sample estimated using the 
calculated values of A and b and the measured value of x.
APPENDIX V
METHOD FOR MEASUREMENT OF PROTEIN 
CONCENTRATION BY RADIAL IMMUNODIFFUSION
V. 1 Preparation of Plates
V.2 Measurement of Protein
Concentration
15
V.1 Preparation of Plates
A stock gel preparation was made up as follows 
2 g lonagar No. 2 was added to 100 ml sodium barbitone / 
hydro chloric acid buffer, pH 8.6, containing 0.1$> 
thiornersal. The solution was heated in a water bath at 
100°C to dissolve the agar and the gel allowed to 
solidify at room temperature and stored in 10 ml 
quantities at 4°C. When required the gel was melted 
and allowed to cool to 50°C. The required quantity of 
antiserum (see Table V below) was warmed in a sterile 
bijou to 48°C in a water bath. 2.5 ml agar solution was 
transferred to the bijou and, after thorough mixing, 
the agar / antiserum mixture was poured onto 5 cm x 5 cm 
glass slides and allowed to solidify at room temparature. 
2 mm diameter wells were then punched out in the gel 
and the agar in the wells removed by suction. The 
optimum spacing of the wells depended on both the 
concentration of the protein in the sample and on the 
the protein concerned. This spacing was determined 
empirically. It was found necessary to dilute serum 
or plasma samples to a quarter of the normal strength 
for measurement of albumin or immunoglobulin-G, though 
undiluted samples could be used for all the other 
proteins. It was not found to be necessary to dilute 
any of the column fractions.
V.2 Measurement of Protein Concentration
The wells were filled with 2 of the sample
1 6
using a.n Oxford Ultramicro-pipetting system and 
disposable plastic tips. Four standards made up of 
dilutions of serum or plasma were included in each plate, 
at concentrations of 100$, 50$> 25$ and 12.5$. The 
absolute value of the protein concentration was found 
when required by including a 1 sample of standard 
serum (Behringwerke, Ltd.) containing known amounts of 
the proteins. The plates were then placed in a moist 
atmosphere at 37°C and diffusion allowed to take place 
for from 16 - 48 hours. After the required time the 
slides were placed in 1$ tannic acid for about 15 minutes 
to make the precipitin rings visible. The diameter of 
the rings was measured using a lens incorporating a 
millimetre scale. From the measured diameters and the 
known concentrations of the standards the equation of the 
standard curve was computed using a least squares fit 
to an exponential function of the diameter of the rings,
i.e an equation of the forra:-
C = where A, b are constants
C = protein concentration 
d = diameter
Using the computed values of A and b and the measured 
values of d the concentration of protein in the samples 
was found.
Table V gives the amounts of antiserum used for 
measurement of the various proteins.
17
TABLE V
Antiserum Amount added to 
2.5 nil agar 
(ml)
Anti-albumin 0.025
Anti-Immunoglobulin-G 0.05
Anti-Haptoglobin 0.10
Anti-O^-macroglobulin 0.05
Anti-Caeruloplasmin 0 . 10
Anti-Transferrin 0.05
Anti-Immunoglobulin-M 0.10
1 8
APPENDIX VI
ESTIMATION OF STABLE ZINC LEVELS USING 
ATOMIC ABSORPTION SPECTROMETRY
19
All measurements were made using a Perkin-Elmer 
atomic absorption spectrometer Model h03 with a Boling 
triple slot burner. The fuel used was acetylene, with 
air as oxidant. A non-luminous acetylene flame was 
used and zinc levels were determined at a wavelength of 
213*8 nm. Instrument adjustments were made according 
to the instruction manual.
All glassware was soaked in 5N nitric acid and
rinsed in deionised double-distilled water before use.
%
A zinc reference standard solution * containing 
1 mg zinc per ml was diluted.with deionised double­
distilled water to give standard solutions containing
0.25, 0.50, 1.00, 2.00, 2.50 J/g zinc / ml. Both
standard and protein sample solutions were diluted one 
in five with 10^ analytical grade Propan- 1-ol. The 
instrument was set to read zero for the Propan-1-ol 
diluent and samples and standard solutions were 
aspirated directly into the spectrometer. A calibration 
curve was then calculated using the standard solutions 
and the zinc content of the samples found using this 
curve•
It was found that the error in the method was 
+. 2j+.g I 100 ml.
All stable zinc measurements were carried out in 
the Department of Biochemistry, Glasgow Royal Infirmary.
* British Drug Houses laboratory reagents products
No. lUOhC
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APPENDIX VII
CALCULATION OF THE TRANSFER FUNCTION FOR 
THE PASSAGE OF ZINC THROUGH THE GUT WALL
2 1
If* the disappearance with time from plasma of a 
bolus of tracer injected intravenously and the uptake 
and clearance by plasma of an amount of the same tracer 
administered orally are known, then it is possible to 
derive the transit function which describes the passage 
of the tracer from the gut into plasma.
If
c(t) = the amount of tracer in plasma at time t 
from an amount given orally at time t = 0 
g(T) = the amount of tracer remaining in plasma at 
time T from unit amount injected at time 
T = 0
f(t) = the fraction of the tracer dose passing
through the gastro-intestinal tract at time t
Of the amount f(t - T).AT absorbed into plasma in 
the short time interval t — T to t - T + AT an amount 
g(t).f(t - t ).&t  remains at time t. Then the amount of 
tracer absorbed into plasma at time t is the sum of 
these amounts.
Therefore as T 0,
f*c (t ) = I g(T).f(t - T)dT
Jo
Since the values but not the equations are known for 
c(t) and g(t) an approximate solution for f(t) can be 
obtained by expanding c(t) in terms of a small finite 
time interval, AT.
22
c ( t) = c(nAt) = g(0).f(nAT).AT + g(AT) . f £ (n-1 ) . &7
+ ... + g(i-1)&T.f^(n-i+1)At J.AT + ..
Hence for n = 1 ,
c(AT) = g(0).f(AT) = f(fcT).&T since g(o) = 1
f(& T) = l/a.T.c(IVr) 
for n = 2,
c (2At) = f(2AT).AT + g(£tT) ,f(at) .At
= f(2At ).At  + g(AT).c(AT)
.#. f(2AT) = 1/AT.c (2AT) - g(AT).cUT)
and similarly for n = 3 ...........
Hence by substituting the known numerical values for 
c(t) . . . .  c(nAT) and g(AT) . . . g(nAT) the values of
f(t) at times T, 2^T . . • n&T can be calculated.
REFERENCES
23
✓
ABDULLA, M. : NORDEN, A. and IIAEGER-ARONSEN, B. ( 1973) 
"Serum levels after oral zinc"
Lancet, i_i, 154 
ALLEN-PRICE y E.D. (i960)
"Uneven distribution of cancer in Vest Devon, 
with particular reference to the divers water 
supplie s"
Lancet, i^, 1235 
BERGNER, P-E.E. (1964)
"Kinetic theory: some aspects on the study of
metabolic processes"
in "Dynamic Clinical Studies with Radioisotopes"
U.S. Atomic Energy Commission
BOYETT, J.D. and SULLIVAN, J.F. (1970)
"Distribution of protein-bound zinc in normal
and cirrhotic serum"
Metabolism, 148
BROWN, M.A.: THOM, J.V.: ORTH, G.L.: COVA, P. and
JUAREZ, J. (1964)
"Food poisoning involving zinc contamination"
Environ. Health, 8 t 657
COHEN, S.: FREEMAN, T. and McFARLANE, A.S. (1961)
"Metabolism of  ^^  ^ I labelled human albumin"
Clin. Sci., 20, l6l
DENNES, E . : TUP P E R, R. and WORMALL, A. (1961 )
"The zinc content of erythrocytes and leucocytes 
of blood from normal and leukaemic subjects"
Biochem. J., 7,8j 578
24
DENNES,
ENGEL, R
FORBES,
FUJIOKA,
FURCHNER
GRAIG, F
GREAVES,
E . : TUPPER, R. and WORMALL, A. (1962)
"Studies on zinc in blood: transport of zinc 
and incorporation of zinc in leucocytes"
Biocheni. J., 82!, 466 
.W.: MILLER, R.F. and PRICE, N.O. (1966)
"Metabolic patterns in preadolescent children:
XIII zinc balance"
"  /in "Zinc Metabolism (ed. A . S. Prasad); Thomas 
(Springfield, Illinois)
l.M. and Y O H E , M. (i960)
"Zinc requirement and balance studies with the 
rat"
J. Nutrition, 70, 53
M. and LIEBERMANN, I. (1964)
"A Zn++ requirement for synthesis of 
deoxyribonucleic acid by rat liver"
J, Biol. Chem., 239« 1164 
, J.E. and RICHMOND, C.R. (1962)
"Effect of dietary zinc on the absorption of 
orally administered zinc-65"
Health Physics, 8, 35
.A. and SIEGEL, E. (i960)
  J . - 6*>'‘Distnoution m  oiood ana excretion 0 1  z.n "
in man"
Proc. Soc. Exptl. Biol. Med., _1_04, 391 
M. and BOYDE, T.R.C. (1967)
"Plasma zinc concentrations in patients with 
psoriasis, other dermatoses and venous leg ulceration 
Lancet, iji, 1019
25
GREAVES, M . W . and SKILLEN , A . 17. ( 1 970 )
"Effects of long-continued ingestion of zinc 
sulphate in patients with venous leg ulceration" 
Lancet, djL, 889 
GREAVES, M.W. ( 19.71)
"Zinc and copper in psoriasis"
Br. J. Derm., £^, 178
GREAVES, M .17. and IVE, F. A. ( 1 972
"Double-blind trial of zinc sulphate in the 
treatment of chronic venous leg ulceration"
Br. J. Derm., 87, 632 
GY OR ICE Y , F. : MIN , K-W. : HUFF , J . A . and GYORKEY, P .
(1967)
"Zinc and magnesium in human prostate gland: 
normal, hyperplastic and neoplastic"
Cancer Research, 2j^ , 13^8
HALLBOOK, T. and LANNER, E. (1972)
"Serum zinc and healing of venous leg ulcers" 
Lancet, Li, 780 
HALSTED, J .A . and SMITH, J.C. (1970)
"Plasma zinc in health and disease"
Lancet, i_i, 322 
HALSTED, J.A.: RONAGHY, H.A. : ABADI, P.: HAGHSHENASS, : 
AMIRHAKEMI, G.H.: BARAKAT, R .M . and RHEINHOLD, J .G . ( 1 972)
"Zinc deficiency in man: the Shiraz experiment1*
Am. J. Med., 2 2 1 277
26
HENZEL, J . H. : DeWEESE, M.S. and LICHTI, E.L. (1970) 
"Significance of post-operative zincuria on 
the availability and requirements during 
tissue repair”
Arch. Surg. , 100, 3^ +9
/
HIMMELHOCH, S.R.: SOBER, H.A.: VALLEE, B.L.:
PETERSON, E.A. and F URWA, K. (1966)
"Spectrographic and chromatographic resolution
of metalloproteins in human serum”
Biochemistry, 2323
/
HOCH, F.L. and VALLEE, B.L. . (1952)
"Extraction of zinc-containing protein from 
human leucocytes”
J . Biol• Chem., 125. 531 
HUSAIN, S.L. (1969)
"Oral zinc sulphate in leg ulcers"
A Lancet, j., 1069 
HUSAIN, S.L. and BESSENT, R.G. (1971)
"Oral zinc sulphate in the treatment of leg 
ulcers"
Proceedings of the International Symposium on 
the Clinical Applications of Zinc Metabolism, 
Cleveland, Ohio (in press)
JOHNSON, N.C. (1961)
"Study of copper and zinc metabolism during 
pregnancy"
Proc, Soc. Exptl. Biol. Med., 108, 518
27
KEILIN, D and MANN, J. (1940)
"Carbonic Anhydrase. Purification and nature
of* the enzyme”
Biochem. J., 1 163
LIEBSCHER, K. and SMITH, H. (1968)
"Essential and nonessential trace elements"
Arch. Environ. Health, 882
McBEAN, L.D.: SMITH, J.: CECIL, B.: BERNARD, H. and
HALSTED, J .A . (1972)
"Serum zinc and alpha-macroglobulin concentration
in patients with various disorders"
*fchpresented at the IX International Congress 
on Nutrition, Mexico 
McCALL, J.T.: MASON, J.V. and DAVIS, G.K. (1961)
"Effect of source and level of dietary protein 
on the toxicity of zinc to the rat"
J. Nutrition, lit. 51 
MANCINI, G.: CARBONAHA, A.O. and HEREMANS, J.F. (1965) 
"Immunochemical quantitation of antigens by 
single radial immunodiffusion"
Immuno chem., 2, 235 
MOLOKHIA, M.M. and PORTNOY, B. (1969)
"Neutron activation analysis of trace elments 
in skin - III, zinc in normal skin"
Br. J. Derm., 8jj_, 759 
MOLOKHIA, M.M. and PORTNOY, B. (1970)
"Neutron activation analysis of trace elements 
in skin - V, copper and zinc in psoriasis"
Br. J. Derm., 376
28
MYERS,
NEWTON,
NIXON,
ORR, J.
OSIS, D
PARISI,
PORIES,
LB. and CHERRY, G. (1970)
"Zinc and the healing of chronic leg ulcers"
Am. J. Surg., 120. 77 
D. and HOLMES, A. (1966)
"A case of accidental inhalation of zinc-65 
and silver-110m"
Radiation Res., £9, 403
; . s .  (1969)
"Trace element content of the hard dental tissues 
and dental plaque"
Caries Res. , J3, 60 
L and GILLESPIE, F.C. (1968)
"Occupancy Principle for radioactive tracers 
in steady state biological systems"
Science, 162. 138
: KRAMER, L.s WIATROWSKI, B.S. and SPENCER, H.
(1972)
"Dietary zinc intake in man"
Am. J. Clin. Nutr., 2 ^ t 582
A.F. and VALLEE, B.L. (1970)
"Isolation of a zinc oC^-macroglobulin from
human serum"
Biochemistry, J?, 2421 
W.J.: HENZEL, J.H.: ROB, C.H. and STRAIN, W.H.
(1967)
"Acceleration of wound healing in man with zinc 
sulphate given by mouth"
Lancet, i., 121
PRASAD, A .S.: HALSTED, J .A . and NADIMI, M . (1961 ) 
"Syndrome of iron deficiency anemia, 
hepatosplenomegaly, hypogonadism, dwarfism 
and geophagia”
Am. J. Med., 2 1 » 532 
PRASAD, A.S.: MIALE, A.: FARID, Z.: SANDSTEAD, H.H.
and SCHULERT, A.R. (1963)
"Zinc metabolism in patients with the syndrome 
of iron deficiency anemia, hepatosplenomegaly, 
dwarfism and hypogonadism”
J. Lab. Clin. Med.,. 61., 537 
PRASAD, A.S. and OBERLEAS, D. (1970)
"Binding of zinc to amino acids and serum 
proteins in vitro"
J. Lab. Clin. Med., J6lj 
PRUNIER, J.H.: BEARN, A.G. and CLEVE, H. (1964)
"Site of formation of the group-specific 
component and certain other serum proteins" 
Proc. Soc. Exptl. Biol. Med.v 115. 1005 
RAULIN, J. (1869)
* 0
"Etudes cliniques sur la vegetation"
✓ *
Ann. Sci. Natl. Botan. Biol. Vegetale, 93
REINHOLD, J .G.: KFOURY, G .A .: GHALAMBOR, M .A . and 
BENNET, J.C. (1966)
"Zinc and copper concentrations in the hair of 
Iranian villagers"
Am. J. Clin. Nutr. , _1_8, 294
SCHLAGE, C. and WORTBERG, B. (1972)
"Zinc in the diet of healthy preschool and 
school children"
Acta Paediat. Scand. , 6j[, 421
3 0
ROMAN, V. (1969)
"Zinc in porphyria"
Am. J. Clin. Nutr., 22, 1290
ROSS, J.F.: EBAUGfl, F.G. and TALBOT, T.R. (1958)
"Radioisotopic studies of zinc metabolism in 
human subjects"
Trans. Ass. Amer. Physicians, II. 322 
SADASIVAN, V . (1951 )
"Studies on the biochemistry of zinc.
1 Effect of feeding zinc on the liver and bones 
of rats."
Biochem. J., 4_8, 527 
SANDSTEAD, H.II. : SHUKRY, A. S.: PRASAD, A. S.: GABR, M.K.:
EL HEFNEY . A. : M0K1-ITAR , N . and DARBY , V . J . ( 1 965 )
"Kwashiorkor in Egypt"
Am. J. Clin. Nutr., ±Z, 15
SAVLOV, E.D.: STRAIN, N.H. and HUEGIN, F. (1962)
"Radiozinc studies in experimental wound 
healing"
J. Surg. Res., 2 , 209 
SCHULTZE, H.E. and HEREMANS, J.F. (1966)
"Molecular Biology of Human Proteins", Vol. 1 
Ch. II.1, p.204 
Elsevier, Amsterdam 
SPENCER, H. : ROSOF.F, B.: FELDSTEIN, A.: COHN, S1H. 
and GUSMANO, E. (1965)
"Metabolism of zinc-65 in man"
Radiation Res., 2^ 4, 432
31
H . : ROSOFF, B.: LEVIN, I. and SAMACH30N, J.
(1966)
"Studies of zinc-65 metabolism in man" 
in "Zinc Metabolism" (ed. A.S. Prasad) Thomas 
(Springfield, Illinois)
H: OSIS, D: KRAMER, L and NORRIS, C. (1972) 
"Studies of zinc metabolism in man"
in "Trace Substances in Environmental Health (v)w
(ed. D.D. Hemphill) University of Missouri Press
(Columbia, Missouri)
STEINFELD, J. (i960)
"Difference in daily albumin synthesis between
1 31 -normal men and women as measured with j l -  
labeled albumin"
J. Lab. Clin. Med., 904
STEWART, A.K. and MAGEE, A.C. (1964)
"Effect of zinc toxicity on calcium, phosphorus 
and magnesium metabolism of young rats"
J. Nutrition, 82, 287 
STOCKS, P. (1960)
"On the relations between atmospheric pollution 
in urban and rural localities and mortality 
from cancer, bronchitis and pneumonia, with 
particular reference to 3:4 benzopyrene, 
beryllium, molybdenum, vanadium and arsenic"
Brit. J. Cancer, J_4, 397
SPENCER,
SPENCER,
3 2
STOCKS,
STRAIN,
STRAIN,
SULLIVAN
SUSO, F.
SUTTON,
TAKEDA,
and DAVIES, R.I. (196k)
"Zinc and copper content of soils associated 
with the incidence of cancer of the stomach 
and other organs"
Brit. J. Cancer, _1_8, 1^
vT. H . : PORIES, W.J. and HINSHAW, J..R, (i960)
"Zinc studies in skin repair"
Surg. Forum, 11, 291 
vT.H. and PORIES, W.J. (1966)
"Zinc levels of hair as tools in zinc metabolism" 
in "Zinc Metabolism" (ed. A.S. Prasad) Thomas 
(Springfield, Illinois)
, J.F. and HEANEY, R.P. (1970)
"Zinc metabolism in alcoholic liver disease"
Am. J. Clin. Nutr., 2J3, 170 
I. and EDWARDS, J.M. (1969)
"Studies on the ability of blood plasma and 
intestinal mucosa to bind zinc"
Fed. Proc. Fed. Am. Socs. Exp. Biol., 28, 761 
tf.R. and NELSON, V.E. (1937)
"Studies on zinc"
Proc. Soc. Exptl. Biol. Med., J^ 6, 211
f. and REEVE, E.B. (1963)
"Studies of the metabolism and distribution of
131albumin with autologous I-albumin in 
healthy men"
J. Lab. Clin. Med., 6_1_, 183
33
TALBOT,
TODD, W.] 
VALLBERG
VALLEE,
VALLEE, 
ROBIN, E
VIKBLADH
\R. and ROSS, J.F. (i960)
"The zinc content of plasma and erythrocytes 
of patients with pernicious anemia, sickle cell 
anemia, polycythemia vera, leukemia and 
neoplastic disease"
Lab. Invest., 17*1
’.: ELVEHJEM, C.A. and HART, E.B. ( 193*0 
"Zinc in the nutrition of the rat"
Amer. J. Physiol., 1071 1*l6 
, L.S.: HOLT, J.M. and CARD, R.T. (1966) 
"Erythrocyte magnesium, copper and zinc in 
malignant diseases affecting the hemopoietic 
system"
Cancer, _1_£» 1^33
I.L. and NEURATH, II. ( 195*0
"Carboxypeptidase, a zinc metalloprotein"
J. Am. Chem. Soc. , .76, $006
t.L.: WACKER, W.E.C: BARTHOLOMAY, A . F . and 
D. (1956)
."Zinc metabolism in hepatic dysfunction"
New Engl. J. Med., j>0, 1077
X. (1951)
"Investigations concerning the binding of zinc, 
in serum"
Scand. J. Clin. Lab. Invest., suppl. 2, 1 et seq.
34
VCORHEES, J.J.: CHAKRABARTI, S.G.: BOTERO, F.:
MIEDLER , I,. and HARRELL , E . R . ( 1 9o9 )
"Zinc therapy and distribution in psoriasis" 
Arch. Derm., 100, 669 
VACKER, W.E.C. and VALLEE, B.L. (1959)
"Nucleic acids and metals"
J. Biol. Chem., 234, 3257 
WIDDOWSON, E.M.: McCANCE, R .A. and SPRAY, C.M. (1951) 
"The chemical composition of the human body" 
Clin. Sci., 10, 113 
WILLIAMS, R.B. and CHESTERS, J.K. (1970)
"The effects of early zinc deficiency on DNA 
and protein synthesis in the rat"
Br. J. Nutr., 24, 1053 
WRENN, H.T. and FEICHTMEIR, T.V. (1956)
"The quantitation of albumin based on its 
dye-binding capacity"
Am. J. Clin. Path., 26., 960
TABLES
35
TABLES 1 - 7
Numbered consecutively as 
mentioned in the text
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TABLE 1
Comparison of* the mean ratios of* albumin— 
to OC^ —globulin—bound zinc—65 on addition of* 
10 and 25y/s zinc / 100 ml plasma, from 
14 sample separations in each case
Amount of* Mean Ratio Standard Probability
zinc added deviation P
(yWg/100 ml) of* mean
10 2.25 O.kl
0.63
25 2.32 0.39
p = probability that the distributions are 
the same, using the Student-t test
37
TABLE 2
Comparison of the mean ratios of albumin- 
to O^-globulin-bound zinc-65 activity, 
obtained on addition of 0.5 10ydg,
100yAg and 1000yUg zinc / 100 ml plasma 
to aliquots of the same plasma sample, 
separated under the same experimental 
conditions and from 12 separations in 
each case
Amount of Mean Ratio Standard Probability
zinc added deviation P
/ 100 ml of mean
0.5 1.31 0.25 -48 x 10
10 1 .88 0.44
10 1 .88 0.44
00 X o
1 ro
100 2.16 0.28
100 2.16 0.28
5 x 10~2
1000 2.43 0.34
10 1 .88 0.44
X o
1 U3
1000 2.43 0.34
p = probability that the distributions of the 
results in the two groups are the same, 
using the Student-t test.
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TABLE 3
Comparison of the mean ratios of albumin- 
to globulin-bound zinc-65 activity 
obtained on addition of 20 ^ g  zinc / 100 ml 
to plasma samples from five normal subjects
Subject 
( Sex)
Number of 
C.A. Strips
Mean Ratio Standard 
Deviation 
of Mean
P
1(M) 6 3.53 0.39
0.44
2 (M) 6 3.31 0.55
3(M) 4 2.96 0.45
0.57
4(m ) 5 3.12 0.33
5(f ) 8 4.04 0.78
0.34
1 (M) 8 4.46 0.92
p = probability that the distributions are 
the same, using the Student-t test.
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TABLE 4
Comparison of the percentages of the . 
total serum zinc level bound to 
O^-macroglobulin and to albumin in 
samples from 6 normal subjects
Subject 
( Sex)
Serum Zinc 
Level 
(Ug/\00 ml)
Protein-bound Zinc (cjc)
^-macroglobulin Albumin
1(M) 80 26 74
2(M) 78 34 66
3(F) 90 37 63
4(m ) 84 46 5^
5(m ) 100 28 72 •
6( m ) 76 19 81
(Separation of 2 ml samples into 2.4 ml 
fractions using a small column of 
Sephadex G75)
40
TABLE 5
Comparison of the percentages of the 
total plasma zinc level bound to 
O^-macroglobulin and to albumin in 
samples from 6 normal subjects
Sub j e c t 
( Sex )
Plasma Zinc 
Level
(/‘&/100 ml)
— ■----------------------------- -j
Protein-bound Zinc (^)
-macro globulin Albumin
C(F) 88 32 68
e (f ) 86 31 69
k (m ) 9 6 26 74
r (m ) 88 ' 31 69
J(M) 124 25 75
D(M) 114 32 68
(Separation of 2 ml samples into 2.4 ml fractions 
using a small column of Sephadex G100)
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TABLE 6
Comparison of the percentage of the total 
plasma zinc bound to albumin in plasma 
samples obtained pre-dose, 1y hours after 
swallowing the zinc sulphate capsule and 
approximately 6 hours after taking the 
capsule
Subject Albumin-bound Zinc ($> total)
pre-do se ly hours 6 hours
C 68 76 53
E 69 73 —
K 74 72' 69
R 69 75 69
J 75 71 49
D 68
pre-dose
63
2 hours
—
J.G. 58 69
R.G. 55 66
Sub je cts C,E,K,R,J and D were normal volunteers, 
J.G and R.G. patients suffering from psoriasis.
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TABLE 7
fj/
^-macroglobulin concentrations in 
Pi asma from 6 normal subjects and 2 patients 
measured using radial immunodiffusion
Sub j e c t ^-raacroglobulin 
Concentration 
(mg / 100 ml)
C 300
E ' 258
K 191
R 145
J 134
D 98
J.G. 278
R.G. 190
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Fig. 1
Variation of* zinc-65 activity, added to plasma 
in vitro t with distance migrated along a cellulose 
acetate strip, measured by counting 2 mm transverse
sections
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Fig. 2
Distributions of* zinc-65 and iodine-131- 
labelled albumin, added in vitro to plasma 
and' separated by electrophoresis on 
cellulose acetate strips.
—  ZIN C -65  
©  — IODINE-131100-
50-
■BikAaAld^SSd
Distance migrated-cm
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Fig. 3
Comparison of a stained cellulose acetate 
strip and an autoradiograph of a similar 
unstained strip from a plasma sample 
containing 20 jjlC± zinc-65 / ml, added 
in v i t r o .
Plasma sample stained using protein 
stain, showing all protein bands.
II
Autoradiograph of similar strip, 
showing zinc-65 associated with only 
the albumin and ^-globulin bands.
k6
Fig. 4
Comparison of the distributions obtained 
vhen 10 yuCi zinc-65 and 5 JLbOi iron-59 
were added to the same 1 ml sample of 
normal plasma.
IRON-59
Distance m igrated -  cm
k7
Fig. 5
Gain of activity with time of non-active 
serum on dialysis of serum samples containing 
trace amounts of zinc-65 and iron-59 against 
serum containing no radioactive material
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Fig. 6
Variation in absorbance at 280 nm among 
the protein fractions, obtained on separation 
of plasma samples of 3 ml, 5 ml and 10 ml 
using a column of Sephadex G200
10 ml
0-6-
5 ml
3 ml
0-4
0-2-
FRACT ION NUMBER
k9
Fig. 7
Protein Content of Serum Fractions Containing 
Maximum macroglobulin and Albumin Concentrations
Separation using electrophoresis on cellulose 
acetate and Immunoelectrophoresis of G200 
column fractions 2 and 3> which contain maximum 
levels of -macroglobulin and 13 and 1^. which
contain maximum levels 
with serum in each cas
Electrophoresis on
of albumin, compared
Serum
13
mmunoelectrophone sis
cellulose acetate
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Fig. 8
Radial ImmunodifFusion Calibration 
Curves
Graphs of* concentration against diameter of* 
the precipitin rings from a range of dilutions 
o f  albumin solutions, measured at times 17> ^ 1 
and 65 hours and showing the least squares 
exponential fits in each case.
100-
1
z
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17 hr 41 hr 65 hrh-
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Fig. 9
Distribution of the serurn proteins among 
the fractions obtained on separation of normal 
serum using a large column of Sephadex G200, 
measured using radial immunodiffusion
Absorbance 
at 280 nm
500
Aib
Ig-G
PROTEIN
CONCENTRATION
mg/100ml
250
Trans
Ig-M
CpI FRACTION NO-
Ig-M - Immunoglobulin—M Hp - Haptoglobin
_ o^-macroglobulin Ig-G - Immunoglobulin-G 
Trans - Transferrin Cpl - Caeruloplasmin
Alb - Albumin
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Fig. 10
Comparison of the sharpness of the albumin 
distributions among the protein fractions 
obtained on separation of plasma samples of 
10 ml, 5 nil and 2.5 ml using a large column 
of Sephadex G200
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m g/m l
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Fig. 11
Distribution of zinc-65 activity among the 
protein fractions, obtained on separation of 
h ml plasma containing a trace amount of zinc-65 
added in vitro, together with a trace quantity 
of iodine-131-labelled albumin, into 6 ml 
fractions using Sephadex G200
100
Zinc-65
ACTIVITY
AS
•/•MAXIMUM
Iodine-131 Ij 
Albumin r
50«
FRACTION NO
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Fig. 12
Distributions of zinc-65 activity among the plasma 
protein fractions from separation of 2.5 nil plasma 
samples containing 50 Mg and 200 wg added zinc / 100 ml
Z IN C -6 5
0  ALBUMIN
50 jig
Activity 
(% max.)
50-
Fraction No.
100
Activity 
(•/» max.)
50-
Fraction No.
(Separation into 3.7 ml fractions using 
a 46 cm x 2.6 cm column of Sephadex G200)
Fig. 13
Distribution of zinc-65 activity among the
0&-globulins obtained after electrophoresis of 
plasma containing added zinc-65 and separated
using-Sephadex G200
100*
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( 7© MAX)
50*
o
, \ A: A-o. o7 V0-0-
V
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EXCLUSION
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Fig. 14
Distributions of endogenous zinc, albumin and 
O^-macroglobulin among the protein fractions 
obtained on separation of 6 ml normal plasma 
into 6 ml fractions using Sephadex G200
15
M9 
Z inc 
per 
100 ml 
Plasma
10-
—  0 —  ZINC
o - -  c^-MACROGLOBULlN 
•  —  ALBUMIN
/V /
©-©
• — •
T “
10
t
15
FRACTION NO.
(The o^-macroglobulin anc* albumin distributions are 
expressed as a fraction of the maximum value, adjusted 
to enable comparison of the distributions with the 
two zinc peaks to be made)
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Fig. 15
Distribution of endogenous zinc among the
serum proteins, together with the in vitro zinc-65
distribution, obtained on separation of
7*5 Nil normal serum into 6 ml fractions
using Sephadex G200
100-
Stable Z inc
MAXIMUM
VALUE
/  \
FRACTION NO.
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Fig. 16
Variation in the absorbance at 280 nm, the 
endogenous zinc level and the albumin level 
among the protein fractions from a 2 ml sample 
of normal serum separated into 2,k ml fractions 
using Sephadex G75
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Fig. 17
Distributions of* endogenous zinc, albumin 
and Of^-macroglobulin among the protein fractions 
from a 2 ml sample of pooled normal serum 
separated into 2.4 ml fractions using 
Sephadex G100
a -Macroglobulin
Albumin
TOTAL
SERUM
LEVEL
FRACTION NO.
6 0
Fig. 18
Oral Plasma Zinc-65 Curve
Variation of plasma zinc-65 level with time 
for subjects C and E after an oral tracer 
dose of zinc-65 chloride
1-5
% DOSE 
PER 
LITRE
10
0-5
TIME - days
Percentage of Dose in 1 litre of 
Plasma Bound to each Protein Fraction
2 hours
Frac tion 
Number
'p Dose 
/ litre
Fraction
Number
■ /o Dose 
/ litre
1 0 . 000 10 0.085
2 0.055 1 1 0.132
3 0.059 12 0 . 186
k 0.026 13 0.216
5 0 . 000 1 4 0 .228,
6 0.01 b 15 0 . 120
7 0 . 0 2 8 16 0.041
8 0.032 17 0.000
9 0.069
25 hours
Fraction
Number
$> Dose 
/ litre
2 - 4 0 . 101
5 - 7 0 . 047
8 - 10 O.O95
1 1 - 1 3 0. 179
14 - 15 0.028
(6 ml fractions in each, case)
6 1
Distribution of plasma zinc-65 among the 
proteins in samples obtained from subject C 
2 hours and 25 hours after ingestion of a 
tracer-dose ^  2 H o u p>s
Fig. 20 25 HOURS
10(H
%
Max.
Value
50‘
m —wr«
y
ysiliiPii
■ - ;
—  £
10 15
F r a c t i o n  No-
V a lu e
50-
100
%
Max.
10 15 
F r a c t io n  No.
Plasma Bound to each Protein Fraction
1.5 hours (6 ml fractions)
Fraction
Number
Dose 
/ litre
Fraction
Number
°jo Dose 
/ litre
1 0 © 0 0 0 10 0.053
2 0.017 1 1 o. 065
3 0.027 12 0.099
4 0.034 13 0.111
5 0. 009 14 0.077
6 0.019 15 0. 048
7 0. 025 16 0.01 1
8 0.032 17 0.000
9 0.033
4.4 hours ( 9 nil fractions)
Fraction
Number
Do se 
/ litre
Fraction
Number
Do se 
/ litre
1 0.032 7 0.077
2 0.051 8 0.098
3 0.010 9 0 . 133
4 0.014 10 0.082
5 0.026 1 1 0.004
6 0.049 12 0.000
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Distribution of* plasma zinc-65 among the 
protein fractions in samples obtained from 
subject E 1.5 hours and 4.4 hours after 
ingestion of a tracer dose
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100-
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Fig. 23
Comparison of the distributions of endogenous 
zinc and plasma zinc-63  ^ hours after an oral 
dose among the protein fractions for subject C
ZINC-65
STABLE ZINC
50*
'©‘
20
Fraction Number
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Fig. 24
Variation of zinc-65 level with time bound 
to plasma, albumin and C^2~macro&-*-°ku lin 
during the first 24 hours after administration 
of an oral dose of zinc-65 to subject C
Plasma
Albumin
a  -  Macroglobulin
DOSE
per
LITRE
0-5 • •
©•
TIME - hours
65
Pig. 25
Variation of zinc-65 level with time bound to 
plasma, albumin and tf^-macroglobulin during 
the first 2k hours after administration of 
an oral dose of zinc-65 to subject E
•  •— » Plasma
Albumin
%  DOSE p ,
per / © ;  
LITRE 1<ZT\
c^-  Macroglobulin
0 4-
s QQ’ o--
T I M E — hours
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Fig. 26
Variation in stable zinc and zinc-65 levels 
in plasma with time after administration of 
an oral dose of 50 mg zinc together with 
5 //£i zinc-65 to patient S.G.
Z i n c -  65
100*
©\' Stable Zinc
% MAX. 
VALUE
50-
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T I M E -  hours
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Fige 27
Variation in stable zinc and zinc-65 levels 
in plasma with time after administration of 
an oral dose of 50 nig zinc together with 
5 yUCi.zinc-65 to patient A.R.
Stable Zinc
100 Z i nc -65
VALUE
\©
TIME - hours
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Variation of plasma zinc-65 level with time on 
intravenous infusion of 0. VCi zinc-65 for 
subjects K and M, expressed as a percentage of 
the maximum level
Fig. 28
Subject K
nfusion stopped
100
%  MAX. 
COUNTS
50*
0-5 2 0
T I M E -  hours
Fig. 29
Subject M
100
Vo MAX. 
COUNTS
100-5 20
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Fig. 30
Variation of plasma zinc-65 level with time on 
intravenous infusion of 0.4 jxCi zinc-65 For 
subject C, expressed as a percentage of the 
total dose administered
Subject C
Infusion
stopped
%  Dose 
per 
l itre
Time -  hours
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Fig. 31
Comparison of the curves obtained 
for the gut transfer function f(t) 
using values of &t of 0.125 hour, 
0.25 hour and 0.5 hour
100
•125 hr 
•250 hr 
•500 hr
as 
%  max. 
value
TIME - hours
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Fig. 32
Comparison of the oral plasma clearance curve 
and the gut transfer function describing the 
variation in the amount of zinc-65 crossing the 
gut wall into plasma, for At - 0.125 hour
5 0
f ( t ) -  Amount entering 
plasma»/
/o Dose 
per 
l i tre Oral plasma curve
2-5
Time -  hours
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Fig. 33
Position of the detector for measurements on 
liver uptake and clearance of zinc-65
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Fig. 3k
Uptake and clearance of zinc-65 by 
erythrocytes after an oral dose of zinc-65 
for subjects C and E, expressed as a percentage 
of the total dose administered
ERYTHROCYTES
3 -
300 
Time — days
200100
7 k
Fig. 35
Whole body clearance curves for subjects C 
and E after an oral dose of zinc-65> expressed 
as a percentage of the administered dose, 
shoving the least squares exponential fit 
to the points in each case
100<
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200 400
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Fig. 36
Uptake and clearance of zinc-65 t»y the 
liver after an oral dose of zinc-63 for 
subject E, expressed as a percentage of the 
total dose administered
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Fig. 37
Uptake and clearance of zinc-65 by muscle 
(thigh and forearm) after an oral dose of 
zinc-65 for subject E, expressed as an 
approximate percentage of the total dose
admini stered
DOSE
Right forearm
200 300100
TIME -  days
Fig. 38a
Variation in plasma zinc level with time after 
an oral dose of 220 mg zinc sulphate in 6 normal 
subjects
200
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T IM E -  hours200* 
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100
hours
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Fig. 38b
Variation in plasma zinc level with time after 
an cral dose of 220 mg zinc sulphate in 
6 normal subjects
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/ 1 0 0  ml
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0
T
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100
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Fig. 39
Comparison of the distributions of the plasma 
zinc among the protein fractions for the 
endogenous zinc and in a plasma sample 
obtained hours after ingestion of a 
220 mg zinc sulphate capsule for subject C
1*5 hours
30* p’asmaPre-dose  o
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| i g / l 0 0  ml 
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20’
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Fig. 40
Variation in urine zinc level with 
time on taking 3 capsules of* zinc 
sulphate daily for 5 days
(subject C)
Urine
Zinc
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0 7
TIME -days
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Fig.
Comparison of the variations in plasma level with 
time after oral administration of a therapeutic 
dose of stable zinc and a tracer dose of zinc-65 
for subjects C and E
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